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 Normal aging is a complex process affecting everyone, and also a major risk 
factor for many complex diseases. Hutchinson Gilford progeria syndrome (HGPS) is 
a rare genetic disease with symptoms of aging at a very early age. There are some 
known and other presumed overlaps between HGPS and normal aging process. My 
goal in this dissertation is to perform computational investigation in both 
transcriptomic and genomic level to uncover potential underpinnings of these two 
models using high throughput genomic data.  
Firstly in order to detect the common and distinct gene expression patterns between 
HGPS and normal aging, which might suggest their potential molecular links, I 
developed a novel approach that leverages co-expressed gene clusters to identify gene 
clusters whose expression co-varies with age and/or HGPS with limited sample size. 
Our results recapitulate previously known processes underlying aging as well as 
suggest numerous unique processes underlying aging and HGPS. Moreover, it is 
  
known that alternative splicing contributes to phenotypic diversity at multiple 
biological scales, and its dysregulation is implicated in both aging and age-associated 
diseases in human. We aim to provide more insight into aging and age related 
diseases by studying splicing regulation. Then secondly we performed the first 
comparative investigation on splicing predictability of genomic and epigenomic 
features using a deep neural network model (DNN). We showed genomic features are 
the primary driver of splicing, and epigenomics is not contributing extra regulatory 
information independent to genomics. In addition, cross-tissue variability in splicing 
further complicates its links to age-associated phenotypes and elucidating these links 
requires a comprehensive map of age-associated splicing changes across multiple 
tissues.  Thus thirdly we generate such a map by analyzing ~8500 RNA-seq samples 
across 48 tissues in 544 individuals. Employing a stringent model controlling for 
multiple confounders, we identify 49,869 tissue-specific age-associated splicing 
events of 7 distinct types. We find that genome-wide splicing profile is a better 
predictor of biological age than the gene and transcript expression profiles, and 
furthermore, age-associated splicing provides an additional independent contribution 
to age-associated complex diseases. In fact in this specific study we presented the first 
systematic investigation of age-associated splicing changes across tissues, and further 
strengthening the links between age-associated splicing and age-associated diseases. 
Besides aging factor, genetic variations also potentially contribute to age-related 
disease shown by GWAS studies. However, potential interactions between aging and 
genomic variations have not been elucidated fully. It is highly likely that phenotypic 
effect of systemic molecular changes through aging may depend on the genotype of 
  
the individual. Lastly we approximate the environmental changes by age-associated 
changes in the levels of regulatory proteins, and exploiting the known mechanisms of 
transcriptional regulation, explore potential causal interaction between genotype and 
aging toward explaining age-related transcriptional and ultimately, age-related 
diseases. We detected numerous interactions across 25 tissues and showed they could 
potentially be associated with hypertension disease. In summary, our investigations in 
this dissertation provided predictive hallmarks along with implied molecular basis 
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1.1 Aging process 
              1.1.1 What is aging? 
   Aging is a longitudinal complex process affecting all human beings, 
during which significant deleterious physiological changes occur correspondingly, 
including wrinkled skin, increased blood pressure, slower metabolism, loss of 
muscle etc. Moreover age could significantly increase the chance to develop age 
related diseases (hypertension, cardiovascular disease, neurodegeneration, heart 
attack and all types of cancers etc) (Finkel et al., 2007; Niccoli and Partridge, 2012; 
Sinclair et al., 2012; Wyss-coray, 2015). Understanding the molecular genetic basis 
of aging process and the mechanisms about age related complex diseases are 
crucial to improve the health care during aging.  
Onsets of Aging in different organs might vary, in other words aging could affect 
different organs at various speeds, which could attribute to tissue-specific gene 
regulation during the aging process. Cassano et al observed significant differential 
age related effect between liver and brain in the rat with respect to the mitochondria 
content (Cassano et al., 2004). In addition, Ismene Karakasilioti and George A. 
Garinis suggested age might have specific effects in adipose tissue due to its unique 
attributes (“fats, oil, lipid peroxidation and inherent propensity”) (Ismene 
Karakasilioti, 2014). Taken together, the tissue-specificity of aging effect could 




1.1.2 Potential mechanisms of aging and age-related diseases 
 Although significant progress has been made in recent years, the underlying 
genetic and molecular basis of aging is still unclear, which is crucial for improving 
the medical health care and increasing lifespan. Two classical theories have been 
proposed to explain aging mechanism: damage theory, which hypothesizes that the 
accumulation of damage in cells causes the failure of the biological systems; 
programmed theory, which assumes an internal program controlling the aging 
process (Jin, 2010).  
For decades, numerous studies have provided insight about hallmarks for aging 
with either computational or experimental evidence. Those hallmarks include 
“genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, 
deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem 
cell exhaustion, and altered intercellular communication” (Blasco et al., 2013). 
Genome instability supports the damage concept, which assumes that accumulation 
of damage could lead to system failure. The genome damage could refer to nuclear 
DNA, mitochondria or nuclear architecture (Blasco et al., 2013). It seems that these 
hallmarks could shed light on the molecular basis of aging process; however, how 
these factors are involved in the aging process in an integrated manner is still a 
mystery. In addition, more in vivo evidence supporting the links between those 




1.1.3 Age-associated gene expression and alternative splicing changes 
 As discussed above, normal aging is a major risk for complex diseases. To 
understand the molecular basis about how aging contributes to those diseases, it is 
necessary to identify age related changes at the molecular level or potential 
predictors for the aging process and complex diseases. Gene expression is one 
crucial measurement reflecting gene function activity since it is supposed to be 
correlated with protein concentration. Alternative splicing, which significantly 
contributes to proteomics diversity, is also an important process in gene regulation. 
Thus age related changes in gene expression and splicing level are expected to 
provide insights about aging process and complex diseases. Previous related studies 
are as follows.  
Age related gene expression changes: de Magalhães et al identified 56 over-
expressed and 17 under-expressed genes which mostly are involved in immune 
response and inflammation process by using a linear regression over 27 microarray 
datasets (de Magalhães et al., 2009); Azad Kumar et al specifically re-assessed age 
related gene expression in different regions of brain tissues using microarray 
datasets, which suggested multiple gene signatures for aging and validated that 
gene RHBDL3 expression is correlated with age by RT-PCR (Kumar et al., 2014); 
Daniel Glass et al proposed a linear mixed model to detect age-associated gene 
across multiple tissues (skin, adipose, blood and brain) using microarray datasets 
from 865 individuals. They specifically detected more age-associated genes (1672) 
in skin tissues than others and showed age-associated changes are more likely to be 




which explicitly controls for potential hidden variables and known confounding 
factors (gender, BMI and genotype) to detect age-associated gene expression using 
RNA-seq data across 9 tissues from GTEx consortium (GTEx Consortium, 2015). 
They identified numerous tissue-specific age-associated genes and suggested those 
genes could be related to complex diseases (Yang et al., 2015).  
Age-associated alternative splicing changes: Tollervey et al detected age-
associated splicing events among normal population using microarray datasets in 
brain tissue and also showed they are present in both frontotemporal lobar 
degeneration (FTLD) and Alzheimer's disease (AD), which suggested a potential 
link between aging and complex diseases (Tollervey et al., 2011b);  Mazin et al 
identified age-associated splicing changes using RNA-seq across 35 individuals 
and in the meantime showed splicing factor expression change could be one 
potential cause for the splicing changes (Mazin et al., 2013a).  
Although age-associated gene expression and splicing changes have been 
investigated, it is still a challenge to capture the causal factors among observed 
correlated predictors, and also the link between those predictors and complex 
diseases is still uncertain. In addition, technically some drawbacks and limitations 
of previous studies (specifically for age-associated splicing studies) need to be dealt 
with: (1) small sample size (2) missed control for confounding factors (3) limitation 




1.2 Age related diseases 
 1.2.1 Hutchinson–Gilford progeria syndrome (HGPS) 
 HGPS (Hutchinson-Gilford progeria syndrome) is an extremely rare (1 of 4 
million live births) genetic disease, caused by one de novo point mutation within 
exon 11 of LMNA gene (Eriksson et al., 2003). Instead of the classical splicing 
site, the point mutation creates a novel splice site, causing the generation of the 
mutated protein – progerin, shown in Fig. 1-1 (Eriksson et al., 2003).  The LMNA 
proteins (LMN A/B) are the major nuclear structure components and also interact 
with various proteins and chromatins (Andrés and González, 2009). The lack of 
LMN proteins unexpectedly causes cell nuclear blebbing of HGPS patients. HGPS 
patients usually have pronounced forehead, short stature, hair loss, a “pinched” 
nose, and extreme lipodystrophy etc (Merideth et al., 2008). What’s more, they 
usually suffer severe organ degeneration and coronary artery disease. Though the 
cause of HGPS – the point mutation has already been discovered, the mechanisms 
linking the point mutation to the symptoms are still not clear. To uncover that, a 
number of hypotheses and studies have been developed and performed, among 
which gene expression model is one. It is proposed that progerin alters the nuclear 
structure and subsequently affects gene expression as well as regulates gene 
expression via interacting with some gene regulator proteins. In other words, 
pathway signals related to the clinical manifestations of HGPS are altered by the 
overexpression of progerin or the lack of LMN proteins. To date, both microarray 
and RNA-seq have been employed to identify differentially expressed genes 




Biological functions like transcription factors, extracellular proteins, and cell cycle 
regulators consistently show up. In addition, due to similar symptoms, HGPS is 
also treated as a reasonable aging model to study with the expectation that the 
mutated protein is also linked to the normal aging process. Progerin was actually 
observed in normal dermal fibroblast cell lines (Rodriguez et al., 2009). However, 
there is still no strong evidence for the link between progerin and normal aging. A 
comparative investigation on pathways between HGPS and normal aging is needed 
to uncover the mystery.  
 
 1.2.2 Hypertension 
 Hypertension is a complex disease, which was clinically characterized as 
having systolic blood pressure persistently higher than 140 mm hg and diastolic 
blood pressure persistently higher than 90 mm hg (Pinto, 2007). Hypertension is 
significantly related to biological age and could also potentially contribute to other 
cardiovascular diseases (Drazner, 2011; Franklin and Wong, 2013; Kokubo, 2014). 
 
 




Investigation on the molecular basis of hypertension pathology could improve the 
prevention and therapy strategies of cardiovascular related diseases.  
Complex diseases could be caused by the interaction between gene regulation and 
environmental factors including diet (Kuneš and Zicha, 2009; Olden et al., 2014; 
Renz et al.). Those hidden confounding factors and variables make the 
investigations more challenging. Differential gene expression is usually an 
important type of predictor for diseases.  Huan et al identified 34 genes associated 
with hypertension across 7017 individuals (Huan et al., 2015).  Basu et al provided 
a tissue-specific map of hypertension related genes across dozens of primary tissues 
using GTEx data (Basu et al., 2017); Chiang et al specifically performed an 
investigation of hypertension related genes in Han Chinese population of Tai Wan 
and they showed those genes could be involved in inflammation, visceral fat 
metabolism and homeostasis (Chiang et al., 2018).  
In addition, hypertension exhibits population bias to some extent (Bosu et al., 
2017). For example, the prevalence of hypertension among Africa Americans is 
significantly higher than that of Caucasian (Fuchs, 2006; Ortega et al., 2015), 
which could be partly attributed to genetic background. GWAS have identified 
~120 SNPs significantly related to elevated blood pressure and hypertension 
(Franceschini et al., 2013; Ortega et al., 2015; Sofer et al., 2017; The UK Biobank 
Cardio-metabolic Traits Consortium Blood Pressure Working Group et al., 2018; 
Wain et al., 2017) , and Basu et al also showed that numerous eQTLs that explain 
the variance of gene expressions are associated with hypertension disease (Basu et 




genome variations is not certain. In addition, as a risky “environment” factor, age is 
significantly related to hypertension, and the interplay between genetic background 
and age factor is uncertain. Comprehensive studies combining regulation and 
association investigation is needed to explore the causalities in complex diseases.  
 
1.3 How genetic information flows in biological system? 
 1.3.1 Central Dogma 
 It is known that inherited genetic information is contained in double strand 
DNA; thus it is crucial to understand how the genetic information flows in the 
biological system, which guides the investigations on gene regulation. What’s more, 
uncovering the disrupted regulation that causes common diseases could provide 
better therapeutic strategies for the diseases. Francis Crick first stated central 
dogma, which assumes the genetic information contained in DNA flows to 
messenger RNA during transcription process in the nucleus, and then mRNA is 
translated to protein in the cytoplasm via translation process (Crick, 1970). Many 
regulatory proteins and complexes are involved in transcription, alternative splicing 
and translation. Disruptions in any of these regulatory processes by mutations, 
environmental factors and their interactions may cause diseases.   
 1.3.2 Tissue-specific transcription and alternative splicing 
Although all eukaryotic cells in an organism have almost identical genomes, 




functions. For example, heart smooth muscle cells could induce heart beatings, 
which cannot be accomplished by skin fibroblast cells. The functional specificities 
are governed by tissue-specific gene regulation, which includes both transcription 
and alternative splicing. 
Transcription is a regulatory process, in which DNA is transcribed to 
mature message RNA (Lee and Young, 2013). The mRNA levels usually referred 
to as gene expression level are correlated with corresponding protein concentrations 
(Li et al., 2014). Thus tissue-specific gene expression should be crucial predictors 
for tissue-specific functions. Tissue-specific regulation could attribute to tissue-
specific regulatory pathway and combinatorial interactions among transcription 
factors (Cheng et al., 2012; Todeschini et al., 2014). In addition, epigenomics also 
plays important roles in tissue-specific regulation (Eccleston et al., 2013). Unlike 
tissue-specific genes, housekeeping genes, which are involved in broad biological 
processes, are expressed ubiquitously across tissues (Eisenberg and Levanon, 2013; 
Kouadjo et al., 2007) .  
Alternative splicing is a regulatory process, in which a gene locus encodes 
multiple transcripts leading to multiple protein isoforms (Chen and Manley, 2010).  
Alternative splicing regulation is also tissue-specific (Barash et al., 2010; Streuli 
and Saito, 1989; Zhang et al., 2008a). Barash et al reported the “splicing code” 
which can predict splicing trends using motifs involved in splicing regulation in a 
tissue-specific manner (Barash et al., 2010). Tissue-specific splicing regulatory 




evidence that epigenomics, which also exhibits tissue-specificity, could also affect 
splicing regulation (Luco et al., 2011; Wang et al., 2017).  
In summary, tissue-specific gene regulation could contribute to cellular 
function variations across tissues, and moreover it complicates the investigation of 
complex diseases. It is crucial to uncover context specific regulation modules to 
solve fundamental problems and improve therapeutic strategies for complex 
diseases.  
 
1.4 Transcription regulation 
 1.4.1 Cis-regulatory elements (enhancers and promoters) for 
transcription 
 Transcription is a regulatory process, during which gene is transcribed to 
mRNA (Lee and Young, 2013).  Numerous regulatory elements mediate the 
transcription process in a tissue-specific manner. Promoters and enhancers are two 
essential cis-regulatory elements. Promoters are usually defined as DNA segments 
extending from the transcription start site of genes, and containing short DNA 
motifs, which could be bound by basal transcription factors. The major 
transcription complex -- RNA polymerase II usually assembles at promoters to 
initiate the transcription process. In addition, another unique feature for promoters 
is TATA-box, which is a DNA region enriched for AT and could be bound by TBP 




1999; Yang et al., 2007). However only a subset of promoter have a TATA-box. 
The activity of promoters is significantly related to transcription level, and 
promoters could be mediation targets for many regulation mechanisms. For 
example, DNA methylation could completely shut down a gene by masking its 
promoter (Maurano et al., 2015; Yin et al., 2017; Zhu et al., 2017). In addition, 
genes could have multiple alternative promoters.  
As another crucial cis-regulatory element for transcription regulation, the definition 
of enhancers is not as clear as that of promoters, however usually they could be any 
DNA segments falling upstream, downstream and within genes, which could 
enhance the activation of genes. Enhancers contain DNA motifs, which could be 
bound by transcription factors. The distance between enhancers and transcription 
start site varies much and it could be up to 1 Mb (Krivega and Dean, 2013; 
Marsman and Hors, 2012). The investigations of enhancer activities confront 
several challenges (Pennacchio et al., 2013): 1) mostly falls within noncoding 
regions which cover ~98% of human genome; the regulatory role of noncoding 
regions is still a big mystery; 2) context-specific transcription variations imply the 
complexity of enhancer activities; 3) difficult to determine the target gene; 4) 
polymorphisms could induce variations to enhancer activities.  
The interaction between enhancer and promoter is a fundamental mechanism to 
enhance transcription, in which distal enhancer could spatially loop over to interact 
with promoters through physical interactions between numerous transcription 




 1.4.2 Transcription factor binding 
 Transcription factors are key regulators of transcription; they could bind to 
both enhancer and promoter regions to mediate transcription (Todeschini et al., 
2014). The short DNA segments bound by transcription factors are named TF 
binding sites.   also contribute to cell and tissue-specific transcription responses 
(Todeschini et al., 2014; Yu et al., 2006). Multiple transcription factors and co-
factor could form a regulatory module complex to enhance transcription 
(Kaufmann et al., 1998; Reiter et al., 2017). Different TFs have a distinct 
preference for the binding sites, which are usually conserved (Dermitzakis and 
Clark, 2002). Disruption of binding sites could cause mis-regulation of 
transcription and diseases (Lee and Young, 2013). Validated transcription factor 
binding sites are extremely limited and investigation of transcription factor binding 
across tissues could help shed light on the underlying context-specific regulatory 
roles of transcription factors. What’s more, robust prediction model could be used 
to estimate the potential transcription response and phenotypic outcome of 
mutations falls within TF binding regions (Lee et al., 2015).  
However, the experimental techniques (such as Chromatin ImmunoPrecipitation) 
are limited and expensive for large-scale studies; dozens of computational 
approaches have been developed to achieve this goal (Bailey et al., 2009; Grant et 
al., 2011; Levy and Hannenhalli, 2002). The most widely used approach is based 
on position weighted matrix (Stormo and Schneider, 1982), which is basically 4×N 
matrices providing the probabilities or likelihoods that respectively 4 types of 




weighted matrices are usually derived from validated transcription factor binding 
sites using experimental techniques (SELEX, PBM, CHIP-Seq, CHIP-CHIP) (Hu 
et al., 2010; Portales-casamar et al., 2010). The power and accuracies may vary 
with different approaches. The two most well-known databases of PWMs for 
human transcription factors are TRANSFAC (commercial) (Wingender et al., 1996) 
and JASPER (open access) (Portales-casamar et al., 2010). 
Most TF binding sites prediction packages (PWM-scan, MEME, FIMO etc) scan 
the query DNA sequence using position weighted matrices to estimate the 
likelihood for a potential TF binding hit. However usually the dependencies 
between neighboring positions (adjacent nucleotides) are not considered (Tomovic 
and Ã, 2007). Relatively ClusterBuster takes into account of the neighboring 
dependencies using HMM model, which could predict a cluster of transcription 
factor binding sites module (Frith et al., 2003). In addition, some methods based on 
supervised learning methods are also developed (Qin and Feng, 2017; Salekin et al., 
2017), which split the validated TF binding sites sequence to k-mers as features to 
train the model and then perform prediction.  
Although consensus information contained in PWM could be powerful for 
predicting putative binding sites, it cannot take into account tissue-specificity, 
which actually could be overcome by using tissue-specific epigenomic features – 
DNase-Seq and ChIP-seq Histone modification data. Combining epigenomic 
features with putative TF binding sites would provide more accurate tissue-specific 




 1.4.3 Epigenomics related to transcription 
 As we know from the central dogma, genetic information is contained in 
DNA sequence, however completely identical nucleotide sequence could not fully 
explain the tissue/cell specific gene expression variations (Jaenisch and Bird, 
2003). “Epigenetics” which refers to any functional heritable chromatin state 
information instead of DNA sequence, could potentially contribute to gene 
regulation and be in charge of the expression variations (Gibney and Nolan, 2010; 
Jaenisch and Bird, 2003). Monozygotic twin studies are playing crucial roles to 
uncover epigenetic effect and suggest that epigenetic features actually involved in 
gene regulation (Bell and Spector, 2011). These epigenetic features could be 
chromatin accessibility state, DNA methylation, Histone modifications (H3K4me1, 
H3K4me3, H3K27ac, H3K36me3, H3K9me1 et al). Ultimately the interplay 
between these functional markers and genetic background will determine the gene 
expression profile.   
Although epigenetic markers’ roles in gene regulation might vary, to target 
transcription factor binding is definitely one of the common mechanisms (Maurano 
et al., 2015; Moore et al., 2012; Zhu et al., 2017). DNA methylation mostly could 
shut down the TF binding in enhancers and promoters regions to inactivate 
transcription (Curradi et al., 2002); Chromatin remodeling process could rearrange 
chromatin accessibility states which then affect the TF binding landscape 
accordingly (Luo and Dean, 1999; Steger and Workman, 1996); multiple histone 
modification markers are observed related to enhancer and promoter activities 




marker for enhancers, H3K4me3 is a marker for promoters, H3K27ac is a marker 
for active enhancers.  
The advent and development of next-generation sequencing technology accelerated 
the investigation of epigenetics by providing more accurate high throughput data. 
ChIP-seq data could provide sensitive histone modification signals, DNase-Seq is a 
powerful tool to estimate the tissue-specific DNA accessibility and Bisulfite-Seq 
could provide high resolution of DNA methylation measurement (Sarda and 
Hannenhalli, 2014). Both ENCODE and Roadmap provides numerous tissue or 
cell-specific epigenetic high throughput data (Roadmap Epigenomics Consortium 
et al., 2015; The ENCODE Project Consortium, 2012), which significantly 
promoted human genetic studies.  
 1.4.4 Expression quantitative trait loci study (eQTL) 
 Individual specific gene expression variations are observed in the large 
population, partly determined by genome variability (Zhang et al., 2008b). 
Expression quantitative trait loci (eQTL) study is the standard approach to detect 
gene expression associated genome polymorphisms -- more specifically, single 
nucleotide polymorphism (SNP) (Gilad et al., 2008). Gene expression associated 
SNPs detected in eQTL studies are also called eSNPs. The distance between eSNPs 
and their potential target gene transcription start site could vary a lot, usually the 
eQTLs are divided to cis-eQTLs (similar locations) and trans-eQTL (different 
locations and chromosome) dependent on the locations (Gilad et al., 2008). eQTL 




specific effect. cis-eQTL mostly are more consistent across tissues relative to trans 
eQTLs which show strong tissue-specificity (Westra and Franke, 2014). The 
detection power is sensitive to the population sample size. In addition, although the 
individual effect of single SNP is usually small, the accumulation of those effects 
could significantly affect gene regulation (Petretto et al., 2006).   
Numerous computational approaches have been developed to detect eSNPs in a 
tissue-specific manner, and the basic well known approach is to measure the 
association between any SNP within a certain distance and the target gene 
expression in a linear model (Rantalainen et al., 2015). Some hidden variables 
could be derived over gene expression profile using packages like PEER, SVA and 
even PCA to control for the hidden confounding factors in the population, which 
could significantly increase the detection power and accuracy (Leek et al., 2012; 
Stegle et al., 2012).  One of the challenges in eQTL study is linkage disequilibrium 
regions, where SNPs are correlated with each other and it make the differentiation 
of real causal polymorphisms difficult (Gilad et al., 2008; Westra and Franke, 
2014).  
GTEx is a publicly funded effort to gather large-scale genotype and gene 
expression data in human primary tissues. Currently, it has data for ~52 tissues with 
transcriptome expression, imputed SNPs and phenotype information. This is meant 
to support tissue-specific gene regulation investigations and provide more insights 
into the underlying molecular basis of expression variations (GTEx Consortium, 
2015). Along with the raw data, tissues-specific eQTL results are also provided, 




efficient approach for eQTL analysis. GTEx consortium provided a comprehensive 
reference of eSNPs and potential corresponding targets genes across 46 tissues.  
eQTL studies are expected to provide  molecular insight into the mechanism, by 
measuring the associations between SNPs and gene expression. One potential 
mechanism is that SNP could fall within enhancers and promoters to disrupt a 
transcription factor binding site or create a cryptic do novo TF binding site (Shi et 
al., 2016).  Since many eSNPs fall within non-coding regions, eQTL studies might 
be able to provide an understanding of the regulatory role of non-coding regions in 
the genome. In order to detect potential functional and causal SNPs, a better idea is 
to employ more biological insight into the model instead of only increasing the 
detection power by adopted more advanced statistical techniques. Based on the 
assumption that SNPs can fall within regulatory regions, transcription related 
epigenetic markers could be used to imply the regulatory potential of the SNPs 
(Acharya et al., 2017; Das et al., 2015). Das et al developed a Bayesian model to 
detect causal SNPs by employing epigenetic markers information (Das et al., 
2015).  
1.4.5 Genome Wide Association Study (GWAS) 
 Whole Genome Association Study is an approach to measure the 
association between genome variations and phenotypic traits (Bush and Moore, 
2012; Visscher et al., 2017). In GWAS, the genome variations are usually single 
nucleotide polymorphisms which could be identified by performing whole genome 




sequencing reference datasets like 1000 genome (Li et al., 2009). The phenotypes 
could be any traits like height, body mass index (BMI) or any clinical outcomes 
(blood pressure, diseases etc.). Basically GWAS measured whether some SNP 
alleles are observed significantly more frequently in the disease group than the 
control group (Bush and Moore, 2012; Visscher et al., 2017). Large population 
sample size is needed to perform an accurate analysis. In addition, similar to eQTL 
studies, potential confounding factors need to be dealt with to improve the 
detection power (Leek et al., 2012; Stegle et al., 2012).   
The first GWAS was performed in 2005 by Haines et al to explore Age related 
Macular degeneration associated SNPs (Haines et al., 2005). Colorectal cancer is 
another significant genetic diseases and multiple groups have already identified 
associated common SNPs using GWAS (Broderick et al., 2007; Cogent Study, 
2008; Tomlinson et al.; Wang et al., 2014a). In addition, blood pressure is a trait 
related to hypertension disease and persistent high blood pressure could potentially 
induce cardiovascular disease. About 120 SNPs have been identified to be related 
to elevated blood pressure (Ehret and Teresa Ferreira et al, 2016; Human et al., 
2016; Kato et al., 2015; The UK Biobank Cardio-metabolic Traits Consortium 
Blood Pressure Working Group et al., 2018).  At this point, hundreds of GWAS 
have been published with thousands of associated genomic loci (Fong et al., 2018; 
Macarthur et al., 2017). However it is still challenge to apply the results to improve 
therapeutic strategies with the actual mechanisms are largely unknown. But GWAS 




phenotypic outcome for predicted functional SNP candidates. It is expected GWAS 
and eQTLs could be aligned to imply more causal SNPs and potential mechanisms.    
1.4.6 Interactions between germline mutation and envirmental factors  
 In general genome variations have been shown related to complex genetic 
diseases, for example ~120 SNPs are associated with hypertension diseases and 
blood pressure (Adeyemo et al., 2009; Wain et al., 2017). In addition, those 
complex diseases are most significantly associated with age – a critical risk factor 
(Niccoli and Partridge, 2012; Sinclair et al., 2012). It is expected that the interplay 
between variations and age factor could also play essential roles in the molecular 
basis (Kuneš and Zicha, 2009). Interactions should be observed through age 
dependent effect for SNPs.  
Multiple previous studies have incorporated SNP-age interaction terms in eQTL 
model to measure the association between the interaction and target gene 
expression; Smino et al detected ~9 SNPs which have age dependent effect in 
blood pressure using a meta-analysis approach (Simino et al., 2014). Dongen et al 
showed the interaction between genetics and age factor could be associated with 
methylome in whole blood (Dongen et al., 2016).  However, the molecular basis of 
how they interact with each other is not clear. Also, simply identifying a statistical 
interaction between Age and SNPs is not sufficient to provide insight into the 
interaction mechanism. Specific mechanism hypothesis based on a reasonable 




1.5 Alternative splicing regulation 
 1.5.1 What is alternative splicing? 
 Alternative splicing is a regulatory process during which multiple isoforms 
are produced (Black, 2003). It was first reported by Berget et al (Berget et al., 1977) 
in the adenovirus model in 1977.  Actually alternative splicing is prevalent in 
eukaryotic cells and almost 90% genes with multiple exons undergo alternative 
splicing (Wang et al., 2008). It is evident that alternative splicing significantly 
contributes to proteomics complexity and diversity across cell types and species. In 
general, there are seven different types of alternative splicing event as Fig. 4-1B 
shows.  The exon skipping event is the most prevalent and the best studied one. 
1.5.2 Cis-regulatory elements for splicing 
 Alternative splicing is carried out by Spliceosome complex following RNA 
Polymerase II. Spliceosome complex is composed of five ribonucleo protein U1, 
U2, U4, U5, U6 and many auxiliary proteins (Black, 2003; Wang and Burge, 2008; 
Will and Lührmann, 2011). The spliceosome crucially regulates alternative splicing 
by recognizing splicing sites and defining exon/intron boundaries (Black, 2003; 
Wang and Burge, 2008; Will and Lührmann, 2011). The splicing sites include 
donor sites and acceptor sites, which refer to the 5’ and 3’ ends of introns 
respectively. ~95% of donor sites and acceptor sites are “GT” and “AG” 
respectively in the human genome (Black, 2003; Mount, 2000). The strength of 




other words stronger splicing sites are more likely to be detected by the 
spliceosome.   
Auxiliary proteins (SR protein or hnRNPs) could bind to splicing cis-regulation 
elements (splicing enhancers and silencers) to enhance or inhibit the recognition of 
splicing sites by Spliceosome (Black, 2003; Chen and Manley, 2010). Alternative 
usage of splicing sites leads to diverse transcriptome. The mechanisms for splicing 
factors and cis-regulatory elements could vary dependent on involved regulatory 
protein and the genomic context, for example PTBP1 is a known splicing repressor 
and it could repress the inclusion of Pbx1 exon7 in neuron cells (Linares et al., 
2015). In addition, SRSF1 could enhance the inclusion of DBF4B exon 6 in colon 
cancer cells (Chen et al., 2017b). Usually the splicing enhancer and silencer are 
divided into four categories based on their locations and function: ESE (exonic 
splicing enhancer), ESS (exonis splicing silencer), ISE (intronic splicing enhancer), 
ISS (intronic splicing silencer). Barash et al suggested a splicing code which could 
accurately predict relative exon inclusion in a cell type using numerous genomics 
features (Barash et al., 2010). What’s more, a branch site, which usually resides 
upstream from the acceptor site, is also crucial for the splicing cutoff since it could 
be bound by U2 to form the catalytic center (Black, 2003). Nonsense-mediated 
mRNA decay (NMD) is another significant mechanism affecting alternative 
splicing level, which could be induced by premature termination codons within the 




1.5.3 Splicing Factor binding 
 Although it is known that Splicing regulatory proteins play essential roles in 
splicing regulation, the mechanisms are far from certain. Searching for splicing 
sites and splicing factor binding sites are important to uncover the mechanisms. As 
for splicing site prediction, the most widely used approach is based on consensus 
sequence comparisons, one of which is Chris Burge’s MaxEntScan tool which 
accepts an adjacent sequence and reports strength scores for the potential splicing 
site candidates (Yeo and Burge, 2004). There are also some other tools based on 
machine learning model trained over benchmarked k-mer datasets (Dogan et al., 
2007). In addition, conservation could be another hallmark of splicing sites, 
Prichard’s group filtered out noisy splicing junctions based on conservation score 
of splicing sites (Pickrell et al., 2010).  
For splicing factor binding sites, specific experiments have been developed: cross-
linking immunoprecipitation (CLIP) is one approach to detect protein-RNA 
interactions by using both UV cross-linking and immunoprecipitation (Jensen and 
Darnell, 2015). CLIP-seq which combined CLIP experiment and high throughput 
techniques could promise genome wide sensitive and accurate protein-RNA 
interaction signals (Stork and Zheng, 2017). There are also some other varied CLIP 
based approaches (PAR-CLIP, iCLIP and sCLIP) with specific advantages and 
limitations (Cook et al., 2014). Ray et al published a comprehensive map of RNA-
binding motifs related to 205 proteins across 24 eukaryotes (Ray et al., 2013), 
which could be a powerful reference for splicing factor binding sites prediction. 




methodology aspect, multiple approaches have proposed to predict splicing factor 
binding sites, most of which (SFmap, SpliceAid, ESEfinder) determine binding 
sites based on the consensus sequence derived from validated binding sites, 
genomic environment and conservation (Akerman et al., 2009; Cartegni, 2003; Paz 
et al., 2010; Piva et al., 2018).   
1.5.4 Epigenomic regulation of splicing 
 Since alternative splicing is coupled to transcription (Schor et al., 2013), it 
is highly likely that epigenomic features could regulate splicing, which has been 
supported by numerous studies (Enroth et al., 2012; Pradeepa et al., 2012; Zhou et 
al., 2012). Correlations between several chromatin marks and splicing have been 
observed by Shindo et al (Shindo et al., 2013), which suggests that histone marks 
could be involved in the mechanism of splicing regulation. Actually they could 
affect the recruitment of splicing regulatory protein indirectly to regulate splicing 
(Luco et al., 2011). For example, MRG15 could recruit PTB to regulate alternative 
splicing by binding to H3K36me3 (Luco et al., 2010), which implies that some 
histone modification features may be able to enhance the recruitment of splicing 
factors to regulate splicing. The RNA polymerase II elongation rate could affect 
splicing by mediating the splicing sites selection (Shukla et al., 2011), more 
specifically weak splicing sites might not be detected by spliceosome at high 
elongation rate. Thus the mediation of elongation rate could modify alternative 
splicing. One of the potential mechanisms could be related to the nucleosome, 
which could specifically work as barriers that slow down RNA polymerase II 




association between nucleosome occupancy and splicing level (Brodsky et al., 2005; 
Schwartz et al., 2009). DNA Methylation is another epigenetic marker, which plays 
a role in splicing regulation. Bound CTCF is also able to decrease RNA polymerase 
II elongation rate, which could enhance splicing level with weak splicing sites 
involved. DNA methylation could avoid the binding of CTCF, which consequently 
affect splicing in a reverse manner (Shukla et al., 2011).  
Although some specific mechanisms and association regarding of epigenetic 
regulation of splicing have been observed, a genome wide analysis is needed to 
further strengthen proposed general mechanisms. In addition, it seems that 
epigenetic markers’ regulatory role in splicing could be dependent on cis-regulatory 
elements. The investigation on the interplay between epigenetic markers and cis 
elements is needed. Moreover, underlying tissue-specificity in epigenetic regulation 
of splicing needs to be addressed. 
 
1.5.5 Potential links between alternative splicing and complex diseases 
 Alternative splicing regulates almost all the protein-coding genes and 
significantly affects the protein structure variation (Wang et al., 2008). Mis-
regulation of alternative splicing could cause numerous human diseases (Wang and 
Cooper, 2007a). As one of the most critical factors, a mutation may happen in 
splicing sites, spliceosome complex components, splicing factor binding sites (Li et 
al., 2016; Wang and Cooper, 2007a), which could potentially cause lack of specific 




genes, which is related to many diseases induced by mutations (Eriksson et al., 
2003; Prince et al., 2001). As mentioned above, HGPS is caused by a de novo 
mutation within exon 11 of LMNA and creates a cryptic splicing site. Instead of 
LMNA protein, which could support the nucleus membrane scaffold and interact 
with numerous regulatory proteins, the mutated dysfunctional protein--progerin is 
generated. Familial partial lipodystrophy type 2 (FPLD2) is caused by a mutation in 
one 5’ splicing site of LMNA gene, leading to intron retention, which triggers 
NMD process (Tu and Ara, 2016). Furthermore, alternative splicing could be 
linked to cancer. Some known hallmarks of cancers like apoptosis and metastasis 
could be affected by mis-regulation of alternative splicing (Sveen et al., 2015). 
SRSF1 is a crucial splicing factor that could promote the assembly of spliceosome 
complex and also play roles in the translation process (Black, 2003; Chen and 
Manley, 2010). SRSF1 is significantly over expressed in multiple types of tumors 
and has already been used as an important biomarker (Sveen et al., 2015). At the 
molecular level, it is known that SRSF1 could interact with many tumorigenesis 
related genes like MYC (Das and Krainer, 2014; Sveen et al., 2015). In addition, 
Shen at al showed splicing variation model could predict survival of cancer patients 
better than gene expression model (Shen et al., 2016), which implies that splicing 
might play crucial roles in tumorigenesis. 
1.5.6 Splicing quantitative trait loci study (sQTL) 
 Alternative splicing is crucial for gene regulation and complex disease and 
numerous biological factors could affect splicing regulation. Genome variation 




polymorphism falling within splicing regulatory cis-elements could affect the ratio 
of SCN1A isoforms, which are related to drug-responsive (Heinzen et al., 2007). 
Splicing quantitative trait loci (sQTLs) is a standard approach to identify SNPs 
which are associated with splicing levels (Monlong et al., 2014; Zhao et al., 2013). 
Many different computational approaches ranging from the simple linear regression 
model to more advanced statistical model accounting for over-dispersion have been 
developed, and numerous sQTLs have been detected. Compared to eQTLs, it seems 
sQTLs exhibit some unique characteristics. They usually have a smaller effect than 
eQTL and reside not too far from the target genes/events (Monlong et al., 2014; 
Zhao et al., 2013).  
One of the major steps for sQTL studies is splicing level quantification. Actually 
splicing complexity is much higher than we expected, and the standard splicing 
annotation may not be sufficient to capture all the local splicing variations. Li et al 
developed “LeafCutter”, an intron-centric splicing quantification approach, which 
basically clusters competing splicing junctions as generalized splicing events and in 
the meantime sQTL could be detected by assessing the association between SNPs 
and the ratio of splicing junctions within each cluster  (Li et al., 2018). The 
advantage is the quantification will not be limited to fixed exon-centric annotation, 
which is far from complete. In addition, regarding tissue-specificity, consistent with 
eQTL studies that a comprehensive map for sQTL across multiple tissues is needed 






1.6 Significance of this study 
 HGPS is a rare premature genetic disease. Although the causal de novo 
mutation has already been identified, its molecular basis is still not certain. What 
are more, common symptoms between HGPS patients and seniors imply potential 
connections in molecular basis between the two models, which raises the difficult 
and interesting question. Gene expression study is expected to be able to shed light 
on both processes. However, the limited RNA-seq sample size in the context of 
HGPS further complicates the challenge. In chapter 2, we provided the first set of 
matched HGPS and aging RNA-seq samples and proposed a novel approach, 
effective with limited sample size, to identify gene clusters whose expression co-
varies with age and/or HGPS. We have applied our approach to our novel RNA-seq 
profiles at three different cellular ages, both from HGPS patients and normal 
samples. Our results suggest novel insights into biological processes underlying 
aging and HGPS.  In addition, our novel approach could be applied to any general 
problems with limited sample size.  
 It is well known that alternative splicing significantly contributes to 
proteomics diversity and mis-regulation of splicing can cause diseases in human. 
Although both genomic and chromatin features have been shown to associate with 
splicing, the corresponding specific mechanism is not clear. Moreover, it is not 
known whether the regulatory effect is context dependent. In chapter 3 we predict 
exon skipping level using a deep neural network model and performed the first 
comparative investigation on splicing regulatory effect of genomic and epigenomic 




and chromatin features probably are not contributing extra regulatory information 
independent to genomic features.  
As we mentioned above, Alternative splicing is one of the key drivers for 
phenotypic diversity and its dysregulation could underlie diseases in human. 
Tissue-specificity in splicing further complicates its links to phenotypes. To 
elucidate these links we generated a comprehensive map of age-associated splicing 
changes across 48 tissues in Chapter 4. More specifically, we identified 49,869 
tissue-specific age-associated splicing events of 7 distinct types using a stringent 
model controlling for multiple hidden confounders by analyzing ~8500 RNA-seq 
samples across 48 tissues. Moreover, we also showed those age-associated splicing 
could be linked to complex diseases. In addition, we performed a comparative 
investigation on predictive ability of age among gene expression, transcript 
expression and splicing level, showing that splicing level is most correlated with 
age.   
 It is known that both normal aging and genomic variation could be linked to 
age related complex diseases. However, a potential interplay between the two 
factors is not understood fully. It is highly likely that genomic variations exhibit 
age dependent effect on phenotypes. Previous studies have incorporated SNP-
Environment term in a regression model to study such interactions. However, those 
interaction terms do not provide insights about the interaction mechanisms. We 
instead incorporate well understood transcriptional regulation mechanism in our 
association model. More specifically, we approximate the age factor as age-




between genotype and age-associated TFs. In addition, we performed analysis in 25 
tissues to account for tissue-specificity.  Numerous SNP-TFs interactions are 
identified across 25 tissues and enriched epigenomic signals associated with 
regulatory elements further validate their functionality.  
 Overall, my dissertation focuses on fundamental questions in gene 
regulation and in the meantime specifically provides new insights into aging 













Chapter 2: Phenotype-Dependent Co-expression 
Gene Clusters: Application to Normal 






Although the causal of HGPS is already known, the mechanisms leading to the 
clinical manifestations are still mysteries. Among numerous hypotheses, the ”gene 
expression” model, which proposes that progerin alters the nuclear structure and 
subsequently affects gene expression, has been supported by various lines of 
evidence (Mounkes et al., 2003). A general loss of heterochromatin and dislocation 
of epigenetic marks have been observed in HGPS cells (Goldman et al., 2004; 
Mccord et al., 2013; Shumaker et al., 2006). In addition, it has been shown that 
lamin A interacts with transcription regulatory proteins (e.g., retinoblastoma 
protein pRb), signaling molecules (e.g., protein kinase C), and chromatin proteins 
(e.g., histones and barrier-to-autointegration factor (BAF)), implicating its direct 
involvement in gene expression and signaling (Gotzmann and Foisner, 2006; 
Somech et al., 2005; Wilson and Foisner, 2010). 
Accordingly, changing expression levels of various genes have been observed in 
HGPS cells. To date, four independent HGPS microarray studies have been 
published. Park et al. examined 384 known genes and reported four genes with 
more than twofold changes (Park et al., 2001). Ly et al. monitored the expression of 
approximately 6,000 genes and found 61 altered in HGPS (Ly et al., 2000). Csoka 
et al. analyzed approximately 33,000 genes and found 361 genes that showed 
statistically significant change (Csoka et al., 2004), and more recently, Marji et al. 
compared 4 HGPS fibroblast lines with four age-matched controls, and suggested 
that a lamin A-Rb signaling is a major defective signaling pathway in HGPS cells 




with each other, transcription factors, extracellular proteins, and cell cycle 
regulators appear to be the largest affected functional category. 
As the relationship between nuclear lamins and gene expression is continued to be 
explored, we are optimistic that the gene expression model may help to shed light 
on the causes of the premature aging phenotypes associated with HGPS. On the 
other hand, it is of great interests to determine how the gene expression pattern in 
this disease resembles and is distinct from the pattern observed in normal aging. A 
detailed comparative investigation of genome-wide gene expression patterns 
associated with HGPS and normal cellular aging has not yet been reported and may 
reveal common and distinctive biological pathways underlying these two 
conditions. Comparative exploration of gene expression changes in normal aging 
and HGPS has not been possible thus far due to unavailability of genome-wide 
expression profiles in HGPS samples at different cellular ages. Thus, in this study, 
we have collected RNA samples from a HGPS primary fibroblast cell line and from 
a genetic background matched normal control at early, middle and late cellular 
passages, and conducted genome-wide RNA-seq. 
Although, we have generated the first whole genome RNA-seq based 
transcriptomic profile in cell cultures at three different ”ages” in both normal and 
HGPS samples, the number of samples (n = 6) is not sufficient to assess individual 
genes with respect to their co-variation with age or HGPS using standard regression 
approaches, such as those used for eQTL studies, with hundreds of samples 
(Stranger et al., 2007). At the same time genes are known to form co-expression 




traditional gene-centric regression approach does not leverage this fact. To address 
the limitations in the sample size, we have developed an iterative procedure that 
leverages co-expressed gene clusters while iteratively refining the cluster based on 
a cluster-centric multivariate regression’s goodness of fit criteria (Wang et al., 
2014b). We have performed a number of tests to show the robustness and efficacy 
of the approach.  
  
2.2 Results 
 2.2.1 Method Performance and Efficacy 
 We first cluster the 9,453 genes into 200 clusters (see METHODS) and 
applied the regression model within each cluster independently. Fig. 2-1 shows 
(”Initial FG” plot) the goodness of fit as represented by Adj-!!. We then iteratively 
refine the clustering with the explicit goal to improve the cluster ”tightness” which 
interestingly has an indirect effect on the Adj-!!. As shown in ”Final FG” plot in 
Fig. 2-1, the Adj-!!distribution shifts to higher values. As a control when we 
randomly permuted the initial expression data and repeat the entire procedure, the 
final refined clusters show a much inferior distribution as shown in ”Final BG” plot 
in Fig. 2-1. This supports the efficacy of the refinement step and indicates a 









 2.2.2 Convergence  
 The maximal matching clustering refinement (see METHODS) 
monotonically decreases the value of F!. Intuitively, the algorithm will converge 
because if F! is minimized the cluster will contain co-expressing genes which will 
have similar regression coefficient vectors. Fig. 2-2 shows changes in F!!and 




Figure 2-1. Goodness of fit (Adj-!!) distributions for gene clusters. Yellow plot: initial 
clustering, Green plot: Final refined clustering, Red plot: Re-fined clustering for randomly 








 2.2.3 Method Robustness 
 Next we assessed the extent to which the quality of final clustering depends 
on the initial clustering step. To do so, starting with initial clustering, we perturb 
the clustering to various extent (defined by parameter α) and quantify the quality of 
final clustering. For instance, we randomly select a fraction of genes and randomly 
assign to existing clusters. We first noticed that as we increase α, it takes longer for 
the clustering to converge—roughly an eight-fold increase in real run time when 
using a random clustering compared with co-expression cluster as described in 
 
 





Methods. We compared the Adj-!! distributions for increasing values of α. As 
shown in Fig. 2-3, the overall Adj-!! distribution shows modest reduction in 
quality (compare plots for α > 0 with α = 0), which nevertheless is better than 
initial clustering (compare plots for α > 0 with initial clustering). A direct 
comparison of Adj-!! between each of the perturbed data and the unperturbed data 
using Wilcoxon test shows no significant difference, thus supporting robustness of 
the iterative procedure. 
 2.2.4 Performance 
 To illustrate the advantage of the proposed RegressionClust model in small 
sample size, we compared its p-values of regression coefficients with those of 
single gene regression model. Figs. 2-4 and 2-5 show the p-value distributions of  
 
Figure 2-3. Robustness of the iterative refinement. For varying degree (α) of 
perturbation of the initial clustering the plots show the Adj-R2 distribution of the 



















regression coefficients of both models for six samples of age-progeria data. We 
observed coefficients estimated from single gene model are not significant. On the 
other hand most of coefficients generated from the RegressionClust model are 
significant. 
 2.2.5 Identification of Gene Clusters Whose Expression Co-Vary with 
Age and/or HGPS 
 We applied our approach to our in house RNA-seq gene expression data for 
six fibroblast samples—three normal at different cellular ages and three from 
HGPS at different ages. Using 200 initial co-expression clusters, we iteratively 
refined the clusters based on tightness of the cluster criterion (see Methods) while 
estimating cluster specific regression coefficients !!, !!, and !! for each final 
cluster along with the p-value for the null hypothesis that the coefficient is zero. 
We corrected all p values thus obtained using Benjamini-Hochberg procedure. Next 
we examined the normalized coefficient values (effect size). 
In clusters where only the age and interaction coefficients were significant, the age 
alone tended to have positive effect on gene expression relative to interaction (Fig. 
2-6). The gene expressions increased with age while the interaction terms in 
general had negative effect on gene expressions (Fig. 2-6). Likewise in clusters 
where only progeria and interaction coefficients were significant, the interaction 






Figure 2-6. Distribution of normalized coefficients β1, and β3 specifically for the clusters for 






2.2.6 Functional Analysis of Specific Gene Clusters Whose Expression Co-
Vary with Age and/or HGPS 
 We selected the significant coefficients whose absolute value was at least 
0.5, to exclude extremely small effect sizes. Considering three coefficients !!,!!! , 
and !!,  and their signs, there are multiple possibilities for various combinations of 
these coefficients being significant (FDR <= 0.05 and effect size >= 0.5). For 







Figure 2-7. Distribution of normalized coefficients β2, and β3 specifically for the clusters for 





(FDR<= 0.05 and effect size >= 0.5) and !! was not. Table 2-1 shows the number 



















We performed functional enrichment analysis (Huang et al., 2008; Huang et al., 
2009) using GO Biological processes and KEGG pathways based on FDR 
threshold of 0.05. For ease of interpretation, we consider only the clusters in six 
categories: 1+: the expression increases with age (and no other significant large 
effect), 1-: the expression decreases with age (and no other significant large effect), 
2+: the expression increases with HGPS (and no other significant large effect), 2-: 
the expression decreases with HGPS (and no other significant large effect), 1-2-: 
the expression decreases both with age and HGPS (no significant large interaction), 
TABLE 2-1 
Number of clusters in various categories based on which combination of coefficients were 





and finally 3+: the expression significantly and largely increases with age only in 
HGPS patients (there were no significant clusters in 3- category). To underscore the 
relative advantage of our specific approach that can potentially distinguish between 
mechanisms mediated by increase or decrease in gene expression, and also age 
related and HGPS-related mechanisms, we directly compare the functions enriched 
in specific categories. Functions enriched in 1+ (73 terms enriched) and 1- (39 
terms enriched) category are significantly distinct. Terms unique to 1+ included 
“extracellular matrix organization”, “regulation of cell proliferation”, “response to 
oxidative stress”, “regulation of cellular metabolic process” and “immune 
response” etc. Interestingly, all terms unique to 1- referred to “cell cycle”, 
“regulation of growth”, “cytoskeleton/spindle organization”, and “chromosome 
segregation”, which according to our analysis are suppressed with age. The number 
of enriched terms in 2+ and 2- clusters were 185 and 251 respectively. To reduce 
this to a manageable list we only considered GO terms with at most 20 genes 
annotated, bringing the numbers down to 63 and 152. The common enriched terms 
referred to “protein localization/transportation”, “signal transduction” and 
“metabolic process”. The terms unique to 2+ referred to “negative regulation of 
molecular function”, “negative regulation of signaling”, “negative regulation of 
response to stimulus”, and “metabolic process”. The terms unique to 2- were 
clearly different and referred to “biosynthetic process”, ”DNA repair/double-strand 
break repair”, “transcription”,“RNA splicing”, “mRNA processing” and 
“chromatin/histone modification”. Interesting we did not detect any gene cluster in 




among the enriched terms in these clusters were “metabolic process”, “apoptosis 
process”, “signal transduction”. Finally, category 3+ which refers to clusters whose 
expression increases with age, particularly in HGPS population has several 
enriched terms in common with 1+ category, which include “signal transduction”, 
“regulation of cell proliferation”, “metabolic process”. The 3+ category includes 
numerous enriched terms not detected for 1+ category. These include “cell 
migration”, “development growth”, “muscle contraction”, “cell adhesion”,  “heart 
growth” and “protein folding”.  
 
 
2.2.7 Functional Comparison of the Initial Clusters and Refined Clusters 
 To assess whether our joint regression clustering approach improves 
functional enrichment of the clusters, we compared the enrichment of functional 
GO terms in the initial and final clusters for a few selected genes previously known 
to be involved in aging or Progeria. For some genes, we found their initial cluster 
and final assigned cluster have different biological functions. As an illustrative 
example when we compared the clusters containing FOXM1 gene, a key 
 
Functional Terms FDR 
Transcription 1.5e-6 
Regulation of transcription 4.9e-6 
DNA binding 3.7e-4 
Transcription co-activator activity 1.1e-4 
Transcription factor binding 2.5e-2 
Transcription co-factor activity 6e-3 
 
Table 2-2. Cluster of enriched terms relating to transcriptions are enriched among gene 





transcriptional regulator of cell cycle progression, the final refines cluster 
containing FOXM1 was specifically enriched for Cell Cycle while the initial cluster 
containing FOXM1 was enriched in general terms such as transcription activity and 
DNA binding but not for Cell Cycle. However we acknowledge that it is difficult to 
quantify the functional enrichment difference between the initial clusters and the 
final reassigned clusters because the clusters compared may have different size that 
will influence the enrichment score. 
 
2.3 Materials and Methods 
 2.3.1 Cell Culture, RNA Preparation, and RNA-Seq Experiment 
 Normal (HGADFN168, Father) and HGPS (HGADFN167, son) primary 
fibroblasts were obtained from the Progeria research foundation. All fibroblast cell 
lines were cultured in MEM (Life Sciences) supplemented with 15 percent FBS 
(Gemini Bio-Products) and 2 mM L-glutamine (Life Sciences) at 37°C with 5 
percent CO2. RNA samples were collected from these two cell lines at early 
(passage 11), middle (passage 16) and late stages (passage 20 for HGPS, and 
passage 23 for normal) during replicative senescence. Total RNA from different 
cell lines was extracted with Trizol (Life Sciences) and purified using the RNeasy 
Mini Kit (Qiagen) according to the manufacturer’s instructions. The RNA yield 
was determined using the NanoDrop 2000 spectrophotometer. The RNA-seq 




Truseq RNA sample preparation V2 guide by the IBBR sequencing Core facility at 
the University of Maryland. 
 
 
 2.3.2 RNA-Seq Data processing 
 We processed each of the six samples identically using the Cufflinks suite 
of tools following the recommended protocol (Trapnell et al., 2012) yielding RNA 
expression value (FPKM) for  ~14,000 human genes in each of the six samples. In 
addition, to guide the iterative cluster refinement procedure (see below), we 
obtained the RNA-seq profiles for 15 independent tissue types from Gene 
 




Expression Omnibus (GEO). There were 9,453 genes in common between our 
samples and the GEO samples, which were ultimately used for all follow up 
analyses. 
     2.3.3 Joint Regression Clustering 
 Workflow. Fig. 2-8 shows the complete workflow of proposed joint 
regression clustering method. We start with initial clustering of genes (k-mean 
clustering) based on age-progeria data. We refine the clusters iteratively to 
minimize the average error of predicted (from cluster regression) gene expression 
till convergence. It is computationally expensive to calculate the average error for 
all possible refinements. Therefore, we approximated the average error by its 
maximum likelihood (ML) estimate. After every k rounds if actual average error 
increases, we randomly reverse some of the gene reassignments.  
 Linear regression model. Linear regression is widely used method to study 
the effect of covariates on expression variance between samples. The linear 
regression model for gene expression with aging and HGPS as covariates can be 
expressed as: 
  !!" = !!! + !!!!!!! + !!!!!! + !!!!!!!! (1) 
Where, !!" is expression of jth gene in ith sample. !! is the basal expression of jth 
gene. !!!!is vector of the regression coefficients of jth gene for covariates age !! (1: 
young, 2: middle age, 3: old) and HGPS state !!  (0: normal, 1: HGPS), and 
interaction term !!!!. A vector of coefficients must be estimated for each gene 
separately for model (1). This is clearly limiting as we have only six samples. 




different sample. To learn regression coefficient separately for each gene is not an 
effective approach because small sample size will have low statistical power (see 
results) and many genes are expected to vary in a similar manner with respect to the 
covariates. Additionally, it will be hard to extract meaningful result and visualize 
the effect of covariates from separate regression coefficients for thousands of 
genes. We can cluster genes based on its expression variance w.r.t its covariates 
and estimate coefficients jointly for a cluster of co-varying genes. 
RegressionClust model. To overcome above limitations and to leverage clusters of 
potentially co-varying genes we propose the following model, RegressionClust: 
  !!"# = !!!" + !!!!!!! + !!!!!! + !!!!!!!!  
!!" − !!" = !!"# !!(2) 
Where, !!"# is imputed expression of jth gene belonging to cth gene-cluster in ith 
sample. !!" is the basal expression of genes in cth gene-cluster in ith sample. !!!!!is 
cluster specific vector of the regression coefficients of the covariates. !!"  is 
distance of jth gene from its cluster center and is computed as the difference 
between the mean expression value of the gene and that of all genes in the cluster 
that the gene is assigned to. !!" is updated after each reassignment. 
This is a dual optimization problem—fit a regression model for each cluster and 
refine clusters to maximize overall explained variance. The objective functions are: 
model for each cluster and refine clusters to maximize overall explained variance. 
The objective functions are: 
Regression: find optimal regression coefficients such that gene expression variance 




i.e. !"#$%!!!!!! = !! !! − !!!"#
!
!! .  
Where, !! !! = !!" + !!!!!!! + !!!!!! + !!!!!!!!.  This is equivalent to 








! is the mean gene expression value in cluster c. 
Cluster refinement: find optimal set of clusters (or, clustering) such that each 
cluster is tight (maximize overall explained variance), i.e. minimize 
!! = ! !!!! = !!" − !!" − !!! !!
!
!!∈!!  (4) 
!
2.3.4 Greedy maximal matching cluster 
 Inference: Independent maximization of !!  is equivalent to linear 
regression, while independent minimization of !!!is clustering. We estimate the 
parameters of RegressionClust model by iteratively optimizing the two objective 
functions. It is important to note that ! !" should be independent of the expression 








Fig. 2-9 The Graph constructed for greedy maximum matching cluster refinement. There are n 
clusters, we construct a node for each cluster, and the edge is added if the possible reassignment will 
decrease the objective function score. The Edge e(1,2,g_id) is the gene reassignment that moves gene 
gene_id from cluster 1 to cluster 2. The red edges are greedily selected edges, based on which we 





15 independent normal expression samples collected from GEO database. As a 
side note, this iterative inference is similar to Expectation Maximization (EM) 
algorithm. In particular, if instead of hard assignment of gene cluster, fuzzy 
assignment to cluster is used, it can be proved that it is equivalent to EM algorithm. 
However, we chose to use hard assignment because we found that fuzzy clustering 
increases computational cost without significant gain in the overall performance. 
Maximization of !! is explained next. 
Initializing the cluster set: We initialized the clusters using k-means clustering 
on the sample data, for different number of clusters (200,300,400,500,600). 
 
  Box. 2-1 This is the greedy maximum matching clusters refinement algorithm.  
 
Greedy maximal matching cluster refinement algorithm: 
 
Greedy_Cluster_Refinement(c_vector,real_gene_exp,geo_gene_exp,num_c)  
      G= Initialize_graph(c_vector,real_gene_exp, geo_gene_exp, num_c);                
      while  |unmarked_E| > 0 
             max(w(e(i, j, gene_id)  ∈  unmarked_E )); 
             marked_E !  e(i, j, gene_id); 
             marked_V !   i, j; 
      for each e(m, n, gene_id’)  ∈  unmarked_E               
            if m or n ∈  marked_V||gene_id=gene_id’ 
                 delete e(m,n,gene_id’);   
     for each e(m, n, gene_id)  
                 c_vector[gene_id] = n; 
    return c_vector; 
 
Initialize_Graph(c_vector, real_gene_exp, geo_gene_exp, num_c) 
    Graph G = (V,E); 
    for each cluster c(i) 
          V !   n(i); 
   for each gene gene_id  
          for t = 1 to num_c - 1  
                update w_jc; 
                calculate obj_diff; 
                if  var_diff < 0  
                     E !  e(c_vector[gene_id], t, gene_id)  
                     w(e(c_vector[gene_id], t, gene_id) = obj_diff; 




Greedy maximal matching cluster refinement: To greedily refine the clusters, 
a change in !! should be calculated for each possible reassignment (move of gene 
from each cluster to another). Each possible reassignment changes !! and !! !! . 
Running linear regression for each possible reassignment is clearly computationally 
limited. We therefore use maximum likelihood estimate of !! !!  to estimate 
change of !! . The Maximum Likelihood (ML) estimate of !! !!  can be 
determined by differentiating equation (3) w.r.t to !! !! : 
!"
!!! !!





!!"# !! = !!! !!"#! !!!!  (5) 
Where !! is total number of genes in cluster c. Now, we can replace this in equation 
(4) to obtain its ML estimate: 
!! = !!" − !!" − !!!"# !! !
!
!!∈!!   (6) 
!!"# !!  can be locally updated efficiently for each possible single gene moves.  
To allow at most (a single gene) change to a cluster in an iteration, we construct 
a graph with all clusters of current clustering as nodes and each single gene move 
as a directed edge between originating and destination cluster and change in !!! 
due to the move as the edge weight. We then performed maximal matching on this 
graph to minimize !!and allowed single change to a cluster. We then proceed with 
single gene moves corresponding to maximally matched edge as our cluster 
refinement. The maximal matching also ensures that same cluster will not be source 




shows pseudo code for this greedy cluster refinement. c_vector, real_gene_exp, 
geo_gene_exp, num_c respectively are cluster membership vector, age-progeria 
data and GEO data. Although we use !! for cluster refinement, but after every k 
iterations if  !! increases for the selected gene moves, we reverse those moves. We 
chose k=10 for all analysis. 
Note that !!" !is re-calculated after every cluster update and multiple changes to a 
cluster can in fact result in overall increase in !!!. Our matching strategy involving 
at most one change to each cluster ensures overall reduction of square errors. In 
addition, by virtue to selecting a maximal matching we maximize the improvement 
in square errors. The steps of calculating !!", !!!!and maximal matching cluster 
refinement are repeated until convergence. 
Adjusted R2: The quality of regression fit is generally estimated using the R2 
statistic as defined above. However, to account for the varying number of clusters 
and the number of parameters, we instead use adjusted R2 (Adj-R2) for a cluster 
computed as:  
!!"#! = 1−
1− !!! ! − 1
! − ! − 1  
Where n is the cluster size, and k is the number of coefficients in the multiple linear 
regressions. !!!! is defined in equation (3). 
 
 2.3.5 GO Analysis 
 We assessed enrichment of GO biological processes and KEGG pathways 




using R’s GOstats package. The significance was corrected for multiple testing 
using the Benjamini-Hochberg procedure. An FDR threshold of 0.05 was used. 
2.4 Summary and Discussion 
Our works make three main contributions which pertain to data, method, and 
application to make new biological discoveries. With regards to data we have 
generated the first RNA-seq data in a controlled fashion for aging HGPS primary 
cells and passage and genetic background matched normal control cells. 
Methodologically, here we have presented a regression based approach that 
leverages clusters of genes with co-varying expression to robustly estimate 
regression coefficients representing dependence on age, HGPS and the interaction 
between the two. Our approach iteratively refines the clusters using a cluster 
”tightness” criterion which, as we show analytically, simultaneously improves the 
goodness of fit while increasing the computational efficiency substantially. The 
proposed method should be useful in several other contexts with limited number of 
samples. Finally, application of our method to the data recapitulates previous 
discovery of age-dependent gene expression changes as well as makes several 
important observations in a comparison between age and HGPS. Previous 
microarray studies of HGPS and aged normal fibroblasts have revealed some 
insights into the gene expression changes during the normal and the premature 
aging. Ly et al. used fibroblast cells from young, middle and aged normal donors as 
well as from a HGPS patient, and identified 61 differentially expressed genes out of 
the 6,000 genes monitored, among which there are two major functional groups: (1) 




remodeling of the extracellular matrix (ECM) (Ly et al., 2000). Interestingly, most 
of the cell cycle genes showed down-regulation in aged cells and HGPS cells, and 
the ECM genes are affected in both directions in aged and HGPS cells. Using 
genome-wide affymatrix microarrays, Csoka et al. defined 361 differentially 
expressed genes in HGPS fibroblast cells (out of 33,000 genes on the array), and 
found that the two most prominent categories encoded transcriptional factors and 
ECM proteins (Csoka et al., 2004). Because of our specific methodology we were 
able to identify gene clusters whose expressions co-vary exclusively with age, or 
disease, or in specific combinations of age and disease. We identified several 
predominant gene clusters, whose expressions were altered either under the disease 
condition HGPS and/or during the normal cellular senescence. Of particular note, 
our analysis indicated that the HGPS gene expression profiles show important 
differences from the profiles of normal fibroblast passaged into cellular senescence. 
In the ”1-” clusters, we found that the majority of genes are related to cell cycle 
regulation, which is in highly significant agreement with the results from Ly et al. 
despite major differences in samples, methods, and data analysis. For example, 
Forkhead box protein M1 (FOXM1), a key transcriptional regulator of cell cycle 
progression, was found to be down regulated in both studies. This gene has been 
shown to regulate a large group of G2-M specific genes (Myatt and Lam, 2007), 
including a key mitotic cyclin, cyclin B1, which was also identified by both our 
analysis and Ly et al. In addition, consistent with previous reports on ECM 
proteins, we found that the ”1+” clusters are enriched with functional categories of 




clusters that positively associate with HGPS disease condition, the prominent 
categories are related to metabolic functions, implying an activation (or at least an 
attempted activation) of the biological processes involved on various cellular 
metabolic activities in HGPS cells. To date, the metabolism in HGPS cells have not 
been systematically examined, nor any metabolite profiling in HGPS cells have 
been reported. Our study provides the first genome-wide evidence of the affected 
metabolisms in HGPS cells, and points to a potentially important direction for 
future HGPS research. Interestingly in the ”2-” clusters whose expression is 
reduced in HGPS, we found gene clusters including transcription, mRNA 
processing, splicing and protein biosynthesis, reflecting an overall slow down in 
cellular growth in the prematurely aged HGPS cells. Table 2-2 shows the cluster of 
terms related to transcription significantly enriched among these gene clusters 
computed by NIH DAVID tool (Huang et al., 2008; Huang et al., 2009). Because 
lamin A/progerin resides in the inner nuclear rim, and plays a role in organizing 
chromatin, it is not surprising to identify wide spreading changes in gene 
expression in HGPS cells. The challenge is to determine the specificity of progerin-
related changes and of the age-related changes, and illuminate their potential 
interplays. In an attempt, we examined the functional groups in the genes whose 
expression increases with age specifically in HGPS cells (the ”3+” clusters). 
Interestingly, a prominent functional gene group is related to signal transduction, 
including trans-membrane receptors (e.g. insulin-like family peptide receptor 1 and 
stannin) and protein kinases (e.g. membrane associated guanylate kinase and 




than fibroblasts, are required before we can understand the contributions of 
progerin/lamin A and cellular aging to gene expression in complex organisms. The 
study reported here provides a first genome-wide, multi stage RNA-seq experiment 

























  Recent availability of RNA-seq data has spurred several computational 
investigations into the determinants of alternative splicing (Barash et al., 2010; 
Flores et al., 2012; Shindo et al., 2013; Xiong et al., 2011; Zhou et al., 2012). While 
several different types of alternative splicing events have been documented, due to 
ease and robustness of inference, most investigations have focused on alternative 
exon inclusion/exclusion events, specifically cassette exons, where an alternative 
internal exon is flanked by ubiquitously included exons. A previous work has 
suggested existence of a ‘splicing code’ composed of numerous genomics features 
such as splice sites signals, conservation score, ESE, ESS, ISE, ISS, etc, that can 
accurately predict relative exon inclusion in a cell type (Barash et al., 2010; Xiong 
et al., 2011). On the other hand, Shindo et al have shown correlation between 
several chromatin marks and splicing (Shindo et al., 2013); they found H3K36me3 
and H3K79me1 around the exon-intron boundaries to be strongly correlated with 
splicing. Zhou et al have shown a correlation between H3K36me3 and splicing 
(Zhou et al., 2012). Another report suggested that DNA methylation within exon 
body may have positive effect on exon inclusion (Flores et al., 2012). Finally, a 
linear regression model to predict exon inclusion based on multiple chromatin 
features showed several chromatin features, especially H3K36me3 and H4K20me1 
to be correlated with exon expression (Zhu et al., 2013). However, this previous 
approach does not separate exon expression and gene expression, and an alternative 
measure – percent splicing index (PSI), better quantifies alternative. What’s more, 




features as control since genomics features can, presumably causally, predict 
chromatin features (Whitaker et al., 2014). Overall, the relative contributions of 
genomic and epigenomic contributions to alternative splicing, specifically, 
alternative exon inclusion event, is not known. Here, based on deep neural network 
model, we carefully analyzed the relative contribution of genomic and epigenomic 
features on exon inclusion levels, in multiple cell lines.  
Our analyses showed that genomics features could predict exon inclusion much 
more accurately than chromatin features. Integrating the two types of features does 
not improve the prediction accuracy. We specifically assessed the contributions 
made by either genomic or epigenomic feature in addition to the other type of 
feature using multiple approaches, and found that, while genomic feature make a 
significant additional contributions to predictability of exon inclusion, the converse 
is not true, suggesting that genomic features encode most information relevant to 
exon inclusion. Besides the assessment of predictability, we specifically model the 
position-specific contribution of each feature. Finally, even though epigenomic 
features do not make substantial contribution independent of the genomic features, 
our model detected specific interactions between genomic and epigenomic features, 
suggesting that the effect of specific genomic features may be sensitive to the 
epigenomic context.  
Overall, we provide a first direct comparative assessment of genomic and 
epigenomic features, and interaction thereof, in predicting cell type specific 






 3.2.1 Chromatin Features are Weak Predictors of Exon Inclusion 
 Previous studies have reported correlations between various types of 
splicing events and proximal chromatin features (Whitaker et al., 2014; Zhu et al., 
2013). We directly assessed the cross-validation predictability of exon inclusion 
using chromatin features alone. Fig. 3-1A shows the 8-fold cross-validation 
classification accuracy in three different cell lines. The prediction accuracies in all 
cell types are significantly higher than the random expectation of 50%, albeit, 
modest. Notably, prediction accuracy is much higher in h1-ESC relative to the 
other two cell lines. This may be either because the chromatin state is indeed more 
closely associated with splicing in pluripotent cells or alternatively, because of 
 
 
Figure 3-1: Cross-validation prediction accuracy of exon inclusion using chromatin features 
for three cell types GM12878 (blood), h1-hESC (human embryonic stem cell) and K562 
(leukemia). The accuracy is the mean accuracy of 8-fold cross validation. (A) Prediction 





better quality of chromatin modification data in h1-ESC cell line; these need to be 
explored in future. 
 3.2.2 Genomic Features are Robust Predictors of Exon Inclusion 
 Previous studies have shown that genomic features can accurately predict 
change in exon inclusion propensity in a cell line relative to other cell lines (Barash 
et al., 2010; Xiong et al., 2011). We emphasize that our goal here is not necessarily 
to improve exon inclusion predictability, but rather to contrast the independent and 
synergistic contributions of chromatin and genomic features and also to assess 
location specificity of various features relative to splice sites. Nevertheless, we first 
establish a baseline for predictability of exon inclusion using genomic features in 
our datasets and using tissue-specific performance metric. Also, in contrast to 
previous genomic element-based relative exon inclusion prediction approach, here 
we only employ genomic features with a potential mechanistic link to splicing 
machinery and excluded features such as ‘exon translatability’ that was shown to 
be the single-most powerful predictor but is not linked to the splicing mechanisms 
per se. We used only the cis-elements discussed above to predict splicing. 
However, we note that by excluding translatability as a feature, our approach does 
not account for nonsense mediated decay of the mRNA caused by pre-mature stop 
codon (Cusack et al., 2011). 
Similar to chromatin features, we employed 8-fold cross validation to estimate 
prediction accuracy. As shown in Fig. 3-1B, genomic features can predict exon 
inclusion very accurately, consistent with previous studies (Barash et al., 2010; 




features. This suggests that exon inclusion, even in a specific context, is largely 






Figure 3-2: (A) The effect size of chromatin features at different genome locations in h1-hESC 






 3.2.3 Location-Specific Map of Chromatin Features  
 In our deep learning model, we assessed the effect of each chromatin mark 
in 3 regions (multiple sub-regions in each broad region) relative to the cassette 
exon; each mark-locus combination is a distinct feature in our model. Here we 
report the locus-specific effect size of various chromatin marks. Fig. 3-2A, 
supplementary Fig. 3-S1, and 3-S2, show, respectively for h1-hESC, GM12878, 
and K562, the most significant chromatin features (Methods) in all locations 
considered  the cassette exon, the 5’ flanking intron and in the 3’ flanking intron. 
Interestingly, by and large, almost all features in exonic regions have negative 
effect on exon skipping, i.e., their presence in specific exonic regions is associated 
with higher inclusion levels, discussed later. Also the trends are largely consistent 
across cell types, particularly across h1-hESC and K562. 
We further ascertained the importance of features selected above as follows. We 
partitioned the entire set of exons into two sets based on the feature values (top and 
bottom half). We then randomly sampled (100 times) 1000 exons from each of the 
two groups and compared their inclusion levels using Wilcoxon test. We noted the 
fraction of tests (out of 100 tests) that yielded significant results consistent with the 
directionality of the feature’s effect according to the model above. To rank the 
features in terms of their overall relevance, which captures both significance and 
effect size, we multiplied each feature’s effect size (obtained from the model) with 
the fraction of Wilcoxon tests that were significant (significance). This procedure 




considering interactions). Fig. 3-2B, supplementary Fig. 3-S3 and 3-S4 shows the 
relevance for all the three tissues. We ranked the features based on their relevance 
as estimated above. Our results suggest that H3K36me3 is one of the most relevant 
features consistent with previous reports (Shindo et al., 2013; Zhu et al., 2013). The 
analysis also reveals H3K79me2, H4K20me1, H3K27me3, H3K9ac to be highly 
relevant to exon inclusion. Interestingly, we found that leukemia and stem cell lines 
have more and stronger feature signals for enhancing inclusion, however, blood cell 
lines have more features associated with repression of exon inclusion. 
 
 3.2.4 Epigenomic features are not contributing extra regulatory 
information in addition to genomics features 
 We have shown in section 2.3 that chromatin features are modestly 
predictive of exon inclusion. Even though specific mechanisms linking histone 
modifications to splicing have been reported (Luco et al., 2010; Luco et al., 2011), 
it is not clear to what extent the predictive power of chromatin features are 
independent of genomic features. To specifically investigate this, we assessed the 
extent to which chromatin features can explain the variance in exon inclusion that 
is unexplained by genomic features. We used two approaches to assess this: (i) we 
trained a model using chromatin (genomics respectively) features and then assessed 
the prediction accuracy using genomic (chromatin respectively) features with an 
additional feature representing the prediction score using the chromatin-based 
(genomic-based respectively) model; an improvement in prediction accuracy 




(ii) we quantified the extent to which chromatin (genomics respectively) features 
could explain the residuals of a linear model based on genomic-based (chromatin-
based respectively) model. A high explanatory power of the residual is consistent 
with an independent contribution. 
Fig. 3-3A and 3-3B show the results for the first analysis, which suggest that while 
adding chromatin-based model score to genomic features does not improve 
prediction accuracy, adding genomic-based model score to chromatin features 
substantially improves the prediction accuracy. Analogously, Fig. 3-4A and 3-4B 
show the result of the residual analysis, consistent with the first analysis, namely, 
chromatin features explain very small fraction of variance of the residual from the 
genomics-based model, as opposed to the converse. Overall, these analyses 
strongly suggest that that genomics features provide robust prediction of exon 
inclusion, largely independent of chromatin features and that the previous observed 
associations between chromatin features and splicing can largely be explained by 
the links between genomics and chromatin features, also noted previously 







 3.2.5 Cross Tissue Generalization of Chromatin and Genomics 
Predictors 
 Next, to assess the extent to which similar rules govern exon inclusion in 
different cell lines, for each pair of tissues we trained the model on one tissue and 
tested on the other. First, for chromatin-based modeling, as shown in Table 3-1, 
GM12878 model cannot predict exon inclusion in the other cell types and 
conversely, model trained on other cell types cannot predict exon inclusion in 
GM12878. However, cross-tissue predictability is much higher than random 
expectation between h1-hESC and K562. As shown in Table 3-2, genomics-based 
model exhibits a similar  
 
Figure 3-3: Cross-validation prediction accuracy using raw genomics (chromatin respectively) 
features and chromatin (genomics respectively) feature prediction score as an additional 
feature, for three cell types, GM12878 (blood), h1-hESC (human embryonic stem cell) and 
K562 (leukemia). The accuracy is the mean accuracy of 8-fold cross validation. RG indicates the 
raw genomics features, PC indicates prediction score using chromatin features. RC indicates raw 
chromatin features, PG means prediction score using genomics features. (A) Comparison between 






trend, however the absolute prediction is much greater for the genomics-based 
models. These results suggest that, even though a large portion of cis elements 
contribute to exon inclusion across cell types, exon inclusion also depends on 
specific cis elements that are recognized by cell type specific splicing factors 
(including splice enhancers and repressors). And the cross-cell type predictability 
for chromatin feature follow similar trend likely because chromatin features are 







Figure 3-4: R-squared for explaining residuals of genomics feature prediction using chromatin 
features and residuals of chromatin feature prediction using genomics features, in three cell 
lines, GM12878 (blood), h1-hESC (human embryonic stem cell) and K562 (leukemia). 
Chro-res: chromatin feature explain residuals of genomics model. Gen: genomics model. Gen_res: 
genomics feature explain residuals of chromatin model. Chro: chromatin model. (A) R-squared of 






















Table 3-1: Cross tissue test using chromatin model. In each row, we used one tissue model to 




















Table 3-2: Cross tissue test using genomics model. In each row, we used one tissue model to 
predict exon inclusion of the rest. Red accuracy means not significant, green ones means significant. 
 
 
 3.2.6 Potential interactions between Chromatin Features and Genomic 
Features 
 Our results thus far suggest that previously observed links between 
chromatin features and splicing may be largely explained by their correlations with 







Nevertheless, it is possible that the effect of some of the location-specific genomic 
features may be modulated by chromatin context. In other words, there may be 
interactions between specific genomic and chromatin features. However, these 
interactions cannot be directly quantified in our DNN model. Therefore, we applied 
L1 norm to the first layer of the DNN model to make the connections sparse, then 
explicitly assessed the interactions among the selected features based on a linear 
regression model, using the model selection package “stepwiselm” in Matlab 
(Create linear regression model using stepwise regression - MATLAB stepwiselm).  
We investigated both chromatin-genomic and chromatin-chromatin interactions. 
The results are summarized in Fig. 3-5 – 3-7 for each cell line respectively. Our 
results suggest that chromatin context can potentially modulate the effect of 
 
Figure 3-5: Potential interactions for chromatins-genomics, chromatins-chromatins in 
GM12878. The red line means negative to exon exclusion, green line means positive to that. The 




genomic features on splicing. Moreover, both chromatin-genomic and chromatin-
chromatin interactions are position specific, which is consistent with a mechanisms 
that relies on specific genomic and RNA conformation and binding of splicing 
factors. What’s more, many cis-elements within the skipped exons tend to interact 
with chromatin features. However, interactions between chromatin and genomic 
features in the context of splicing has not been studied before making it difficult to 
directly assess the observed interactions based on existing literature and more 








Figure 3-6:Potential interactions for chromatins-genomics, chromatins-chromatins in h1-
hESC. The red line means negative to exon exclusion, green line means positive to that. The 





3.3 Materials and Methods 
 3.3.1 Approach Overview 
 We downloaded MISO skipped exon splicing events annotations (Katz et 
al., 2010). Based on the MISO skipped exon splicing events annotations and the 
RNA-seq data in three cell lines, we used MISO package (Katz et al., 2010) to 
estimate the sample-specific exon inclusion fractions for all annotated cassette 
exons. We excluded the genes which are not expressed in any given cell type based 
on expression data from Gene Expression Omnibus as an independently ascertained 
expression data. The distributions of exon inclusion levels are bimodal as 
supplementary figure 3-S5 shows, suggesting that most exons tend to be either 
included or excluded in a given context. Moreover, these extreme cases are more 
likely to be robust. We therefore considered 40% of events from each end (total of 
80% of data) of the distributions for three tissues for the investigation of 
determinants of exon inclusion. Exons whose inclusion levels are closer to 0 
 
Figure 3-7: Potential interactions for chromatins-genomics, chromatins-chromatins in K562. 
The red line means negative to exon exclusion, green line means positive to that. The numbers on 




represent excluded exons, whereas the exons to the right of the spectrum are 











Figure 3-8: Predictive model for exon inclusion prediction. We extracted features from the 7 
regions in yellow in the skipping exon event structure. We employed deep neural network model 









We obtained processed Histone modification (Chip-seq), CTCF (ChIP-seq), RNA-
seq, DNA Methylation (Methyl RRBA), Dnase-seq data for each other for Blood 
tissue (GM12878), Embryonic Stem cell tissue (H1-hESC), Leukemia tissue (K562) 
respectively from ENCODE project (www.encode.org). The chromatin features 
include histone modifications (H2AFZ, H3K36me3, H3K27ac, h3K27me3, 
H3K4me1, H3K4me2, H3K4me3, H3K79me2, H3K9me3, H3K9ac, H4K20me1), 
DNA methylations, DNase hypersensitivity (DHS), and CTCF binding. The 
genomics features include a total of 560 motifs (which include validated known 
splicing motifs (Barash et al., 2010; Cartegni, 2003) and new potential splicing 
 




motifs (Fairbrother et al., 2002; Yeo et al., 2004), splice sites scores, exon length, 
intron length and conservation scores for the 7 regions. 
For each cassette exon, given the flanking exons and the introns, we selected seven 
regions for feature extraction as shown in Fig. 3-8. Regions 1, 4, 7 are exons whose 
length varied. Regions 2, 3, 5, 6 are 450 bps intron regions proximal to the 3 exons. 
A previous work used the regions 1–7 for genomics features (Barash et al., 2010). 
For chromatin features we only used regions 3, 4, and 5 because we found signals 
from region 1, 2, 6, 7 not to be effective by comparing the prediction accuracies 
before and after we include these regions (results not shown). For each region, we 
divided it into 9 windows and used as the chromatin feature value, the fraction of 
the windows overlapping a broad peak for each feature. 
 
 
3.3.2 Deep Neural Network model 
As mentioned earlier we treat the exon inclusion prediction problem as a two-class 
classification problem. We applied the deep neural network model, which has been 
widely used in computer vision and nature language processing field. DNNs are 
probabilistic generative network models with multiple hidden layers (Deep Neural 
Networks for Acoustic Modeling in Speech Recognition - Microsoft Research - 
http://research.microsoft.com/apps/pubs/default.aspx?id=171498). All nodes at a 
layer have complete directed connections to the nodes in the next layer. Each layer 
includes multiple neural units, which contain a transfer function. Transfer function 




The activation ac of each node depends on the input features f, connection weights 
w, the bias b and transfer function T: 
 !" = !!( !!"!!" + !!) 
We used logistic function as the transfer function: 
 ! ! = ! !!!!!!! 
The DNN architecture is shown in Fig. 3-9. There is a one-to-one mapping between 
features and the nodes in the input layer. The number of nodes for the output layer 
is two since this is a two-class classification problem; one of the nodes outputs the 
probability pe for an exon to be excluded, and the other node outputs the 
probability of being included pi. The predicted class c is based on maximum of the 
two probabilities: 
 ! = max !! ,!! ? (!"#$%&!&, !"#$%&'&) 
We utilized previously developed convenient deep neural network toolbox 
(Prediction as a candidate for learning deep hierarchical models of data). 
 
 
3.3.3 Restricted Boltzmann Machine Pre-training 
A Restricted Boltzmann Machine (RBM) is an undirected stochastic neural 
network model (Hinton et al., 2006), composed of a visible layer and a hidden layer. 
In neural network architecture this model could efficiently provide better 
initialization compared to random initialization based on maximum likelihood 
approach (Hinton et al., 2006). We treat each pair of adjacent layers as RBMs to 








Overfitting is a potential concern in supervised learning, especially for complex 
model with numerous parameters. Dropout technique introduced by Hinton et al. 
Dropout could be used to significantly reduce overfitting (Srivastava et al., 2014). 
Essentially, it tries to randomly drop some nodes along with all their connections in 
every round, followed by a fine-tuning phase. In this way, dropout can randomly 
sample diverse network structures and combine them in prediction step. 
 
3.3.5 Feature Selection 
We counted the occurrences of motifs within the regions of interest as motif 
features. For both chromatin states and sequence conservation, we determined the 
average signal within our regions of interest as feature values. We performed 
greedy feature selection based on the feature contributions derived from the first 
model. We used all the features to build the model and then employed Milne’s 
method (Milne, 1995) to calculate all the features’ contributions by making use of 
the connection weights from the model as follows: 
!" ! = ! ( !!"!!"!"!!!













Where 1h is the number of units in the first hidden layer, 2h indicates the number 
of units in the second hidden layer, rc(i) is the raw contribution of the ith feature, 
nc(i) is the normalized contribution of the ith feature, w is the connection weight, 
fea is the number of input features. 
Then we ranked all features based on their contributions, and greedily added 
features to the feature set till convergence of prediction accuracy. 
 
 
3.4 Summary and discussion 
In this study, we formalized the exon inclusion prediction problem as a 2-class 
supervised learning problem. Our primary goals here were to assess the relative 
contributions of chromatin and genomic features and specifically test the possibility 
that the previous reported associations between chromatin features and exon 
skipping might be largely due to their correlations with genomic features (Whitaker 
et al., 2014). Our additional goal was to test whether the effect of specific cis 
elements may be modulated by the chromatin context. Based on a comprehensive 
set of genomic and chromatin features in 7 and 3 regions respectively, and using 
deep learning model, we first verified that the genomics features are robust 
predictors of exon inclusion consistent with previous studies (Barash et al., 2010; 
Xiong et al., 2011). At the same time we found that, not only chromatin features 
can only modestly predict exon inclusion, they do not lend substantial information 
beyond what is captured by genomic features. However, our analysis reveals 




suggesting that the effect of latter on exon inclusion may depend on the context 
provided by the former. 
 
We employed DNN with pre-training and dropout methods, which have been 
widely used and proved effective in computer vision and natural language 
processing domains, relative to other machine learning approaches. Essentially, 
DNN, as a model with greater number of hidden layers, can represent higher level 
of abstract features, which should contribute to modeling of the association 
between splicing inclusion and features, in a situation such as splicing where the 
precise mechanisms are not known and there are likely to be several interactions 
among features and stepwise decision being made,. However, complex model are 
more vulnerable to overfitting. Pre-training and dropout algorithms are meant to 
reduce overfitting (Srivastava et al., 2014). Finally, it is not easy to quantify 
interactions within this complicated network model. While we rely on DNN to rank 
features by significance, to assess interaction we employed a simpler model. In our 
study we used standard linear regression to model interactions because of their high 
interpretability. 
 
Previous works relying entirely on genomic features have proposed a highly 
accurate context-specific splicing code (Barash et al., 2010). We rely on the 
dictionary of cis elements compiled in these previous works. However, there are 
some notable differences between our work and these previous works. Our focus is 




of genomic and chromatin features. We have therefore explicitly excluded 
operational, but non-mechanistic, features such as ‘translatability’. Moreover, while 
we estimate prediction accuracy within a cell line independent of other cell lines, 
these previous works in fact predict increase/decrease in exon inclusion in a cell 
line relative to other cell lines, and as such they rely on data from all cell lines 
simultaneously and boost the accuracy through information shared across cell lines. 
Therefore the absolute prediction accuracy reported here are not directly 
comparable to the previous reports. 
 
Even though, by and large, the chromatin features are not highly predictive of exon 
inclusion, we found specific features to be highly significant. H3k36me3 is one of 
the most significant features and is consistent with previous report. For each feature 
revealed by our model as significant, we also directly verified the association 
between that specific feature and splicing inclusion, and examined the joint effect-
size and significance as the feature relevance (Fig 3-2B, 3-S3, 3-S4). We found that 
most of the detected relevant features are consistent with previous correlation study 
(Shindo et al., 2013; Zhou et al., 2012; Zhu et al., 2013). In both GM12878 and h1-
hESC, H3K36me3 is one of the most significant chromatin marks contributing to 
splicing, consistent with previous reports (Shindo et al., 2013; Zhou et al., 2012; 
Zhu et al., 2013). While previous computational association studies suggest that 
H3K36me3 at exon-intron boundary and exon has a positive effect on exon 
inclusion, in contrast, our analyses suggest that this mark can have both positive 




consistent with various potential mechanisms based on experimental studies (Zhou 
et al., 2014). H4k20me1 is significant in all three tissues, consistent with (Zhu et al., 
2013). Moreover, H3K79me2, H3K9ac, H3K27me3, H3K9me3 also showed 
varying degrees of significance. In addition, in stem cell most chromatin features 
within skipped exon have strong positive correlation with exon inclusion, which 
may imply that they can contribute to define exon or recruit SR proteins during 
splicing. 
 
Our finding that genomic signals carry almost all of the information predictive of 
exon inclusion, and that predictive power of chromatin features is not independent 
of genomic elements should not come as a surprise. Despite previously shown 
associations between chromatin marks and splicing, it is likely that the chromatin 
signals themselves may be ultimately governed by the underlying genomic 
elements and the proteins binding to them. This could be true even in the rare cases 
where a direct mechanistic link has been inferred from a specific chromatin feature 
and splicing (Luco et al., 2010; Luco et al., 2011). Recent reports showing highly 
accurate predictability of chromatin features by genomic sequence strongly 
suggests that not just for splicing, but, unsurprisingly, numerous other cellular 
processes, such as transcription initiation, poly-Adenylation, etc., even when there 
strong association and mechanistic links with chromatin features, the ultimate 





We performed cross tissue test using genomics and chromatin model respectively. 
We found that the rules learnt from one cell type are reasonably applicable to a 
different cell type. The differences can be attributed to cell type specific splicing 
factors. We expect that chromatin features, after being largely determined by 
genomic features, should have conserved rules governing exon inclusion across cell 
types. We found high cross-cell type predictability for stem cell and leukemia. This 
specific observation is consistent with known broad similarities in active cellular 
processes between stem cell and cancers (Epigenetic similarities between Wilms 
tumor cells and normal kidney stem cells found -- ScienceDaily; Li and Neaves, 
2006; Spike and Wahl, 2011). 
 
Even though our analyses suggest that chromatin features are not likely to be the 
primary drivers of alternative splicing, they might still be able to affect splicing at 
the molecular level, as suggested by our interaction study (Fig. 5-7). First, 
chromatin features may serve to provide the recognition specificity for specific 
factors, similar to genomics features. At the molecular level, in most of the reported 
potential mechanism, chromatin features interact with many other molecules to 
affect splicing, such as chromatin remodeling protein and SR protein. We speculate 
that the spatial position of those chromatin marks may influence their protein 
recruitment or conformational changes after recruiting other factors. Moreover, 
recruitment of different protein factors can have different effect on splicing. For 
example, H3K36me3 can both facilitate or suppress splicing by recruiting MRG15 




we observed interaction between H3K27me3 and H3K4me1, which have been 
suggested to together mark poised enhancer (Creyghton et al., 2010; Rada-Iglesias 
et al., 2011); In h1-hESC cell line we identified interaction between CTCF and 
H3K9me3, which have been shown to co-localize (Thomas et al., 2011). In K562, 
we observed interactions between H3K79me2 and H3K36me3, which are both 
markers of gene bodies, that is likely to be important for exon definition process in 
splicing regulation. While we do observe interactions between chromatin and 
genomic features, very little is known in the literature to reasonably corroborate our 
findings. Moreover, the mapping between specific cis element and corresponding 
splicing factor is not known for the most part, making it difficult to interpret the 
results pertaining to cis element interactions. In GM12878 sample, we detected a 
potential interaction between H3K9ac and motif “GGCTGC”. Even though the 
protein interacting with the cis elements is not known, we speculate that a splicing 
repressor like hnRNP binds to the motif to repress inclusion when H3K9ac is 
present. In h1-hESC, we identified an interaction between SRSF9 protein and 
H3K79me2. However, the specific locations of the two features are genomically 
distal from each other (Fig. 6). Such distal interactions are entirely possible due to 
looping at both DNA and RNA level (Matthews, 1992; Paek et al., 2015; Rueda et 
al., 2009). In K562 sample, the interactions of H3K36me3 with different motifs 
























Chapter 4: Comprehensive map of age-associated splicing 






 4.1 Introduction 
 Almost all multi-exon genes in human exhibit alternative splicing (Black, 
2003; Wahl et al., 2009), which alongside transcriptional regulation, significantly 
contribute to the transcriptomic as well as phenotypic diversity at multiple 
biological scales (Nilsen and Graveley, 2010). Much like transcription, splicing is 
highly regulated, by both genetic and environmental factors, and its dysregulation 
is implicated in, among other things, normal aging as well as age-associated 
diseases (Deschênes and Chabot, 2017; Eriksson et al., 2003; Wang and Cooper, 
2007b; Watson et al., 2013).  
Normal aging is associated with systemic changes in cellular processes involving 
both transcriptional and post-transcriptional controls (Johnson et al., 1999). While 
some of the changes in molecular processes are caused by age-related changes in 
the cellular environment, it is possible that molecular changes may further 
contribute to the aging process, and to age-related diseases such as hypertension 
and cardiovascular diseases. Moreover, such age-associated changes in the 
transcriptional and post-transcriptional regulation are likely to vary across tissues 
and organs. While age-associated gene expression changes across several tissues 
have been previously reported (Glass et al., 2013; Yang et al., 2015), similar 
investigations of age-associated splicing changes are limited.  
Mazin et al. have previously reported age-associated splicing changes in two brain 
regions (Mazin et al., 2013b), and Tollervey et al. (Tollervey et al., 2011b) have 




Alzheimer's disease samples.  However, these few previous studies: (1) focused 
only on a single or very few tissues in contrast to 48 primary tissues included in our 
study, (2) investigated only exon skipping events while we have studied 7 types of 
splicing events (exon skipping, alternative 5’, alternative 3’, mutually exclusive 
exon, alternative first exon, alternative last exon, and intron retention), (3) are 
based on very few individuals (around 35), in contrast to 177 individuals on 
average per tissue in our study, and highly importantly, (4) in contrast to our study, 
do not explicitly control for batch effect and potential hidden confounding factors, 
which may lead to false positives.  Our study addresses these limitations in the 
previous studies toward a comprehensive investigation of age-associated splicing 
changes across human tissues, which may provide insights into age-related diseases 
mediated by splicing changes.  
Based on ~8500 RNA-seq samples from 544 donors across 48 tissues in the 
Genotype-Tissue Expression dataset (GTEx version 6) (GTEx Consortium, 2015), 
here we report a comprehensive detection of age-associated splicing changes across 
tissues in human. Using a stringent model, we identified 49,869 age-associated 
splicing events of 7 distinct types (Keren et al., 2010), including 17,447 exon-
skipping events, across the 48 tissues.  
Overall, we report the first systematic genome-wide analysis of age-associated 
splicing events spanning 7 types of splicing events (Alamancos et al., 2015) across 
48 primary tissues, paving the way for future investigations of links between 




 4.2 Results 
 4.2.1 Age-associated splicing events are prevalent in most tissues and 
are largely tissue-specific 
Our overall pipeline is illustrated in Fig. 4-1A, and the details are provided in the 
Methods section. Briefly, we obtained a total of ~8500 expression samples across 
48 tissues (the ones having at least 50 donor samples) and a total of 544 donors 
from GTEx (GTEx Consortium, 2015). The number of samples for each tissue and 
distributions of age and gender are shown in supplementary Fig. 4-S1. Based on 
GENCODE annotations (Harrow et al., 2012), we compiled 163,505 alternative 
splicing events of 7 different types (Fig. 4-1B) (Alamancos et al., 2015), and 
estimated sample-specific PSI values (Percent Splicing Index) for each event in 





events. To ensure sufficient statistical power, we only analyzed 48 tissues with at 
least 50 samples. Moreover, in a particular tissue, we only analyzed the events that 
could be quantified in at least 50 samples. More specifically, in a given tissue, we 
only analyzed the genes that are expressed in at least 50 individuals in the tissue. 
We thus analyzed a total of 163,505 splicing events spanning 7 types of events 
across the 48 tissues; a total of 3,723,596 tests. 
Summarized in Fig. 4-2A, overall 49,869 events (1.3%) were found to be 
significantly associated with aging (FDR <= 0.05 and permutation p-value <= 0.05; 
see Methods) in at least one tissue; on average 1,018 events were detected in each 
tissue. We ascertained that the number of significant events detected in a tissue is 
not correlated with sample size (Supplementary Note 4-1). In addition, we show 
 
 
Figure 4-1: Overall pipeline and seven types of splicing events. (A) Overall pipeline to detect 
age-associated splicing events. (B) Seven types of alternative splicing events before and after 
splicing. Blue rectangles represent constitutive portion of the exons. Purple and beige rectangles 
represent the alternatively used portion of the exons. Solid lines represent introns. Dashed lines 
connect the ends of alternatively spliced out portions of the gene. The splicing event structures 






that our results are robust to the potential confounding by human ancestry (detailed 
in Supplementary Note 2). Fig. 4-2B specifically summarizes the exon skipping 
event. In Supplementary Table 4-S1 and Supplementary Fig. 4-S2 we provide a 
detailed summary of significant age-associated events across 48 tissues for each 
type of splicing event. Age-associated splicing changes are found to be most 
abundant in Skin (Sun exposed) and Esophagus-Mucosa; interestingly, both these 
tissues are composed of epithelial cells and are most exposed to external 
environment, have a well-established effect of aging (Berdyyeva et al., 2005).  
To further illustrate age-associated splicing events, Fig. 4-2C shows clustering of 
samples using the sample-specific PSI values of significant age-associated exon 
skipping in uterus, revealing subgroups with distinct age distributions (Fig. 4-2D; 
cluster 2 > cluster 1: Wilcoxon p-value = 3.7e-04; cluster 3 > cluster 2: p-value = 
7.8e-3). While inter-cluster differences in age distribution are expected, 
interestingly, the three splicing-based clusters reflect three important 
reproductive/hormonal stages in females (Menopause, 2015): the median age of 
individuals in cluster 1 is 33 years which roughly corresponds to age of first child 
birth, and the median age of individuals in cluster 2 is 50 years which roughly 
corresponds to the onset of menopause, while the individuals in cluster 3 are 60 





Figure 4-2: Summary of significant age-associated splicing events. (A) Number of significant 
age-associated splicing events across 48 tissues. (B) Number of significant up-regulated (increased 
with aging) and down-regulated (decreased with aging) exon skipping events across 48 tissues in 
gray and yellow color respectively. (C) Hierarchical biclustering of top age-associated exon 
skipping events in Uterus across individuals, based on PSI value of each event; the columns 
represent events and the rows represent 83 individuals with age information; blue indicates higher 
PSI and red indicates lower PSI. (D) Box plot of age distributions of the three identified clusters of 
individuals. (E) Scatter plot illustrating an up-regulated cassette exon event (COL6A3: 
chr2:238285987-238287279:238287878-238289558) in Uterus. (F) Scatter plot illustrating a down-





corresponding to post-menopause. Fig. 4-2E and 4-2F illustrate two examples of 
significantly age-associated events in the uterus. Fig. 4-2E shows an exon skipping 
event in COL6A3, a procollagen gene important in the extracellular matrix 
organization, previously shown to be linked to aging in rat muscle tissue (Chaves et 
al., 2013). In addition, COL6A3 is related to different stages of pregnancy in mouse 
uterus tissue (Diao et al., 2011). Fig. 4-2F shows an exon skipping event in a 
nuclear factor gene NFE2L1, whose worm ortholog SKN-1 has been linked to 
lifespan extension (Tullet et al., 2008). In addition SKN-1 is significantly related to 
collagen expression (Ewald et al., 2015), which is critical for uterus. Interestingly, 
these two genes are also age-dependent in the other 6 and 7 tissues respectively.  
Alternative splicing has been shown to be tissues-specific (Barash et al., 2010; 
Chen et al., 1999; Xu et al., 2002). Here we assessed the extent to which this is true 
of age-associated splicing changes. Toward this, we quantified tissue-pair similarity 
in age-related splicing as the Jaccard index based on the genes involving age-
related splicing in the two tissues. As evident in Fig. 4-3A, most tissues do not 
share age-associated alternatively spliced genes, implying that such events are 
tissue-specific, similar to the alternative splicing itself.  Hierarchical clustering of 
tissues based on their pairwise Jaccard index revealed three clusters (Fig. 4-3A). As 
expected, Skin – Not Sun Exposed (Suprapubic) and Skin – Sun Exposed (Lower 
leg) have a high Jaccard index, and so do Colon – Sigmoid and Colon – Transverse. 
The cluster of 9 tissues (Fig. 4-3A top right corner), share 19 age-associated 




the 19 genes are involved in regulating macromolecule interactions, including 
binding to proteins, lipids, or nucleic acids. 
4.2.2 Age-related splicing events are potentially functionally linked to aging 
process 
The 49,869 significant age-associated events across 48 tissues correspond to 9,884 
genes. We performed functional term enrichment analysis in these genes in a 
tissue-specific fashion, using NIH’s David online tool (Huang et al., 2008; Huang 
et al., 2009). We selected the terms that were enriched (FDR <= 5%) in at least 3 
tissues and performed hierarchical biclustering based on those terms’ enrichment 
levels (fold change) across tissues (Supplementary Fig. 4-S3). We also provide a 
TreeMap view (Supek et al., 2011) of GO terms that are enriched among age-
associated spliced genes in at least one tissue in supplementary Fig. 4-S9. GO 
annotation is far from complete, noisy, and lacks resolution, and tissue context, 
making functional interpretation of enriched process in a specific context 
challenging. Therefore, even though we identified enriched processes in a tissue-
specific way, we chose to take a broad look at the enriched processed across 
tissues, for a more robust interpretation. Supplementary Table 4-S3 lists the top 15 
biological functions ranked according to either the number of affected tissues or 
fold change. These top functional terms include some well-studied processes linked 
to aging. For example, mitochondrion and peroxisome and their associated 
processes are implicated in balancing the levels of reactive oxygen species in the 
cell (Wallace, 2005), and cell-cell adhesion is essential for mediating tissue 




ribonucleoprotein were ranked among the top by both measures, which is in 
agreement with the emerging view that the ability of cells to maintain a healthy and 
relatively stable pool of proteins under continuous stresses that accumulate over 
time is a major determinant of lifespan (Andrew Dillin Cell Meta 2016). 
Interestingly, genes with age-associated splicing in Muscle – Skeletal (358 genes), 
Whole Blood (2,073 genes) and Adipose-Subcutaneous tissues (1,143 genes) are 
linked with all top enriched processes, with very little overlap among the respective 
gene sets. The interaction between aging process and alternative splicing can be bi-
directional, that is, many age-related events may be downstream effects, rather than 
causes, of aging. The genes that are involved in typical aging-related biological 
functions, as well as exhibit age-associated splicing patterns may contribute to 
aging and aging related phenotypes, while other genes that although exhibit age-
associated splicing pattern but otherwise are not involved in aging-related 
processes may represent downstream effects.  Overall, these results show that in 
some tissues age-related splicing events may be functionally linked to the 
phenotypic changes associated with aging, while they may be the downstream 
effect of aging process in others.  In addition, 78.6% of overall biological processes 
(include most aging related processes) are recaptured by only performing gene 
ontology analysis on genes uniquely associated with splicing changes, which 
implies that these reported aging related process may be related to age-associated 






4.2.3 A focus on splicing uniquely reveals numerous age-associated genes 
Both transcriptional and splicing processes can change with age. With regards to 
splicing regulation, while the age-associate changes must be mediated at the level 
of individual splicing events, the downstream effects of these changes on the age-
related phenotypes are mediated by changes in the levels of specific transcripts. 
Toward obtaining a global view of age-associated changes in these various aspects 
of the transcriptome, analogous to splicing event-based model above, we 
implemented linear models to detect age-associated changes in gene expression, 
transcript expression, and relative transcript ratios (Methods), and compared the 
genes corresponding to the significant age-associated events in the four categories – 
individual splicing events, gene expression, transcript expression, and relative 
transcript usage, shown in Fig. 4-3B, for 4 select tissues (all tissue results are 
provided in Supplementary Fig. 4-S4). It is apparent from this result that a focus on 
splicing and transcripts uniquely reveals numerous age-associated genes. 
Specifically, for instance, 18% of the metabolic genes, known to be significant 
aging markers, are revealed as age-associated only at the transcript level, and not at 
the level of overall gene expression, e.g., Phosphofructokinase gene locus (PFK), 
which has previously been targeted in cancer therapy (Yi et al., 2012), exhibits age-
associated changes at the transcript level in 21 tissues but not at the level of gene 
expression (Supplementary Fig. 4-S5 illustrates the known isoforms of PFK and 
their age-associations) (Liu et al., 2015).  These results suggest that aging process 
has substantial association with post-transcriptional regulation beyond its known 





Figure 4-3: Comparison of age-associated genic changes across tissues and across approaches 
to capture genic changes. (A) Clustering of tissues based on pair-wise similarity of genes affected 
by age-associated splicing, based on Jaccard Index. The darker blue color indicates higher similarity 
and darker brown indicates lower similarity. (B) Overlap of gene sets affected by age-associated 
changes detected at the level of gene expression (sky blue), transcript ratio (medium orchid), 
splicing events (orange) or transcript expression (pink). (a) – (d) show the data for whole blood, 
Skin, Muscle-skeletal, and Thyroid tissues respectively, as examples. Data for all tissues are 





Figure 4-4: Prediction of age and computational validation. (A) Accuracies of prediction of age 
using models based on gene expression (pink circle), splicing events (green triangle) and isoform 
expression (blue square) across tissues. The accuracy is measured by Pearson correlation between 
predicted and true ages based on cross-validation.(B) The figure shows predicted relative ages for 
two sets of skin fibroblast cell culture (D1 and D2) across three passages (PX: passage X). (C) The 
figure shows predicted relative ages of ten pairs (from individuals S1 through S10) of longitudinal 
skin fibroblast samples. The matched young and old samples were derived from the same individual 







Figure 4-5: Potential mechanism and contributions to hypertension. (A) The 7 functional 
regions relative to an exon (yellow rectangle) potentially impacting the splicing event. (B) 
Illustration of a potential mechanism of age-associated change in exon inclusion whereby the 
expression of a splicing factor PTBP1, which suppresses the inclusion of the cassette exon, 
decreases with age, thereby resulting in an increase in exon inclusion with age. (C) Additional 
contribution of splicing events to the explained variance of Hypertension, in multiple tissues shown 
on x-axis. The y-axis denotes the significance (-log(p-value)) based on a log-likelihood ratio test. 






4.2.4 A splicing-based model is informative of biological and cellular age 
We first assessed the extent to which genome-wide splicing profile in an individual 
is reflective of the individual’s biological age. Furthermore, to compare the merits 
of splicing profile relative to gene expression and transcription expression profiles, 
we constructed three analogous models of age based on splicing profile, gene 
expression profile, and transcript expression profile (Methods). The accuracy was 
quantified as the Pearson correlation between predicted ages and true ages in cross-
validation samples. Fig. 4-4A shows the 10-fold cross-validation prediction 
accuracies of the three models across 33 tissues; only the tissues in which all three 
models yielded positive predictive accuracy are shown. A direct comparison of 
model accuracies based on paired Wilcoxon test across tissues reveals that splicing-
based model outperforms the other two models (p-values <= 1.1e-3). Surprisingly, 
the isoform-based model is not significantly better than the gene expression-based 
model, which may be due to incompleteness and inaccuracies in isoform 
annotations and noisy quantification of isoform expression. In addition, we 
implemented an alternative approach to estimate accuracy. We partitioned the 
individuals into two classes of old and young (Old class: the oldest 25% and Young 
class: the youngest 25%) and performed a standard classification based on Lasso 
regression. The results are consistent, in that the splicing events results in better 
prediction accuracy than the other two modalities, and on average the prediction 
accuracy is 71% (supplementary Fig. 4-S6). Overall our results suggest that global 




We also compared the 7 types of splicing events regarding their individual ability 
to predict age following an analogous procedure as above. The results are shown 
for the 25 tissues in which all seven models yielded positive predictive accuracies 
(Supplementary Fig. 4-S7). Overall the exon-skipping events are the best predictor 
of age compared to the other 6 types of events (all Wilcoxon test p-values <= 7.4e-
3). 
Next, we assessed whether a splicing-based model of age constructed using GTEx 
skin fibroblast samples can successfully predict relative ages of two independent 
longitudinal datasets of skin fibroblast (Methods). This analysis is limited by the 
data availability. The first dataset consists of cell passage (a standard proxy for 
cellular age) data, which includes young (11 passages), middle (16 passages) and 
old samples (21 or 20 Passages) for two healthy individual derived skin fibroblasts 
(6 samples). In addition, donor 1 is younger than donor 2. The second dataset 32 
includes 10 pairs of longitudinal samples from 10 donors at two different ages 
separated by 15.7 years on average (20 samples). To specifically assess the 
contributions of age-associated splicing events, the model was constructed using 
only the significant age-associated splicing events detected in GTEx (Methods).  
In the first validation dataset (Fig. 4-4B), our GTEx-trained model correctly 
predicts the lowest passage cells to be younger than the oldest passage cells in 
donor 1 (D1), but fails to correctly predict the age of middle passage cells. 
However, in donor 2 our model correctly predicts the relative ages of the three cell 
passages. Out of total 19 pairwise comparisons (based on donors’ age and cellular 




Wilcoxon test of the 19 pairwise predicted ages showed significance with p-value 
is 0.0047.  In the second longitudinal dataset (Fig. 4-4C), in 8 out of 10 cases, our 
model correctly predicts the relative ages of the two samples from the same 
individual.  
 
4.2.5 Some of the age-associated splicing events may be driven by age-
associated expression changes in the upstream splice factors 
In exploring the mechanisms underlying age-associated splicing changes, we 
assessed whether certain motifs near the splicing event recognized by a splicing 
factor, along with age-associated changes in the expression level of the splicing 
factor, can together explain the changes in splicing.  This analysis was restricted to 
exon skipping events. In each tissue independently, using the significant tissue-
specific events, separately for up-regulated and down-regulated event, we identified 
the splicing regulators whose RNA-recognition motifs (obtained from (Ray et al., 
2013) ) were significantly enriched in any of the 7 regions near the cassette exon 
(Fig. 4-5A), relative to the background cassette exons whose usage did not vary 
with age (Methods). An enrichment threshold (FDR <= 0.1) was applied to retained 
potential functional motifs.  
Supplementary Table 4-S4 lists the 9 potential splicing factor drivers of age-
associated splicing changes identified in skin fibroblast. Splice factor PTBP1 is 
known to inhibit exon retention by binding to exonic splicing enhancers (Spellman 




the middle exon among up-regulated exon inclusion events and consistently, 
PTBP1 expression showed a significant decrease with age (standardized age 
covariate coefficient = -35.8). Illustrated in Fig. 4-5B, this example suggests a 
potential mechanism whereby an age-associated decrease in PTBP1 concentration 
lifts its inhibitory effect resulting in increased exon retention at multiple loci.  
We sought for experimental support for splicing factor-mediated changes in 
splicing through age. We obtained 3546 potential PTBP1 targets in HeLa cell based 
on PTBP1 CLIP-seq data (Dror et al., 2016); such data is not available for skin. We 
then independently, using our approach, identified 46 genes whose age-associated 
splicing is potentially a downstream effect of PTBP1. We found that 
experimentally identified potential target genes of PTBP1 are highly enriched 
among the targets identified by our pipeline (Fisher test p-value = 1.3E-05; Odds-
ratio = 2.4).  
 
4.2.6 Age-associated splicing contributes to complex age-related diseases 
Several complex diseases, many of which exhibit increased incidence with age, 
have been shown to be associated with distinctive tissue-specific gene expression 
profiles (Bruneau, 2008; Demichelis et al., 2012). Potential mechanisms linking 
alternative splicing to age-related diseases have been explored previously. 
Alternative splicing might change the transcript ratio leading to a greater fraction of 
impaired protein isoform, truncated wild type protein, or suboptimal isoform ratios, 




(Deschênes and Chabot, 2017; Li et al., 2017).  Alternative splicing within genes 
EAAT2, SALL1 and TAU have been shown to contribute to age-related diseases 
(Li et al., 2017; Lin et al., 1998).  Given our observed links between splicing and 
aging, we assessed the extent to which tissue-specific splicing profile potentially 
contributes to age-related diseases. We tested this for 4 diseases, including 
hypertension, for which there are a sufficient number of samples in GTEx in 
multiple tissues. For a given disease and tissue, Log Likelihood Ratio (LLR) test 
(Method) was used to assess the independent contribution of splicing profile to the 
disease by controlling for age, gender, and gene expression. As shown in Fig. 4-5C, 
relative to gene expression, age and gender, splicing can significantly (p-value <= 
0.05) explain additional hypertension disease state variance in all of the 15 tissues 
tested. The three most significant tissues are Heart, Artery, and Adipose, which 
have well-established mechanistic links to hypertension. Results for three 
additional pathologies – Heart Attack, Chronic Respiratory Disease, and Diabetes 
mellitus type II, show consistent results (Supplementary Fig. 4-S8). Due to 
relatively small sample size, we analyzed fewer tissues for these three diseases. In 7, 
4 and 3 tissues respectively for Diabetes mellitus type II, Chronic Respiratory 
Disease and Heart Attack, age-associated splicing events provide significant 
independent contribution in addition to age, gender and gene expression.  In 
addition, we show that our results are robust to potential confounding by human 
ancestry (race) by additionally controlling for race in both the null and alternative 




0.98). These results suggest links between splicing and complex age-related 
diseases independent of age and the genome-wide gene expression profile. 
 
4.3 Materials and Methods 
 4.3.1 Splicing Level Quantification using GTEx data 
 The processed transcript expression data for ~8500 samples from 544 
donors across 48 tissues were downloaded from Genotype-Tissue Expression 
(GTEx) database version 6 (GTEx Consortium, 2015). GENCODE genome 
annotation version 19 (Harrow et al., 2012) and SUPPA software package 48 was 
employed to extract 7 types of exon-centric splicing event annotations (exon 
skipping, alternative 5’, alternative 3’, mutually exclusive exons, alternative first 
exon, alternative last exon, intron retention). Then in each sample SUPPA was used 
to quantify the splicing level of each annotated event in terms of PSI values 
(Percent Splicing Index). 
 
 4.3.2 Model for detecting age-associated splicing events 
 To detect significant age-associated splicing events, we modeled the 
association between each event and age across multiple samples as follows : 




Where !"!!" ! is the splicing level for event i in sample j, !"!! ! and 
!"#$"!! !denote the age and gender of individual j respectively, PEER CF!!  




individual j. !!  is the intercept for the model of event i, !!!  and !!! are the 
coefficients respectively for age and gender covariate for event i, !!!!!  is the 
coefficient of the kth confounding factor for event i,  !!" !is the error in the model 
for event i of individual j. In addition, in this model n is the number of hidden 
confounding factors we estimated (n= 20) compared to 15 hidden confounding 
factors used in Brinkmeyer-Langford et al’s age-associated gene expression study 
50.  
Since some genes are not expressed in some of the samples, when modeling such 
splicing events corresponding to those genes, we excluded samples where the gene 
was not expressed (reported as -1 by SUPPA package). Further, to ensure statistical 
power, we only analyzed events having at least 50 samples where the 
corresponding gene had non-zero expression. For each event, we fitted the data to 
the model and examined the age covariate coefficient !!! , and assessed the 
significance for its deviation from zero, and applied FDR control across all tested 
events. In addition, we performed permutation test by shuffling the age distribution 
across all individuals. For each event, permutation test is performed for 1000 times 
and estimate the significance of the age covariate. Events with FDR <= 0.05 and 
fewer than 5% of the permuted data showing significance (p-value <= 0.05) were 
deemed significantly age-associated.  
 
 4.3.3 Correcting for confounding factors using PEER package 
 We ensured that our detected link between an event and age is not due to 




studies to correct for potential hidden confounding factors such as batch effects 
(Stegle et al., 2012). For each tissue, given the global PSI profiles (including all 
events of all types) for all individuals, we estimated 20 ‘PEER’ factors. Then we 
estimated Pearson correlation between each PEER factor and age across all 
individuals, and excluded the factors, in an event-specific way, that were 
significantly correlated with age (p-value < 0.05). 
 
 4.3.4 Functional Enrichment analysis 
 We map each significant age-associated splicing event to its corresponding 
gene, and identified significantly enriched (FDR <= 0.05) GO terms in a tissue-
specific manner using NIH’s David online tool (Huang et al., 2008; Huang et al., 
2009). We further retained only the terms that were enriched in at least three 
tissues.  Finally we performed hierarchical biclustering based on the enrichment 
level (fold change) of enriched functional terms across tissues. In addition, we used 
package “REVIGO” (Supek et al., 2011) to generate a TreeMap view of the 
enriched GO terms, and for each GO term the number of tissues in which it was 
significantly enriched (FDR <= 0.05) was used as the enrichment score for 
visualization.  
 
 4.3.5 Cross tissue similarity in age-associated splicing 
 Jaccard index is a metric to measure the similarity between two sets 
(! !,! = (!∩!)(!∪!) !(0 ≤ ! !,! ≤ 1)). We employed this metric to measure the 




identified the genes having at least one age-associated splicing event, and estimated 
the Jaccard index using the tissue-specific gene sets.  
 
 
  4.3.6 Age-associated gene, isoform and isoform ratio detection across 
tissues 
 In order to assess age-associated changes in gene expression, isoform 
expression, and isoform ratio levels, we developed three linear models.  
Gene model:  




Transcript model:  




Transcript ratio model:  




i and j represent an event and an individual respectively, and n denotes the number 
of confounding PEER factors considerd. !!!,!!!!"#!!!!!! denote the coefficient for 
age, gender and kth confounding factor for event i of individual j.  G denotes gene 
expression, T represents for transcript expression and TR denotes transcript ratio 
( !!!!). CFG (equation 2) and CFT (equation 3 and 4) denote confounding factors 








 4.3.7 Predicting Age using splicing level, isoform expression, and gene 
expression 
 To compare the power of splicing level, isoform expression and gene 
expression in predicting age, we built a LASSO regression model for each of them. 
For the splicing model, MDS analysis was performed over the population PSI 
values, and top 30 PCs were used as features in the linear model to predict age. In 
order to remove sampling bias, we performed randomized 10-fold cross validation 
100 times and estimate the average cross-validation predicted age for each sample, 
and estimate the accuracy as the Pearson correlation between the predicted and the 
given age. For comparison, we implemented an identical procedure using gene-





 4.3.8 Predicting relative ages in independent datasets using splicing-
based model of age 
 To validate our splicing-based model of relative age, we build a lasso 
regression model based on our detected top age-associated splicing events in GTEx 
data to predict the relative ages in longitudinal data and cellular age data. Recall 
that in detecting significant age-associated splicing events, we perform a 
permutation test. Since the permutation is stochastic, we repeated it 10 times and 
selected 141 age-associated events detected in at least 8 permutations. These 141 
events were then used to build a model of age in GTEx data, which is used to 
estimate the age of each sample in the independent validation set. The predicted age 
is transformed into a z-score using the predicted age distribution of GTEx data ro 
represent the relative ages. 100 rounds of model fitting were performed to remove 
sampling bias (the penalty parameter lambda was optimized based on randomized 
cross-validation) to generate a distribution of predicted z-scores for each sample in 
the independent dataset. Then Wilcoxon tests were performed to compare the 
relative ages of two samples. 
 
 4.3.9 Detecting potential upstream drivers of age-associated splicing 
changes 
 Here the goal was to test the hypothesis that the age-associated changes in 
expression of the upstream splicing factor gene contribute to the downstream age-
associated splicing changes. We obtained 121 experimentally validated RNA 




corresponding splicing factors are also known.  All significant age-associated exon 
skipping events from skin fibroblast tissue were divided to 3 classes based on the 
direction of their age-associate change ( class 1: increase with age, class 2: stable, 
class 3: decrease with age). We performed motif enrichment analysis between class 
1 and 2, and also between 2 and 3. More specifically, the frequency of each motif 
between two classes was compared using Wilcoxon test, and FDR control was 
applied to select significantly enriched motifs.  
Next, we performed differential gene expression (transcript level) analysis across 
aging using a model analogous to the model for splicing above, and detected the 
splicing factors (i) whose gene expression (transcript level) is significantly (p-value 
<= 0.05) associated with age, and (ii) whose motifs are enriched near the age-
associated splicing events.  
 
 4.3.10 Estimating contribution of splicing profile to complex diseases 
 We build two nested linear models of age-related diseases in the GTEx 
population independetly in each of the 48 tissues. The first ‘null’ model (Equation 
5) relates the binary disease state to age (AGE), gender (GENDER), and gene 
information (GE), and the second ‘splicing’ model (Equation 6) additionally uses 
splicing information; however, we only included significant age-associated splicing 
events.  
!"##! "#$% ∶ !!!! ! = !! + !!!"!! + !!!!"#$"!! + !!!!! !(5)              




!!  denotes dieases status (0: normal, 1: disease). For both gene and splicing 
information, we reduced the dimensionality by performing MDS analysis using the 
top 100 PCs in both cases. Given the two model fits, we estimated the Log-
Likelihood ratio and estimated the contribution of splicing information using Chi-
sqaure test.  
 
4.4 Summary and Discussion 
Overall, exploiting ~8,500 tissue-specific transcriptomes in 544 individuals, we 
identified 49,869 age-related splicing events for 7 distinct types of splicing events 
across 48 tissues. In contrast to previous related works, our model stringently 
controls for potential hidden confounding factors. In addition to validating our 
splicing-based model of age in independent longitudinal and cell passage datasets, 
we show that splicing profiles are a better predictor of biological age than gene and 
transcript expression levels alone, and the splicing profile provides an independent 
contribution to age-related complex diseases. Finally, we propose a potential 
mechanism underlying age-associated splicing changes mediated by a concomitant 
change in the expression level of the upstream regulatory splice factor. 
Mazin et al. identified 3,132 and 6,114 significant age-related splicing events in the 
two brain regions respectively, with 1,484 events in common, which represents 
~5% of all events assessed. In contrast, we identified 1,066 events from the same 
regions. However, these represent ~0.06% of all events that we assessed, 
potentially reflecting the stringency of our approach. A direct comparison of events 




event definition. These differences could potentially be attributed to multiple 
factors related to sample sizes and controls.  
Besides age-associated splicing studies mentioned above, recently, Yang et al. 
reported age-associated gene expression changes across 7 tissues from GTEx 
version 4 (Yang et al., 2015), and found that Blood has the most age-related gene 
expression changes, consistent with our splicing-based results. Lung, Muscle and 
Heart tissues were also shown to have significant age-associated changes in both 
our studies. Our study however uniquely identifies Skin to have a large number of 
age-associated splicing changes, which may suggest that age-associated effects in 
skin primarily affect splicing levels and are not reflected in gene expression levels. 
However, broadly, the genes revealed by both our and previous studies are related 
to common aging-related biological processes such as mitochondrial function, 
DNA repair, Cell Cycle, ATP-binding, etc. in Whole Blood, Muscle and Heart 
tissues. 
Anomalous gene expression is often the first major factor considered when 
investigating aging and complex age-related diseases. However, our study suggests 
that tissue-specific splicing profiles may provide an additional contribution to aging 
and age-related diseases. Indeed previous studies have directly linked splicing 
dysregulation to diseases, independent of gene expression (Dror et al., 2016). 
As the first multi-tissue study of age-associated splicing changes, we were able to 
compare such changes across tissues. Our observed lack of cross-tissue 
commonality is consistent with previous studies suggesting that the alternative 




Corces, 2011), and tissue-specific changes in the expression and splicing regulators 
can explain tissue-specificity of the age-related splicing changes.   
Importantly, our analysis suggests one potential mechanism of age-associated 
splicing changes, namely, via age-associated expression changes of splicing 
regulators. Given the links between splicing and transcription (Naftelberg et al., 
2015), it is conceivable that several other transcriptional mechanisms can 
contribute to age-related splicing changes. For instance, age-related changes in 
DNA methylation and histone modifications have been previously reported (Jung 
and Pfeifer, 2015; Kawakami et al., 2009). Specifically, DNA methylation has been 
shown to be an excellent biomarker of age (Horvath, 2013). Polymorphisms can 
also affect age-associated splicing changes, which may in turn manifest in variable 
vulnerability to age-related diseases. Our study provides a methodological 
framework and resource for future targeted investigation of links between splicing 


























Chapter 5: Interactions of SNPs and age-related TFs are 



























 Normal aging is a critical “environmental” risk factor that is significantly 
associated with complex diseases such as hypertension, cardiovascular defects, 
macular degeneration, Parkinson's disease and cancers (Blasco et al., 2013; Niccoli 
and Partridge, 2012). Specifically, the prevalence of hypertension among people 
older than 60 years is around 65% compared to only 7.3% for people between 18 
and 39 years old in 2011-2014 year based on the report of Centers for Disease 
Control and Prevention (CDC) in the USA (Sug et al., 2015). Numerous crucial 
biological functions like immune response, wound healing, DNA repair, 
metabolism and mitochondria function etc also significantly decline with aging 
(Blasco et al., 2013; Niccoli and Partridge, 2012; Wyss-coray, 2015), which further 
support potential pathological role of aging in complex diseases. However, the 
concrete mechanism are far from clear, although profound transcriptomic changes 
with both aging and complex diseases have been identified (Glass et al., 2013; 
Tollervey et al., 2011a; Wang et al., 2014b). In addition, genomic variations, 
associated with transcriptome variability shown by eQTL studies (Acharya et al., 
2017; Das et al., 2015; Gilad et al., 2008; Westra and Franke, 2014), also 
potentially contribute to complex diseases revealed by GWAS studies (Adeyemo et 
al., 2009; Jiang et al., 2011; Visscher et al., 2017). ~120 SNPs have been found to 
be associated with elevated blood pressure and hypertension in GWAS studies 
(Franceschini et al., 2013; Ortega et al., 2015; Sofer et al., 2017; The UK Biobank 
Cardio-metabolic Traits Consortium Blood Pressure Working Group et al., 2018; 




with colorectal cancer using GWAS (Dror et al., 2016; Lubbe et al., 2012; Wang et 
al., 2014a).  
It is plausible, and indeed likely, that both aging and genome variations could 
contribute to complex diseases; however, potential interplay between the two 
factors has not been elucidated fully. It is highly likely that phenotypic effect of 
systemic molecular changes through aging may depend on the genotype of the 
individual. In other words, the genome variations might mediate age-dependent 
effect on phenotype or transcriptome variability. Such genotype-environment 
interactions have been previously investigated via incorporating SNP-Environment 
term in a regression model. Yao et al identified 10 age dependent eQTLs in Whole 
Blood (Yao et al., 2014). Using a meta-analysis approach, Simino et al detected 9 
SNPs which have age dependent effect in blood pressure (Simino et al., 2014). 
Dongen et al also showed the methylome in whole blood could be affected by the 
interactions between SNPs and age (Dongen et al., 2016). However, insights about 
interaction and regulation mechanisms are limited in previous studies.  
In our study, we incorporated an interaction mechanism in our model. More 
specifically, we approximate the environmental changes by age-associated changes 
in concentration of regulatory proteins (transcription factor), and with the 
hypothesis that age-associated TF might exhibit allelic binding imbalance, explore 
potential causal interaction effect between genotype and aging toward explaining 




To test our hypothesis, we proposed a novel pipeline, in which we first predicted 
allele-specific binding sites for putative age-associated TFs in accessible chromatin, 
then tested the association between interaction term and potential target gene 
expression and complex diseases. We performed the analysis in 25 tissues due to 
availability of chromatin accessibility data and detected ~591 SNP-TF-Gene 
triplets on average across 25 tissues. Interestingly, numerous detected interactions 
are related to hypertension. To assess the robustness, we estimated the replication 
rate in cross validation. In addition, significantly enriched epigenomic markers 
(chromatin accessibility, H3K27ac, H3K4me1, H3K4me3) related to regulatory 
elements in the interaction regions, suggest potential functionality of our detected 
interactions. Finally we showed target genes regulated by reported significant 
interactions could be linked to aging process and complex diseases by performing 
enrichment analysis.   
In summary, we reported a novel framework to explore the potential causal 
interactions between SNPs and aging, in the context of transcriptional regulation, in 










 5.2.1 Overall Pipeline to detect interactions between SNPs and age-
associated TF 
The overall pipeline is illustrated in Fig. 5-1 and described in Methods. We 
obtained the imputed SNPs and the corresponding transcriptome from ~570 











As a specific mechanism of SNP-Age interaction, we hypothesized that Age-
associated TFs exhibiting allele-specific binding will lead to Age-associated 
expression of the target gene in an allele-specific manner (Fig. 5-2). We therefore 
retained only the SNPs within open chromatin regions (using tissue-specific DNase 
hypersensitivity (DHS) (Roadmap Epigenomics Consortium et al., 2015)) within 
250Kb of genes (standard threshold for cis-eSNPs (Monlong et al., 2014; 






Figure 5-2: The proposed mechanism for SNP-Age interactions. (A): TF exhibits allelic binding 
preference (biased on binding to allele A here); (B) The concentration of the same TF could be 
affected by aging process, which induces the interaction between SNP and Age through that TF to 
regulate target genes; (C) The same TF could bind when individuals do not have allele A here and 





Our analysis is limited to 25 tissues for which DHS profiles are available. We 
detected Age-associated TFs based on their gene expression, controlling for genetic 
background and hidden variables. For Age-associated TFs, based on published 
DNA-binding motifs, we identified their putative allele-specific binding at all 
retained SNPs. For each SNP the genes within 250Kb are considered its potential 
targets. Finally, based on a linear model, we identified significant SNP-TF 
interactions associated with the target gene’s expression. 
 
 
   
 
Table 1: The number of detected interactions across 25 tissues. 
 
Tissues Number*of*Tests SNP0TF0Gene*Triplets Target*Genes Age*realted*TFs SNPs Hypertension*related*Triplets
Whole&Blood 943417 7252 1562 142 3466 385
Adipose&6&Subcutaneous 493460 566 289 100 479 77
Muscle&6&Skeletal 566391 1720 763 124 1368 615
Artery&6&Coronary 2074 16 15 2 15 1
Heart&6&Atrial&Appendage 106904 29 24 21 23 3
Adipose&6&Visceral&(Omentum) 957720 161 92 86 113 15
Ovary 53202 6 3 5 4 0
Breast&6&Mammary&Tissue 494743 260 185 93 226 53
Brain&6&Cortex 119627 20 13 17 18 0
Adrenal&Gland 28498 40 36 6 39 1
Lung 1028636 501 323 159 437 67
Esophagus&6&Muscularis 30523 58 50 8 57 2
Esophagus&6&Mucosa 715331 1785 842 202 1274 304
Esophagus&6&Gastroesophageal&Junction 280979 229 126 66 197 41
Stomach 405829 517 299 67 420 63
Colon&6&Sigmoid 531151 539 299 113 464 64
Colon&6&Transverse 373347 319 170 86 239 29
Heart&6&Left&Ventricle 171261 483 359 104 415 76
Brain&6&Cerebellum 4745 0 0 0 0 0
Artery&6&Aorta 406923 183 140 81 167 20
Brain&6&Hippocampus 5949 1 1 1 1 0
Brain&6&Frontal&Cortex&(BA9) 40255 20 17 7 20 0
Brain&6&Cerebellar&Hemisphere 74170 36 28 25 30 3
Brain&6&Caudate&(basal&ganglia) 12516 29 28 5 27 6





 5.2.2 Numerous SNP-Age-associated TF interactions are detected 
 across 25 tissues 
 The numbers of significant SNP-TF-Target genes triplets across 25 tissues 
are summarized in table 5-1. We tested a total of 7851107 SNP-TF-Gene triplets 
involving 447 TFs, 202978 SNPs, and 15315 Genes across the 25 tissues, and 
identified ~591 SNP-TF-Gene triplets on average in each of the 25 tissues. As a 
technical control, when we randomly shuffle gene expression across samples (while 
preserving gene-gene covariance among the target genes) the signals largely 
disappear. Interestingly, we detected the largest number of interactions in whole 
blood. We found that on average ~37% of the SNPs involved in an interaction were 
previously detected as eSNPs (GTEx Consortium, 2015), which is ~1.8 fold (Fisher 
test p-value<2.2e-16) greater than that for a control based on expression 
randomization, as above. What’s more, on average ~44% of the target genes 
involved in an interactions are themselves significant associated with age (enriched 
over the background control; Fisher test p-value = 4e-3), consistent with a 
regulatory role of Age-associated TFs in driving Age-associated expression of the 
target gene.  
 
A specific example of a detected SNP-TF-Gene interaction is illustrated in Fig. 5-
3A, suggesting that TF GATA1 binds at SNP rs4857406 to regulate the expression 
of CPOX in whole Blood tissue. GATA1 exhibits a significant Age-associated 








moreover its functional role is supported by DNase HS, H3K4me3, and H3K27ac 
peaks in K562 cell line (Epigenetic regulation of RNA processing#: Nature 
ENCODE#: Nature Publishing Group). In addition, the GATA1 ChIP-Seq peak also 
appears in the same region in K562 and PBDE cell lines, further supporting 
rs4857406’s functional role. Based on GATA1 DNA-binding motifs, it is expected 
 
 
Figure 5-3: One example for SNP-TF-Gene interaction triplet. (A) GATA1 bind to the major 
allele (rs4857406) to regulate gene CPOX. The SNP region is enriched for DNase, H3K4me3, 
H3K27ac and GATA1 CHIP-seq binding signals; (B) GATA1 expression is correlated with age; (C) 
GATA1 expression is significantly correlated with CPOX expression among the population with at 
least one major allele (spearman correlation = 0.27 and p-value = 4e-7); (D) GATA1 expression is 
not correlated with CPOX expression among the population with only minor allele (spearman 




to differentially bind to the major allele at rs4857406. Accordingly, we observed 
genotype-specific correlation between GATA1 and CPOX; as shown in Fig. 5-3C-
D, CPOX expression is significantly positively correlated (Spearman correlation = 
0.27; p-value = 4e-7) with GATA1 expression when the individuals have at least 
one major allele, while for minor allele homozygotes, the correlation is not 
significant (p-value = 0.25).  
 
5.2.3 Detected interactions are replicated in cross validation 
 To assess the robustness of the detected interactions, we estimated their 
replication rate following a standard cross-validation approach. We randomly 
divided two tissue samples (Whole Blood and Muscle –skeleton) into two equal 
subsets as discovery and validation datasets. FDR threshold of 0.1 was used for 
discovery, and p-value threshold of 0.05 was used as the validation threshold 
(Methods). Fig. 5-4 A-B show the replication rate for Top N (N = 20, 40, 60, 100) 
percent of detected interactions for standard cross validation respectively for whole 
blood and skeletal muscle tissues. The replication rate in Whole blood is ~85% 
(~797 interaction triplets) for top 20% of the discovered interactions and ~47% 
(~2206 interactions) for all discovered 4693 interactions. Muscle–skeleton exhibit 
relatively lower replication rate than whole blood tissue, the replication rates are 
still reasonable and significantly higher than the background (replication rate for 
random selected interactions). In addition, as expected both tissues exhibit a 
significant increasing trend with top selected interactions. These results support 














Figure 5-4: Replication rate for interaction triplets in cross validation for top α% ( α  = 20, 40, 
60, 80, 100) . (A) Replication rates in cross validation for whole blood tissue. (B) Replication rates 






 5.2.4 SNPs mediating the detected interactions are likely to be 
functional 
 In view of our hypothesis that Age-associated TFs bind to SNP locus, the 
detected SNP loci are expected to be in potential cis-regulatory elements, such as 
enhancers and promoters. We therefore checked whether the detected SNP loci are 
enriched for open chromatin signals (DHS) and known active regulatory region 
 
Figure 5-5: Enrichment analysis for transcription related epigenetic signals. Blue is for the 
foreground and red is for the background. (A): Enrichment for DNase signals across Blood, Breast, 
Lung, Stomach and Heart tissues; (B) Enrichment for H3K27ac across Blood, Adipose, Muscle,  
Lung, Esophagus, Stomach, Colon-Sigmoid, Colon-Transverse and Heart tissues; (C) Enrichment 
for H3K4me3 for Blood, Adipose, Muscle,  Breast, Lung, Esophagus, Stomach, Colon-Sigmoid, 
Colon-Transverse and Heart tissues; (D) Enrichment for H3K4me1 across Blood, Adipose, Muscle,  




related histone modifications (H3K27ac, H3K4me1 and H3K4me3). While 
H3K27ac and H3K4me1 are markers for active enhancers (Creyghton et al., 2010; 
Gibney and Nolan, 2010; Luco et al., 2010), H3K4me1 could be related to poised 
enhancers. H3K4me3 is also associated with gene promoters.  Even though DHS 
peaks were used as an inclusion criterion for the SNPs, we tested whether the 
detected SNPs exhibit higher DHS intensity compared to the background SNPs, 
which also qualified the initial DHS filter. As the foreground for this analysis, we 
used 200 bps regions around the SNPs involved in a significant interaction, and as 
the background control we used 200 bps regions around all the SNPs that were 
tested but failed were not part of any detected interaction. Each of the 4 epigenomic 
marks was analyzed for the tissues in which the relevant data was available and at 
least 200 foreground SNP loci. As shown in Fig. 5-5A, the foreground DHS 
intensities are significant higher than the background in 4 tissues of 5. This was 
also broadly true for H3K27ac and H3K4me3 (Fig. 5-5B-C). However, we 
observed a significant difference between the foreground and the background SNPs 
for H3K4me1 in four of the ten tissues analyzed in Fig. 5-5D. Overall, these results 
strongly suggest that the SNPs involved in the detected interactions are likely to 
play a regulatory role.  
 
 5.2.5 Functional analysis of target genes suggests the link of detected 
 interactions to age related processes and complex diseases 
 The genes involved in our detected interactions are expected to exhibit age-




aging and age-associated complex diseases. To explore this further, first we 
performed functional enrichment analysis over target genes in a tissue-specific 
manner using GOstats Package in R (Falcon and Gentleman, 2007). Then a  
 
 
comprehensive TreeMap view of enriched GO terms across tissues (FDR <= 0.05; 
Methods) are generated in supplementary Fig. 5-S1. Among them, defense 
response and immune response, are well known to be linked to aging (Licastro et 
al., 2005) and several age-associated complex diseases including hypertension, 
diabetes, neurodegeneration, and even cancer (Blasco et al., 2013; Jin, 2010; 
Sinclair et al., 2012). Metabolic process is crucial for the maintenance of biological 
system homeostasis; especially for aging process which has to confront numerous 
 
Figure 5-6: Significant contributions of detected interactions to hypertension. (A) Interactions 
are contributing to hypertension in 13 tissues showed by log likelihood ratio test; (B) in 7 tissues, 





harmful interventions (Barzilai et al., 2012). Actually extra cellular matrix 
component is related associated with aging process suggested by previous study 
(Ly et al., 2000) and it could contribute to stem cell maintenance and function 
(Kurtz and Oh, 2012). In addition, it is known that cell cycle regulation which 
drives reproduction is crucial for survival, and stressful stimulus to cell cycle could 
directly lead to cell senescence (Johnson et al., 1999; Molecular Biology of the 
Cell, 5th Edition: The Problems Book / Edition 5 by John Wilson | 9780815341109 
| Paperback | Barnes & Noble).    
 
Next, using Hypertension as an exemplar age-associated complex disease, we 
assessed the association of each detected SNP-TF-Gene triplet with Hypertension 
by detecting hypertension related target genes in the same model (Method). The 
numbers of hypertension-associated interactions across 25 tissues are summarized 
in Table 5-1. What’s more, we performed enrichment test on our detected 
hypertension related interaction targets genes by comparing with previous reported 
hypertension related genes (Rouillard et al., 2016). More specifically, we 
performed fisher’s test to compare our detected foreground and the background 
(target genes which failed in the significance test) in both tissue-specific and 
comprehensive manner.  Interestingly we showed hypertension genes are enriched 
in 7 out of 13 tissues as Figure 5-6B shows. And also comprehensively across all 
tissues our detected targets are enriched for hypertension related genes with fold 
change = ~1.8 (fisher’s test p-value = 3.9e-18). Moreover by performing log 




alternative model), we showed in 13 out of 15 tested tissues, detected interactions 
significantly contribute to hypertension (Figure 5-6A).  
 
In addition, we obtained GWAS signals for 16 age related diseases and directly 
performed enrichment for our detected SNPs in both tissue-specific and 
comprehensive manner. The same as above, fisher’s test is used for the enrichment 
test. We specifically found our detected SNPs in Stomach tissue are enriched for 
association with aging (p-value = 0.049 and fold change = 23). What’s more, 
detected SNPs in both Skeletal Muscle and Heart tissues are significantly 
associated with cardiovascular diseases (p-values are 0.043 and 0.048 respectively; 
fold changes are 2.4 and 3.9 respectively). Detected SNPs in whole blood tissue are 
related to immune response.  In addition, our comprehensive detected SNPs across 
25 tissues are enriched for ageing, cardiovascular diseases and immune response 
associated SNPs.  
Overall, these results suggest that some of the detected SNP-Age-associated TF 
interactions could affect aging linked processes and age-associated complex 
diseases (including hypertension) by mediating the target gene expression. 
 
5.3 Materials and Methods 
 5.3.1 Transcriptome and Epigenomic data  
 We obtained the processed transcriptome data across 25 tissues from 
Genotype-Tissue Expression (GTEx) database version 6 (GTEx Consortium, 




H3K4me1 and H3K4me3 are downloaded from Roadmap consortium (Roadmap 
Epigenomics Consortium et al., 2015). In addition, top three principal components 
generated over SNP profile and PEER factors generated over gene expression 
profile are also obtained from GTEx database. GENCODE genome annotation 
version 19 (hg19) (Harrow et al., 2012) is used consistently in this study.  
 
 5.3.2 Age-associated TF detection 
 We derived the linear regression model from previous studies (Glass et al., 
2013; Yang et al., 2015) to detect significant age-associated genes as follows:   








Where !!" is the expression of target gene i for jth sample and !! !is the basal 
expression and the intercept on y axis for gene i.  !! is the coefficient for covariates 
in the ith gene model. !"!! and !"#$"!! are the age and gender for jth sample  
respectively. !! is the covariate derived from SNPs for jth sample. PEER CF!!  is 
the kth PEER factor (hidden variable) derived over gene expression profile for jth 
sample. !!" denotes the error term.  
We removed PEER factors, which significantly correlate with age (Pearson 
correlation coefficient < 0.05). Then we checked whether the coefficient of age is 
significantly deviated from zero (FDR <= 0.1) and selected the significant age-





 5.3.3 Putative allele specific binding site prediction 
 We generated allele specific sequence (~100 bps) around all the SNP loci 
and scan the sequences for age-associated TFs binding sites using PWM-scan, 
which is an approach for putative TF binding sites prediction based on positional 
weighted matrix (PWM). Tissue-specific DNase-seq broad peaks data is applied to 
remove false positive prediction regarding of chromatin accessibility. Allele 
specific binding events are selected as interaction candidates (SNP-TF).  
 
 5.3.4 Interaction detection 
 We modeled the association between the interaction (SNP-TF) and potential 
target gene expression (within 250kb bps) as follows:  
!!" = !!! + !!!!"!! + !!!!!"#$"!! + !!!!!"#! + !!!!!"! + !!!!! + !!!!"#! ∗
!"! + !!!!! ∗ !"! + !!!!"#! ∗ !!! + !!!!"#! !∗ !!! !∗ !!"! !+
! !!!!!!!! + !
!
!!!




Where !!" is the expression of gene i for ith sample, !! !is the basal expression and 
the intercept on y axis for gene i. !! is the coefficient for covariates in the ith gene 
model. !"!! !and!!"#$"!!  are the age and gender respectively for jth 
sample.!!"#!is allele frequency for ith sample.!!"! is adjusted concentration of TF 
which only includes age component (residuals after controlled for gender, 
covariates derived from SNP profile and PEER factors that are not correlated with 
age) for jth sample.  !! is the hypertension disease state for jth sample (0/1). All the 




!"#! ∗ !"!, !! ∗ !"!, !"#! ∗ !!! and !"#! !∗ !!! !∗ !!"! .!!!! !is the covariate derived 
from SNPs for jth sample and PEER CF!!  is the kth PEER factor (hidden variable) 
derived over gene expression profile for jth sample. !!" denotes the error term.    
Whether !!! is significantly deviated from zero (FDR <= 0.1) implies potential 
interaction mechanism for general gene regulation, moreover coefficients!!!!, !!!, 
!!! and !!! together could suggest the ith target gene is related to hypertension.  
 
 5.3.5 Functional analysis  
 We performed functional analysis on target genes involved in significant 
interaction across 25 tissues using GOstats (Falcon and Gentleman, 2007). The 
frequency of each GO term is observed across 25 tissues is assigned as the weight 
for GO terms. Then a TreeMap view is generated using Revigo package (Supek et 
al., 2011). For the background control, we picked up random target genes, which 
also fall within 250kb from the significant SNPs, to repeat the same functional 
analysis.  
 
 5.3.6 Enrichment test for Epigenomic signals 
 We extracted 100 bps windows centering around significant SNP loci and 
map raw DNase-seq, ChIP-seq signals for H3K27ac, H3K4me1 and H3K4me3 to 
those window regions using “bedtools”. The average score across all the base pairs 
within the window is referred as the signal score for each significant SNP region. 




significant SNPs. One tailed Wilcoxon test is performed to compare the two 
distributions (foreground and background).  
 
 5.3.7 Estimation of the replication rate  
 To estimate the replication rate, we detect age-associated TF in both 
training and testing datasets respectively first, then extract overlapped interaction 
triplet candidates following the pipeline. We identified significant interactions in 
training dataset using a stringent threshold (FDR <= 0.1), following which we 
validate whether those reported significant interactions still retain in testing dataset 
with a relaxed threshold (p-value <= 0.05). Moreover, for visualization we measure 
the replication rate for top α% (α = 20, 40, 60, 80, 100) of detected significant 
interaction triplets respectively. For cross validation approach, we equally divided 
blood tissue as training and testing dataset randomly. 
 
5.4 Summary and Discussion 
In summary, we reported a novel pipeline and framework, which incorporates a 
specific hypothesized interaction mechanism, to test the association between SNP-
age interactions and phenotypes (gene expression/diseases). We hypothesized that 
age-related TF might preferentially bind to one of the alleles, which actually forms 
the basis for the interplay between SNPs and age. Numerous SNP-TF-Gene 
interaction triplets (average ~591) are detected across 25 tissues, some of which are 
also associated with hypertension. The detected significant SNP regions are 




validates their functionality. In addition, we showed the robustness by estimating 
the replication rates of detected interactions in cross validation. Enrichment tests 
for both biological terms and previous reported diseases associated genes also 
suggest that our detected interactions are linked to aging process and age related 
diseases.  
As we have mentioned, although multiple previous studies incorporating intuitive 
SNP-Age terms reported some potential interactions, both the detection power and 
insights about explicit interaction mechanisms are extremely limited, which could 
be addressed by our approach. The approximation of age factor by age-associated 
TF changes does not only increase the detection power but also provide evidences 
for a specific potential mechanism of the interactions.  What’s more, tissue-specific 
studies are missed previously; relatively in our study analysis across 25 tissues are 
carried out, which will definitely provide more insight into tissue-specific gene 
regulation and complex diseases.  
As an “environmental” risk factor, aging has to play a role by interacting with gene 
regulation, which could be complex and diverse. Age-associated TF may be just 
one specific type of aging agent, and some other factors could be also involved. For 
instance, it could be also age-associated splicing factor or epigenetic markers, both 
of which play essential roles in gene regulation and potentially could be linked to 
complex diseases. We explicitly observed age-associated splicing factor expression 
changes across aging in our study. Age-associated splicing factor need to bind to 
RNA motif regions, which may contain polymorphisms, which thus forms the basis 




have shown methylation to be a robust age biomarker (Horvath, 2013) and 
moreover it is well known that methylation usually blocks TF binding (Maurano et 
al., 2015; Moore et al., 2012; Yin et al., 2017). Thus, it is reasonable to expect that 
age-associated methylation changes could affect TF binding landscape across aging, 
in which age factor would interact with allele specific binding sites to regulate gene 
expression. It is especially exciting since DNA methylation has also been identified 
as a robust cancer biomarker. Combination of genome variations, aging factor, 
methylation and gene regulation might be able provide novel insights into cancer.  
Tissue-specificity complicates our understanding of gene regulation and complex 
diseases. We expect our analysis across 25 tissues could shed light on molecular 
basis underlying tissue-specific genetic regulation. In fact, we specifically observed 
more interactions in tissues like whole blood and adipose, which might imply they 
are affected more severely by aging process. What’s more, tissue-specific genetic 
investigations might be able to suggest tissues causality involved in complex 
diseases. In our studies, multiple intuitively known hypertension related tissues 
have relatively more interactions detected associated with hypertension disease.  
In addition, our study might promote the annotation and interpretation of GWAS 
and eQTL signals. In recent years, large scales of GWAS and eQTL signals are 
reported; however, it is still difficult to decode the observed associated into explicit 
pathways and mechanisms. Alignment of our detected interaction with reported 
associations by GWAS and eQTL could suggest potential explicit links between 




















6.1 Summary of the dissertation  
  Overall, my dissertation work focuses on gene regulation (transcription and 
alternative splicing) in normal aging and HGPS.  
First, in order to understand the common and distinct pathways underlying HGPS 
and normal aging, we developed a novel regression based clustering approach to 
identify gene clusters whose expression co-vary with aging and HGPS. Our 
approach could specifically address problems of limited sample size, which might 
be advantageous especially when used for rare disease studies. In this study, we 
also provided the first novel set of matched normal aging and HGPS RNA-seq data. 
We applied our approach to our RNA-seq profile and suggested numerous unique 
insightful biological processes underlying aging and HGPS.  
Second, we performed an investigation on alternative splicing regulation, which is 
related to both aging and HGPS. Besides re-assessment the predictive ability of 
genomic features for alternative splicing, we also predicted alternative splicing 
using numerous epigenomic features based on our novel benchmark datasets using 
a deep neural network model (DNN). Most importantly, we provided the first 
comparative investigation of the predictability of genomic and epigenomic features 
for alternative splicing across three tissues. Consistently across three tissues we 
concluded that genomic features play the primary role in alternative splicing 
compared to epigenomic features and it seems that epigenomic features are not 
contributing independent regulatory information relative to genomic features. We 




epigenomic features, which might imply context specific regulatory roles of 
epigenomic features.  
 
Third, we performed investigation on age-associated splicing changes across 
numerous human primary tissues. Alternative splicing regulation could be linked to 
diverse phenotype and cross-tissue variability complicates these links. In this study, 
we provided the first systematic comprehensive map of age-associated splicing 
changes across multiple tissues. We detected 49869 tissue-specific age-associated 
splicing events of 7 types across 48 tissues in 544 individuals by analyzing ~8500 
processed RNA-seq samples employing a stringent linear model controlling for 
multiple confounding factors. Functional analysis showed those age-associated 
splicing changes potentially are linked to aging process, in addition, we specifically 
showed they could contribute to age related complex diseases. In addition, we 
performed the first comparisons on predictability of age for splicing level, gene 
expression and transcription expression, which showed splicing information could 
be more correlated with age. We suggested that age-associated splicing factor 
concentration change could be the potential driver for age-associated splicing 
changes.  
 Lastly, we performed investigations on interactions between genome 
variations and normal aging, both of which have been linked to gene regulation and 
complex diseases. Instead of simply incorporating the SNP-age interaction term in 
the eQTL model, we hypothesized an interaction mechanism and proposed a novel 




factor by age-associated transcription factor concentration and expect interplay 
might happen while age-associated TFs specially bind to one allele instead of the 
other one. We detected ~591 SNP-TF-Gene interaction triplets in average across 25 
tissues and we also showed some of them are associated with hypertension diseases. 
Our detected significant SNPs are more likely to be functional since those regions 
are enriched for epigenomic signals related to regulatory activities. In the meantime, 
high replication rates in cross validation and similar tissues suggest robustness for 
our detections. In this study, we provided a new framework for investigation on 
interactions between genome polymorphisms and environment factors.  
 In summary, my dissertation work specifically focus on fundamental gene 
regulation mechanism (transcription and alternative splicing) in aging and HGPS, 
by measuring the association between molecular levels (gene expression, splicing 
level and transcript expression) and phenotype (age, complex diseases), we 
provided more insight about the underpinning of aging and HGPS.  
 
6.2 Future directions 
 As mentioned in the introduction, although the causal de novo mutation in 
HGPS has already been identified, the mechanism underlying the syndrome is still 
not clear. Importantly, the common symptoms in normal aging suggest HGPS as a 
reasonable aging model, which hypothesizes mutated protein--progerin would play 
an essential role in aging process. Whether progerin is one key driver of aging 




Intriguingly, we observed significant progerin transcript expressed in non-HGPS 
individual in GTEx consortium. It would be extremely interesting to identify 
specific mechanism that generate progerin in normal individuals from GTEx data 
and assess the potential phenotypic effect of progerin in that population, which 
might provide novel insights into both HGPS and aging process.  
 In our second study, we predicted alternative splicing using k-mer motif and 
epigenomic features around splicing events; actually polymorphisms could also 
affect splicing regulation. Moreover splicing factor proteins play essential roles in 
splicing regulation and could explain large tissue-specific splicing variations 
(Black, 2003; Chen et al., 1999; Linares et al., 2015).  It would be exciting to 
develop a mixture model to impute splicing level across tissues by appropriately 
combining all those information. It would enhance our understanding of the 
fundamental question about tissue-specific splicing; additionally it will provide 
imputed splicing data for related studies.  
  We have detected numerous age-associated splicing events across 48 tissues 
in our third study, however it is still difficult to explicitly show those age-
associated splicing events are actually functional and playing important roles in 
aging and complex diseases. It would be interesting and helpful to develop an 
approach to estimate the likelihood that a specific splicing event is functional by 
combining all existed annotation datasets.  
 Age-associated TF probably is not the unique aging “agent”, splicing factor 




Splicing factors plays essential roles in splicing regulation and could be affected by 
aging and bind to splicing regulatory cis-elements (splicing enhancers, silencers, 
branch sites, splicing sites) containing polymorphisms in an allele-specific fashion, 
which forms the basis for interaction between SNPs and aging. As for methylation, 
it is well known that as a robust age biomarker, DNA methylation could block TF 
binding, thus age-associated DNA methylation changes could significantly affect 
the landscape of TF binding tissue-specifically. What’s more, there are many 
evidence that methylation is an important biomarker for cancers. Colorectal cancer 
is significantly related to genetic background, ~29 related SNPs have been 
identified (Lubbe et al., 2012; Spring). A novel and exciting project could be to 
explore the potential interactions between SNPs and TF binding affected by age-



























































Figure 3-S4: Adjusted feature enrichment map for h1-hESC. 
 
 


























Figure 4-S2: Number of significant up and down-regulated splicing events across tissues for 














Figure 4-S3: Functional enrichment among genes affected by age-associated splicing across tissues. Columns correspond to tissues, rows 

















Figure 4-S4: Overlap of gene sets affected by age-associated changes detected at the level of 
gene expression (sky blue), transcript ratio (medium orchid), splicing events (orange) or 
transcript expression (pink). (1) – (48) show the data for  Whole Blood,Adipose - 
Subcutaneous,Muscle - Skeletal,Artery - Tibial,Artery - Coronary,Heart - Atrial 
Appendage,Adipose - Visceral (Omentum),Ovary,Uterus,Vagina,Breast - Mammary Tissue,Skin - 
Not Sun Exposed (Suprapubic), Minor Salivary Gland,Brain - Cortex,Adrenal 
Gland,Thyroid,Lung,Spleen,Pancreas,Esophagus - Muscularis,Esophagus - Mucosa,Esophagus - 
Gastroesophageal Junction,Stomach,Colon - Sigmoid,Small Intestine - Terminal Ileum,Colon - 
Transverse,Prostate,Testis,Skin - Sun Exposed (Lower leg),Nerve - Tibial,Heart - Left 
Ventricle,Pituitary,Brain - Cerebellum,Cells - Transformed fibroblasts,Artery - Aorta,Cells - EBV-
transformed lymphocytes,Liver,Brain - Hippocampus,Brain - Substantia nigra,Brain - Anterior 
cingulate cortex (BA24),Brain - Frontal Cortex (BA9),Brain - Cerebellar Hemisphere,Brain - 
Caudate (basal ganglia),Brain - Nucleus accumbens (basal ganglia),Brain - Putamen (basal 












Figure 4-S5: The annotated 12 transcripts of PFKL gene and the number of tissues in which 
















Figure 4-S6: Age classification accuracy for three models. The green one is for splicing model, 









Figure 4-S7: Accuracies of prediction of age using models based on 7 different types of splicing 
events across tissues.  The symbols represent the 7 types of splicing events (as defined in Fig. 5). 













Figure 4-S8: Additional contribution of splicing events to the explained variance of complex 
diseases: (A) Diabetes mellitus type II, (B) Chronic Respiratory Disease, (C) Heart Attack, in 
multiple tissues shown on x-axis. The y-axis denotes the significance (-log(p-value)) based on a log-

































Table 4-S2 Nineteen alternatively spliced genes shared by 9 tissues. 
 
 











Supplementary Note 4-1 
We ascertained that the number of significant events detected was not correlated 
with the number of samples across tissues; Pearson correlation between sample size 
and fraction of events found to be 0.06 (p-value = 0.8). We also assessed, for each 
event type, the potential bias between up-regulated and down-regulated events 
using paired Wilcoxon test, and found most types of splicing events to be relatively 
balanced. There was a modest bias in alternative 5’ usage (toward down-regulated 
events; p-value = 0.047) and alternative first exons events (toward longer isoforms; 
p-value = 0.03). 
 
 








Supplementary Note 4-2 
PEER factors are expected to capture a variety of known hidden confounders such 
as batch effects and a global population variance. We explicitly remove the PEER 
factors that are correlated with age to minimize false negatives, because such PEER 
factors will occlude the signal for specific splicing events. Since some of the 
removed PEER factors are also correlated with race or ethnicity, we may falsely 
detect splicing events associated with race/ethnicity instead of age.  To test whether 
our results are robust to human ancestry (ethnicity/race here), we assessed our false 
discovery rate by comparing our results with those without controlling 
ethnicity/race for skipped exons events using two approaches as following: 
First, naively we controlled the ethnicity/race by including all the confounding 
factors which are correlated with both age and ethnicity/race (Pearson correlation 
p-value <= 0.05). In Skin (sun exposed) tissue, we found that on average across all 
23192 Skipped exon events, (1) Of the removed factors, almost none (8e-3%) are 
correlated with ethnicity and 2.4% are correlated with race. (2) If we include PEER 
factors correlated with ethnicity, none of detected events would be deemed 
insignificant. (3) If we include PEER factors correlated with race, only 0.05% of 
detected events would be deemed insignificant. We also have done this assessment 
for all tissues and found that (1) Of the removed factors, on average 4.8% are 
correlated with ethnicity and on average 8.2% are correlated with race. (2) If we 




events would be deemed insignificant. (3) If we include PEER factors correlated 
with race, around 0.35% of detected events would be deemed insignificant in 45 
tissues, even though significant difference (~95%) were observed in three tissues 
(Blood, Lung and  Colon – Sigmoid).  
However, since the correlation between age and race can be true due to population 
sampling bias, the “95% significant difference” in three tissues by directly 
including PEER factors correlated with both age and race is more likely to be false 
negatives. In addition, the ethnicity information is extremely limited compared to 
race information in GTEx. Thus instead of keeping PEER factors correlated with 
both age and race, we have evaluated the false positive rate by including race 
information directly in our model as a confounding covariate, which is more 
reasonable and fair. In this way, on average only 3% of detected events would be 
deemed insignificant. The three significant affected tissues do not show significant 
differences (only ~5%) either. 
Thus, overall, the possible false positive due to exclusion of PEER factors that 
might be associated with race/ethnicity is not substantial and our model should be 











































Acharya, C. R., Owzar, K., Allen, A. S. and Carlo, M. (2017). Mapping eQTL 
by leveraging multiple tissues and DNA methylation. BMC Bioinformatics 1–
11. 
Adeyemo, A., Gerry, N., Chen, G., Herbert, A., Doumatey, A., Huang, H., 
Zhou, J., Lashley, K., Chen, Y., Christman, M., et al. (2009). A Genome-
Wide Association Study of Hypertension and Blood Pressure in African 
Americans. 5, 1–11. 
Akerman, M., David-eden, H., Pinter, R. Y. and Mandel-, Y. (2009). A 
computational approach for genome-wide mapping of splicing factor binding 
sites. Genome Biol. 10,. 
Alamancos, G. P., Pages, A., Trincado, J. L., Bellora, N. and Eyras, E. (2015). 
Leveraging transcript quantification for fast computation of alternative 
splicing profiles. RNA 21, 1521–1531. 
Andrés, V. and González, J. M. (2009). Role of A-type lamins in signaling , 
transcription , and chromatin organization. 187, 945–957. 
Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., 
Ren, J., Li, W. W. and Noble, W. S. (2009). MEME SUITE#: tools for motif 
discovery and searching. 37, 202–208. 
Barash, Y., Calarco, J. A., Gao, W., Pan, Q., Wang, X., Shai, O., Blencowe, B. 
J. and Frey, B. J. (2010). Deciphering the splicing code. Nature 465, 53–9. 
Barzilai, N., Huffman, D. M., Muzumdar, R. H. and Bartke, A. (2012). The 




Basu, M., Sharmin, M., Das, A., Nair, N. U. and Wang, K. (2017). Prediction 
and subtyping of Hypertension from pan-tissue transcriptomic and genetic 
analyses. 
Bell, J. T. and Spector, T. D. (2011). A twin approach to unraveling epigenetics. 
Trends Genet. 27, 116–125. 
Berdyyeva, T. K., Woodworth, C. D. and Sokolov, I. (2005). Human epithelial 
cells increase their rigidity with ageing in vitro: direct measurements. Phys. 
Med. Biol. 50, 81–92. 
Berget, S. M., Moore, C. and Sharp, P. A. (1977). Spliced segments at the 5 ’ 
terminus of adenovirus 2 late mRNA. Proc. Natl. Acad. Sci. 74, 3171–3175. 
Black, D. L. (2003). Mechanisms of alternative pre-messenger RNA splicing. 
Annu. Rev. Biochem. 72, 291–336. 
Blasco, M. A., Partridge, L., Serrano, M., Kroemer, G. and Lo, C. (2013). 
Review The Hallmarks of Aging. 
Bosu, W. K., Aheto, J. M. K., Zucchelli, E. and Reilly, S. (2017). Prevalence , 
awareness , and associated risk factors of hypertension in older adults in 
Africa#: a systematic review and meta- analysis protocol. 4–11. 
Broderick, P., Carvajal-carmona, L., Pittman, A. M., Webb, E., Howarth, K., 
Rowan, A., Lubbe, S., Sullivan, K., Fielding, S., Jaeger, E., et al. (2007). A 
genome-wide association study shows that common alleles of SMAD7 
influence colorectal cancer risk. Nat. Genet. 39, 1315–1317. 
Brodsky, A. S., Meyer, C. A., Swinburne, I. A., Hall, G., Keenan, B. J., Liu, X. 




polymerase II reveals sites of co-transcriptional regulation in human cells. 
Genome Biol. 6, 1–9. 
Bruneau, B. G. (2008). The developmental genetics of congenital heart disease. 
Nature 451, 943–948. 
Bush, W. S. and Moore, J. H. (2012). Chapter 11#: Genome-Wide Association 
Studies. Plos Comput. Biol. 8,. 
Cartegni, L. (2003). ESEfinder: a web resource to identify exonic splicing 
enhancers. Nucleic Acids Res. 31, 3568–3571. 
Cassano, P., Lezza, A. M. S., Leeuwenburgh, C., Cantatore, P. and Gadaleta, 
M. N. (2004). Measurement of the 4,834-bp mitochondrial DNA deletion 
level in aging rat liver and brain subjected or not to caloric restriction diet. 
Ann. N. Y. Acad. Sci. 1019, 269–273. 
Chaves, D. F. S., Carvalho, P. C., Lima, D. B., Nicastro, H., Lorenzeti, F. M., 
Siqueira-Filho, M., Hirabara, S. M., Alves, P. H. M., Moresco, J. J., Yates, 
J. R., et al. (2013). Comparative proteomic analysis of the aging soleus and 
extensor digitorum longus rat muscles using TMT labeling and mass 
spectrometry. J. Proteome Res. 12, 4532–4546. 
Chen, M. and Manley, J. L. (2010). Mechanisms of alternative splicing 
regulation: insights from molecular and genomics approaches. 10, 741–754. 
Chen, C. D., Kobayashi, R. and Helfman, D. M. (1999). Binding of hnRNP H to 
an exonic splicing silencer is involved in the regulation of alternative splicing 
of the rat#??-tropomyosin gene. Genes Dev. 13, 593–606. 




large-scale inference of transcription factor binding sites from chromatin 
accessibility. 45, 4315–4329. 
Chen, L., Luo, C., Shen, L., Liu, Y., Wang, Q., Zhang, C., Guo, R. and Zhang, 
Y. (2017b). SRSF1 Prevents DNA Damage and Promotes Tumorigenesis 
through Regulation of DBF4B Pre- mRNA Splicing. CellReports 21, 3406–
3413. 
Cheng, C., Alexander, R., Min, R., Leng, J., Yip, K. Y., Rozowsky, J., Yan, K., 
Dong, X., Djebali, S., Ruan, Y., et al. (2012). Understanding transcriptional 
regulation by integrative analysis of transcription factor binding data. 1658–
1667. 
Chiang, K., Yang, H. and Pan, W. (2018). A Two-Stage Whole-Genome Gene 
Expression Association Study of Young-Onset Hypertension in Han Chinese 
Population of Taiwan. Sci. Rep. 1–11. 
Cogent Study (2008). Meta-analysis of genome-wide association data identifies 
four new susceptibility loci for colorectal cancer. Nat. Genet. 40, 1426–1435. 
Cook, K. B., Hughes, T. R. and Morris, Q. D. (2014). High-throughput 
characterization of protein-RNA interactions. Br. Funct. genomics 14, 74–89. 
Create linear regression model using stepwise regression - MATLAB 
stepwiselm. 
Creyghton, M. P., Cheng, A. W., Welstead, G. G., Kooistra, T., Carey, B. W., 
Steine, E. J., Hanna, J., Lodato, M. A., Frampton, G. M., Sharp, P. A., et 
al. (2010). Histone H3K27ac separates active from poised enhancers and 




Crick, F. (1970). Central dogma of molecular biology. 561–563. 
Csoka, A. B., English, S. B., Simkevich, C. P., Ginzinger, D. G., Butte, A. J., 
Schatten, G. P., Rothman, F. G. and Sedivy, J. M. (2004). Genome-scale 
expression profiling of Hutchinson – Gilford progeria syndrome reveals 
widespread transcriptional misregulation leading to mesodermal / 
mesenchymal defects and accelerated atherosclerosis. Aging Cell 235–243. 
Curradi, M., Izzo, A., Badaracco, G. and Landsberger, N. (2002). Molecular 
Mechanisms of Gene Silencing Mediated by DNA Methylation. 22, 3157–
3173. 
Cusack, B. P., Arndt, P. F., Duret, L. and Roest Crollius, H. (2011). Preventing 
dangerous nonsense: selection for robustness to transcriptional error in human 
genes. PLoS Genet. 7, e1002276. 
Das, S. and Krainer, A. (2014). Emerging functions of SRSF1, splicing factor and 
oncoprotein, in RNA metabolism and cancer. Mol. Cancer Res. 12, 1195–
1204. 
Das, A., Morley, M., Moravec, C. S., Tang, W. H. W., Hakonarson, H., 
Consortium, M., Margulies, K. B., Cappola, T. P., Jensen, S. and 
Hannenhalli, S. (2015). Bayesian integration of genetics and epigenetics 
detects causal regulatory SNPs underlying expression variability. Nat. 
Commun. 6, 1–11. 
de Magalhães, J. P., Curado, J. and Church, G. M. (2009). Meta-analysis of 
age-related gene expression profiles identifies common signatures of aging. 




Deep Neural Networks for Acoustic Modeling in Speech Recognition - 
Microsoft Research. 
Demichelis, F., Setlur, S. R., Banerjee, S., Chakravarty, D., Chen, J. Y. H., 
Chen, C. X., Huang, J., Beltran, H., Oldridge, D. A., Kitabayashi, N., et al. 
(2012). Identification of functionally active, low frequency copy number 
variants at 15q21.3 and 12q21.31 associated with prostate cancer risk. Proc. 
Natl. Acad. Sci. 109, 6686–6691. 
Dermitzakis, E. T. and Clark, A. G. (2002). Evolution of Transcription Factor 
Binding Sites in Mammalian Gene Regulatory Regions#: Conservation and 
Turnover. Mol. Biol. Evol. 1114–1121. 
Deschênes, M. and Chabot, B. (2017). The emerging role of alternative splicing in 
senescence and aging. Aging Cell 16, 918–933. 
Diao, H., Aplin, J. D., Xiao, S., Chun, J., Li, Z., Chen, S. and Ye, X. (2011). 
Altered Spatiotemporal Expression of Collagen Types I , III , IV , and VI in 
Lpar3 -Deficient Peri-Implantation Mouse Uterus 1. 265, 255–265. 
Dogan, R. I., Getoor, L., Wilbur, W. J. and Mount, S. M. (2007). SplicePort — 
An interactive splice-site analysis tool. Nucleic Acids Res. 35, 285–291. 
Dongen, J. Van, Nivard, M. G., Willemsen, G., Hottenga, J., Helmer, Q., 
Dolan, C. V, Ehli, E. A., Davies, G. E., Iterson, M. Van, Breeze, C. E., et 
al. (2016). Genetic and environmental influences interact with age and sex in 
shaping the human methylome. Nat. Commun. 7, 1–13. 
Drazner, M. H. (2011). The Progression of Hypertensive Heart Disease. 327–334. 




Maor, G., Shilo, A., Schwartz, S., Barshack, I., et al. (2016). A network-
based analysis of colon cancer Splicing changes reveals a tumorigenesis-
favoring regulatory pathway emanating from ELK1. Genome Res. 26, 541–
553. 
Eccleston, A., Cesari, F. and Skipper, M. (2013). Transcription and epigenetics. 
502, 7472. 
Ehret, G. B. and Teresa Ferreira et al (2016). The genetics of blood pressure 
regulation and its target organs from association studies in 342 , 415 
individuals. Nat. Genet. 48, 1171–1184. 
Eisenberg, E. and Levanon, E. Y. (2013). Human housekeeping genes , revisited. 
Trends Genet. 29, 569–574. 
Enroth, S., Bornelöv, S., Wadelius, C. and Komorowski, J. (2012). 
Combinations of histone modifications mark exon inclusion levels. PLoS One 
7, e29911. 
Epigenetic regulation of RNA processing!: Nature ENCODE!: Nature 
Publishing Group. 
Epigenetic similarities between Wilms tumor cells and normal kidney stem 
cells found -- ScienceDaily. 
Eriksson, M., Brown, W. T., Gordon, L. B., Glynn, M. W., Singer, J., Scott, L., 
Erdos, M. R., Robbins, C. M., Moses, T. Y., Berglund, P., et al. (2003). 
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford 
progeria syndrome. Nature 423, 293–8. 




W. (2015). remodelling in longevity. 519, 97–101. 
Fairbrother, W. G., Yeh, R.-F., Sharp, P. A. and Burge, C. B. (2002). Predictive 
identification of exonic splicing enhancers in human genes. Science 297, 
1007–13. 
Falcon, S. and Gentleman, R. (2007). Using GOstats to test gene lists for GO 
term association. Bioinformatics 23, 257–258. 
Finkel, T., Serrano, M. and Blasco, M. A. (2007). The common biology of cancer 
and ageing. 448,. 
Flores, K., Wolschin, F., Corneveaux, J. J., Allen, A. N., Huentelman, M. J. 
and Amdam, G. V (2012). Genome-wide association between DNA 
methylation and alternative splicing in an invertebrate. BMC Genomics 13, 
480. 
Fong, C., Ko, D. C., Wasnick, M., Radey, M., Miller, S. I. and Brittnacher, M. 
(2018). GWAS Analyzer#: integrating genotype , phenotype and public 
annotation data for genome-wide association study analysis. Bioinformatics 
26, 560–564. 
Franceschini, N., Fox, E., Zhang, Z., Edwards, T. L., Nalls, M. A., Sung, Y. J., 
Tayo, B. O., Sun, Y. V, Gottesman, O., Adeyemo, A., et al. (2013). 
Genome-wide Association Analysis of Blood-Pressure Traits in African-
Ancestry Individuals Reveals Common Associated Genes in African and Non-
African Populations. 545–554. 
Franklin, S. S. and Wong, N. D. (2013). Hypertension and Cardiovascular 




Frith, M. C., Li, M. C. and Weng, Z. (2003). Cluster-Buster#: finding dense 
clusters of motifs in DNA sequences. 31, 3666–3668. 
Fuchs, F. D. (2006). Why Do Black Americans Have Higher Prevalence of 
Hypertension? 379–381. 
Geiger, H., Koehler, A. and Gunzer, M. (2007). Stem cells, aging, niche, 
adhesion and Cdc42: A model for changes in cell-cell interactions and 
hematopoietic stem cell aging. Cell Cycle 6, 884–887. 
Gibney, E. R. and Nolan, C. M. (2010). Epigenetics and gene expression. 
Heredity (Edinb). 105, 4–13. 
Gilad, Y., Rifkin, S. A. and Pritchard, J. K. (2008). Revealing the architecture of 
gene regulation#: the promise of eQTL studies. Trends Genet. 24, 408–415. 
Glass, D., Viñuela, A., Davies, M. N., Ramasamy, A., Parts, L., Knowles, D., 
Brown, A. A., Hedman, A. K., Small, K. S., Buil, A., et al. (2013). Gene 
expression changes with age in skin, adipose tissue, blood and brain. Genome 
Biol. 14, R75. 
Goldman, R. D., Shumaker, D. K., Erdos, M. R., Eriksson, M., Goldman, A. 
E., Gordon, L. B., Collins, F. S., Gruenbaum, Y., Khuon, S. and Mendez, 
M. (2004). Accumulation of mutant lamin A causes progressive changes in 
nuclear architecture in Hutchinson – Gilford progeria syndrome. Proc. Natl. 
Acad. Sci. U. S. A. 101, 8963–8968. 
Gotzmann, J. and Foisner, R. (2006). A-type lamin complexes and regenerative 
potential#: a step towards understanding laminopathic diseases#? Histochem. 




Grant, C. E., Bailey, T. L. and Noble, W. S. (2011). FIMO#: scanning for 
occurrences of a given motif. 27, 1017–1018. 
GTEx Consortium, Gte. (2015). Human genomics. The Genotype-Tissue 
Expression (GTEx) pilot analysis: multitissue gene regulation in humans. 
Science 348, 648–60. 
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, 
P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. 
(2005). Complement Factor H Variant Increases the Risk of Age-Related 
Macular Degeneration. Science (80-. ). 308, 419–422. 
Harrow, J., Frankish, A., Gonzalez, J. M., Tapanari, E., Diekhans, M., 
Kokocinski, F., Aken, B. L., Barrell, D., Zadissa, A., Searle, S., et al. 
(2012). GENCODE: The reference human genome annotation for the 
ENCODE project. Genome Res. 22, 1760–1774. 
Heinzen, E. L., Yoon, W., Tate, S. K., Sen, A., Wood, N. W., Sisodiya, S. M. 
and Goldstein, D. B. (2007). Nova2 Interacts with a Cis -Acting 
Polymorphism to Influence the Proportions of Drug-Responsive Splice 
Variants of SCN1A. Am. J. Hum. Genet. 80, 876–883. 
Hinton, G. E., Osindero, S. and Teh, Y.-W. (2006). A fast learning algorithm for 
deep belief nets. Neural Comput. 18, 1527–54. 
Horvath, S. (2013). DNA methylation age of human tissues and cell types. 
Genome Biol. 14, R115. 
Hu, M., Yu, J., Taylor, J. M. G., Chinnaiyan, A. M. and Qin, Z. S. (2010). On 




Seq data. Nucleic Acids Res 38, 2154–2167. 
Huan, T., Esko, T., Peters, M. J. and Pilling, L. C. (2015). A Meta-analysis of 
Gene Expression Signatures of Blood Pressure and Hypertension. 1–29. 
Huang, D. W., Sherman, B. T. and Lempicki, R. A. (2008). Systematic and 
integrative analysis of large gene lists using DAVID bioinformatics resources. 
Nat. Protoc. 4, 44–57. 
Huang, D. W., Sherman, B. T. and Lempicki, R. A. (2009). Bioinformatics 
enrichment tools: paths toward the comprehensive functional analysis of large 
gene lists. Nucleic Acids Res. 37, 1–13. 
Human, T., Beadchip, E., Chip, E., Chip, T. E., Chip, E., Chip, E., Chip, E., 
New, R., Fig, S., Table, S., et al. (2016). Meta-analysis identifies common 
and rare variants influencing blood pressure and overlapping with metabolic 
trait loci. Nat. Genet. 48,. 
Ismene Karakasilioti, G. A. G. (2014). Tissue-specific aging: a tale of functional 
asymmetry. 6, 7–8. 
Jaenisch, R. and Bird, A. (2003). Epigenetic regulation of gene expression#: how 
the genome integrates intrinsic and environmental signals. 33, 245–254. 
Jensen, K. B. and Darnell, R. B. (2015). CLIP: Crosslinking and 
ImmunoPrecipitation of In Vivo RNA Targets of RNA-Binding Proteins. 
Methods Mol. Biol. 85–98. 
Jiang, Y., Shen, H., Liu, X., Dai, J., Jin, G., Qin, Z., Chen, J., Wang, S., Wang, 
X., Hu, Z., et al. (2011). Genetic variants at 1p11.2 and breast cancer risk: A 




Jin, K. (2010). Modern Biological Theories of Aging. 1, 72–74. 
Johnson, F. B., Sinclair, D. A. and Guarente, L. (1999). Molecular biology of 
aging. Cell 96, 291–302. 
Jung, M. and Pfeifer, G. P. (2015). Aging and DNA methylation. BMC Biol. 13, 
7. 
Ka, J. and La, H. (2015). BinDNase#: a discriminatory approach for transcription 
factor binding prediction using DNase I hypersensitivity data. 31, 2852–2859. 
Kato, N., Loh, M. and Takeuchi, F. et al (2015). Trans-ancestry genome-wide 
association study identifies 12 genetic loci influencing blood pressure and 
implicates a role for DNA methylation. Nat. Genet. 1282–1293. 
Katz, Y., Wang, E. T., Airoldi, E. M. and Burge, C. B. (2010). Analysis and 
design of RNA sequencing experiments for identifying isoform regulation. 
Nat. Methods 7, 1009–15. 
Kaufmann, R. G., Ahrens, K., Koop, R. and Smale, S. T. (1998). CIF150 , a 
Human Cofactor for Transcription Factor IID-Dependent Initiator Function. 
18, 233–239. 
Kawakami, K., Nakamura, A., Ishigami, A., Goto, S. and Takahashi, R. 
(2009). Age-related difference of site-specific histone modifications in rat 
liver. Biogerontology 10, 415–421. 
Keren, H., Lev-Maor, G. and Ast, G. (2010). Alternative splicing and evolution: 
diversification, exon definition and function. Nat. Rev. Genet. 11, 345–55. 





Kouadjo, K. E., Nishida, Y., Cadrin-girard, J. F., Yoshioka, M. and St-amand, 
J. (2007). Housekeeping and tissue-specific genes in mouse tissues. 16,. 
Krivega, I. and Dean, A. (2013). Enhancer and promoter interactions — long 
distance calls. 22, 79–85. 
Kumar, A., Gibbs, J. R., Beilina, A., Dillman, A., Kumaran, R., Trabzuni, D., 
Ryten, M., Smith, C., Traynor, B. J., Hardy, J., et al. (2014). Age 
associated changes in gene expression in human brain and isolated neurons. 
34, 1199–1209. 
Kuneš, J. and Zicha, J. (2009). The Interaction of Genetic and Environmental 
Factors in the Etiology of Hypertension. 58,. 
Kurtz, A. and Oh, S. J. (2012). Age related changes of the extracellular matrix 
and stem cell maintenance. Prev. Med. (Baltim). 54, S50–S56. 
Lee, T. I. and Young, R. A. (2013). Review Transcriptional Regulation and Its 
Misregulation in Disease. Cell 152, 1237–1251. 
Lee, D., Gorkin, D. U., Baker, M., Strober, B. J., Asoni, A. L., Mccallion, A. S. 
and Beer, M. A. (2015). A method to predict the impact of regulatory variants 
from DNA sequence. Nat. Publ. Gr. 47, 955–961. 
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E. and Storey, J. D. (2012). 
The sva package for removing batch effects and other unwanted variation in 
high-throughput experiments. Bioinformatics 28, 882–883. 
Levy, S. and Hannenhalli, S. (2002). Identification of transcription factor binding 
sites in the human genome sequence. 514, 510–514. 




niche matters. Cancer Res. 66, 4553–7. 
Li, Y., Willer, C., Sanna, S. and Abecasis, G. (2009). Genotype Imputation. 
Annu. Rev. Genomics Hum. Genet. 387–406. 
Li, J. J., Bickel, P. J. and Biggin, M. D. (2014). System wide analyses have 
underestimated protein abundances and the importance of transcription in 
mammals. 
Li, Y. I., van de Geijn, B., Raj, A., Knowles, D. A., Petti, A. A., Golan, D., 
Gilad, Y. and Pritchard, J. K. (2016). RNA splicing is a primary link 
between genetic variation and disease. Science (80-. ). 352, 600–604. 
Li, H., Wang, Z., Ma, T., Wei, G. and Ni, T. (2017). Alternative Splicing in 
Aging and Age-related Diseases. Transl. Med. Aging 1–9. 
Li, Y. I., Knowles, D. A., Humphrey, J., Barbeira, A. N., Dickinson, S. P., Im, 
H. K. and Pritchard, J. K. (2018). Annotation-free quantification of RNA 
splicing using LeafCutter. Nat. Genet. 50, 151–158. 
Licastro, F., Candore, G., Lio, D., Porcellini, E., Colonna-romano, G., 
Franceschi, C. and Caruso, C. (2005). Innate immunity and inflammation in 
ageing#: a key for understanding age-related diseases. Immun. Aging 14, 1–14. 
Lin, C. L. G., Bristol, L. A., Jin, L., Dykes-Hoberg, M., Crawford, T., 
Clawson, L. and Rothstein, J. D. (1998). Aberrant RNA processing in a 
neurodegenerative disease: The cause for absent EAAT2, a glutamate 
transporter, in amyotrophic lateral sclerosis. Neuron 20, 589–602. 
Linares, A. J., Lin, C., Damianov, A., Adams, K. L., Novitch, B. G. and Black, 




transcription factor Pbx1 during neuronal differentiation. Elife 1–25. 
Liu, W., Xie, Y., Ma, J., Luo, X., Nie, P., Zuo, Z., Lahrmann, U., Zhao, Q., 
Zheng, Y., Zhao, Y., et al. (2015). IBS: An illustrator for the presentation and 
visualization of biological sequences. Bioinformatics 31, 3359–3361. 
Lubbe, S. J., Pittman,  a M., Olver, B., Lloyd,  a, Vijayakrishnan, J., Naranjo, 
S., Dobbins, S., Broderick, P., Gómez-Skarmeta, J. L. and Houlston, R. S. 
(2012). The 14q22.2 colorectal cancer variant rs4444235 shows cis-acting 
regulation of BMP4. Oncogene 31, 3777–84. 
Luco, R. F., Pan, Q., Tominaga, K., Blencowe, B. J., Pereira-Smith, O. M. and 
Misteli, T. (2010). Regulation of alternative splicing by histone modifications. 
Science 327, 996–1000. 
Luco, R. F., Allo, M., Schor, I. E., Kornblihtt, A. R. and Misteli, T. (2011). 
Epigenetics in alternative pre-mRNA splicing. Cell 144, 16–26. 
Luo, R. X. and Dean, D. C. (1999). Chromatin Remodeling and Transcriptional 
Regulation. 91, 1288–1294. 
Ly, D. H., Lockhart, D. J. and Lerner, R. A. (2000). Mitotic Misregulation and 
Human Aging. 287, 2486–2493. 
Macarthur, J., Bowler, E., Cerezo, M., Gil, L., Hall, P., Hastings, E., Junkins, 
H., Mcmahon, A., Milano, A., Morales, J., et al. (2017). The new NHGRI-
EBI Catalog of published genome-wide association studies ( GWAS Catalog ). 
Nucleic Acids Res 45, 896–901. 
Maquat, L. E. (2004). Nonsense-mediated mRNA decay: splicing, translation and 




Marji, J., Donoghue, I. O., Mcclintock, D., Satagopam, V. P., Schneider, R., 
Ratner, D., Worman, H. J., Gordon, L. B. and Djabali, K. (2010). 
Defective Lamin A-Rb Signaling in Hutchinson-Gilford Progeria Syndrome 
and Reversal by Farnesyltransferase Inhibition. PLoS One 5,. 
Marsman, J. and Hors, J. A. (2012). Long distance relationships#: Enhancer – 
promoter communication and dynamic gene transcription. 1819, 1217–1227. 
Matthews, K. S. (1992). DNA looping. Microbiol. Rev. 56, 123–36. 
Maurano, M. T., Wang, H., John, S., Canfield, T., Lee, K. and 
Stamatoyannopoulos, J. A. (2015). Role of DNA Methylation in Modulating 
Transcription Article Role of DNA Methylation in Modulating Transcription 
Factor Occupancy. CellReports 12, 1184–1195. 
Mazin, P., Xiong, J., Liu, X., Yan, Z., Zhang, X., Li, M., He, L., Somel, M., 
Yuan, Y., Phoebe Chen, Y.-P., et al. (2013a). Widespread splicing changes 
in human brain development and aging. Mol. Syst. Biol. 9, 633. 
Mazin, P., Xiong, J., Liu, X., Yan, Z., Zhang, X., Li, M., He, L., Somel, M., 
Yuan, Y., Phoebe Chen, Y.-P., et al. (2013b). Widespread splicing changes 
in human brain development and aging. Mol. Syst. Biol. 9, 633. 
Mccord, R. P., Nazario-toole, A., Zhang, H., Chines, P. S., Zhan, Y., Erdos, M. 
R., Collins, F. S., Dekker, J. and Cao, K. (2013). Correlated alterations in 
genome organization , histone methylation , and DNA – lamin A / C 
interactions in Hutchinson-Gilford progeria syndrome. Genome Res. 260–269. 
Menopause (2015). Med. Clin. North Am. 99, 521–534. 




Perry, M. B., Brewer, C. C., Zalewski, C., Kim, H. J., Solomon, B., et al. 
(2008). Phenotype and course of Hutchinson-Gilford progeria syndrome. N. 
Engl. J. Med. 358, 592–604. 
Milne, L. Feature Selection Using Neural Networks with Contribution Measures. 
Milne, L. (1995). Feature Selection Using Neural Networks with Contribution 
Measures. 1–8. 
Molecular Biology of the Cell, 5th Edition: The Problems Book / Edition 5 by 
John Wilson | 9780815341109 | Paperback | Barnes & Noble. 
Monlong, J., Calvo, M., Ferreira, P. G. and Guigo, R. (2014). Identification of 
genetic variants associated with alternative splicing using sQTLseekeR. Nat. 
Commun. 
Moore, L. D., Le, T. and Fan, G. (2012). DNA Methylation and Its Basic 
Function. Neuropsychopharmacology 38, 23–38. 
Mounkes, L., Kozlov, S., Burke, B. and Stewart, C. L. (2003). The 
laminopathies#: nuclear structure meets disease. Curr. Opin. Genet. Dev. 223–
230. 
Mount, S. M. (2000). Genomic Sequence , Splicing , and Gene Annotation. Am. J. 
Hum. Genet. 6, 788–792. 
Myatt, S. S. and Lam, E. W. F. (2007). The emerging roles of forkhead box ( Fox 
) proteins in cancer. Nat. Rev. cancer 7, 847–859. 
Naftelberg, S., Schor, I. E., Ast, G. and Kornblihtt, A. R. (2015). Regulation of 
Alternative Splicing Through Coupling with Transcription and Chromatin 




Niccoli, T. and Partridge, L. (2012). Ageing as a Risk Factor for Disease. Curr. 
Biol. 22, R741–R752. 
Nilsen, T. W. and Graveley, B. R. (2010). Expansion of the eukaryotic proteome 
by alternative splicing. Nature 463, 457–63. 
Olden, K., Freudenberg, N. and Dowd, J. B. (2014). Discovering how 
environmental exposures alter genes and could lead to new treatments for 
chronic illnesses. 30, 1–9. 
Ong, C. and Corces, V. (2011). Enhancer function: new insights into the 
regulation of tissue-specific gene expression. Nat. Rev. Genet. 12, 283–93. 
Ortega, L. M., Sedki, E. and Nayer, A. (2015). Hypertension in the African 
American population#: A succinct look at its epidemiology , pathogenesis , and 
therapy. Nefrol. (English Ed. 35, 139–145. 
Paek, K. Y., Hong, K. Y., Ryu, I., Park, S. M., Keum, S. J., Kwon, O. S. and 
Jang, S. K. (2015). Translation initiation mediated by RNA looping. Proc. 
Natl. Acad. Sci. 112, 201416883. 
Park, W., Hwang, C., Kang, M., Seo, J. Y., Chung, J. H., Kim, Y. S., Lee, J., 
Kim, H., Kim, K., Yoo, H., et al. (2001). Gene Profile of Replicative 
Senescence Is Different from Progeria or Elderly Donor. 939, 934–939. 
Patikoglou, G. A., Kim, J. L., Sun, L., Yang, S., Kodadek, T. and Burley, S. K. 
(1999). TATA element recognition by the TATA box-binding protein has 
been conserved throughout evolution. 3217–3230. 
Paz, I., Akerman, M., Dror, I., Kosti, I. and Mandel-gutfreund, Y. (2010). 




binding sites. Nucleic Acids Res. 38, 281–285. 
Pennacchio, L. A., Bickmore, W., Dean, A. and Nobrega, M. A. (2013). 
Enhancers#: five essential questions. Nat. Publ. Gr. 14, 288–295. 
Petretto, E., Mangion, J., Dickens, N. J., Cook, S. A., Kumaran, M. K., Lu, H., 
Fischer, J., Maatz, H., Kren, V., Pravenec, M., et al. (2006). Heritability 
and Tissue Specificity of Expression Quantitative Trait Loci. Plos 2,. 
Pickrell, J. K., Pai, A. A., Gilad, Y. and Pritchard, J. K. (2010). Noisy Splicing 
Drives mRNA Isoform Diversity in Human Cells. PLoS Genet. 6,. 
Pinto, E. (2007). Blood pressure and ageing. 
Piva, F., Giulietti, M., Nocchi, L. and Principato, G. (2018). SpliceAid#: a 
database of experimental RNA target motifs bound by splicing proteins in 
humans. Bioinformatics 25, 1211–1213. 
Portales-casamar, E., Thongjuea, S., Kwon, A. T., Arenillas, D., Zhao, X., 
Valen, E., Yusuf, D., Lenhard, B., Wasserman, W. W. and Sandelin, A. 
(2010). JASPAR 2010#: the greatly expanded open-access database of 
transcription factor binding profiles. Nucleic Acids Res 38, 105–110. 
Pradeepa, M. M., Sutherland, H. G., Ule, J., Grimes, G. R. and Bickmore, W. 
A. (2012). Psip1/Ledgf p52 binds methylated histone H3K36 and splicing 
factors and contributes to the regulation of alternative splicing. PLoS Genet. 8, 
e1002717. 
Prediction as a candidate for learning deep hierarchical models of data. 
Prince, P. R., Emond, M. J. and Monnat, R. J. (2001). Loss of Werner syndrome 




Qin, Q. and Feng, J. (2017). Imputation for transcription factor binding 
predictions based on deep learning. 1–20. 
Rada-Iglesias, A., Bajpai, R., Swigut, T., Brugmann, S. A., Flynn, R. A. and 
Wysocka, J. (2011). A unique chromatin signature uncovers early 
developmental enhancers in humans. Nature 470, 279–83. 
Rantalainen, M., Lindgren, C. M. and Holmes, C. C. (2015). Robust Linear 
Models for Cis-eQTL Analysis. PLoS One 1–16. 
Ray, D., Kazan, H., Cook, K. B., Weirauch, M. T., Najafabadi, H. S., Li, X., 
Gueroussov, S., Albu, M., Zheng, H., Yang, A., et al. (2013). A 
compendium of RNA-binding motifs for decoding gene regulation. Nature 
499, 172–177. 
Reiter, F., Wienerroither, S. and Stark, A. (2017). Combinatorial function of 
transcription factors and cofactors. Curr. Opin. Genet. Dev. 43, 73–81. 
Renz, H., Autenrieth, I. B., Brandtzæg, P. and Cookson, W. O. Gene-
environment interaction in chronic disease#: A European Science Foundation 
Forward Look. J. Allergy Clin. Immunol. 128, S27–S49. 
Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., 
Bilenky, M., Yen, A., Heravi-moussavi, A., Kheradpour, P., Zhang, Z., 
Wang, J., et al. (2015). Integrative analysis of 111 reference human 
epigenomes. Nature 317–330. 
Rodriguez, S., Coppedè, F., Sagelius, H. and Eriksson, M. (2009). Increased 
expression of the Hutchinson-Gilford progeria syndrome truncated lamin A 




Rouillard, A. D., Gundersen, G. W., Fernandez, N. F., Wang, Z., Monteiro, C. 
D., McDermott, M. G. and Ma’ayan, A. (2016). The harmonizome: a 
collection of processed datasets gathered to serve and mine knowledge about 
genes and proteins. Database (Oxford). 2016, 1–16. 
Rueda, D., Lamichhane, R., Auweter, S. D., Manatchal, C., Austin, K. S., 
Valniuk, O. and Allain, F. (2009). Evidence of RNA looping by PTB using 
Fluorescence Resonance Energy Transfer and NMR spectroscopy. 
&lt;I&gt;The FASEB Journal&lt;/I&gt; 23,. 
Salekin, S., Zhang, J. M. and Huang, Y. (2017). A deep learning model for 
predicting transcription factor binding location at Single Nucleotide 
Resolution. 57–60. 
Sarda, S. and Hannenhalli, S. (2014). Next-Generation Sequencing and 
Epigenomics Research: A Hammer in Search of Nails. 12, 2–11. 
Schor, I. E., Gómez Acuña, L. I. and Kornblihtt, A. R. (2013). Coupling 
between transcription and alternative splicing. Cancer Treat. Res. 158, 1–24. 
Schwartz, S., Meshorer, E. and Ast, G. (2009). Chromatin organization marks 
exon-intron structure. Nat. Struct. Mol. Biol. 16, 990–995. 
Shabalin, A. A. (2012). Matrix eQTL#: ultra fast eQTL analysis via large matrix 
operations. Bioinformatics 28, 1353–1358. 
Shen, S., Wang, Y., Wang, C., Wu, Y. N. and Xing, Y. (2016). SURVIV for 
survival analysis of mRNA isoform variation. Nat. Commun. 7, 11548. 
Shi, W., Fornes, O., Mathelier, A. and Wasserman, W. W. (2016). Evaluating 




Nucleic Acids Res. 44, 10106–10116. 
Shindo, Y., Nozaki, T., Saito, R. and Tomita, M. (2013). Computational analysis 
of associations between alternative splicing and histone modifications. FEBS 
Lett. 587, 516–21. 
Shukla, S., Kavak, E., Gregory, M., Imashimizu, M., Shutinoski, B. and 
Kashlev, M. (2011). CTCF-promoted RNA polymerase II pausing links DNA 
methylation to splicing. Nature 479, 74–79. 
Shumaker, D. K., Dechat, T., Kohlmaier, A., Adam, S. A., Bozovsky, M. R., 
Erdos, M. R., Eriksson, M., Goldman, A. E., Khuon, S., Collins, F. S., et 
al. (2006). Mutant nuclear lamin A leads to progressive alterations of 
epigenetic control in premature aging. Proc. Natl. Acad. Sci. U. S. A. 21, 21–
26. 
Simino, J., Shi, G., Bis, J. C., Chasman, D. I., Ehret, G. B., Lyytika, L., Nolte, 
I. M., Sim, X., Dehghan, A., Eiriksdottir, G., et al. (2014). Gene-Age 
Interactions in Blood Pressure Regulation#: A Large-Scale Investigation with 
the CHARGE , Global BPgen , and ICBP Consortia. Am. J. Hum. Genet. 24–
38. 
Sinclair, D., North, B., Editors, G., North, B. J. and Sinclair, D. A. (2012). The 
Intersection Between Aging and Cardiovascular Disease. 2115, 1097–1108. 
Sofer, T., Wong, Q., Hartwig, F. P., Taylor, K., Warren, H. R., Evangelou, E., 
Cabrera, C. P., Levy, D., Kramer, H., Lange, L. A., et al. (2017). Genome-
Wide Association Study of Blood Pressure Traits by Hispanic / Latino 




Somech, R., Shaklai, S., Geller, O., Amariglio, N., Simon, A. J., Rechavi, G. 
and Gal-yam, E. N. (2005). The nuclear-envelope protein and transcriptional 
repressor LAP2 ␤ interacts with HDAC3 at the nuclear periphery , and 
induces histone H4 deacetylation. J. Cell Sci. 2, 4017–4025. 
Spellman, R. and Smith, C. W. J. (2006). Novel modes of splicing repression by 
PTB. Trends Biochem. Sci. 31, 73–76. 
Spike, B. T. and Wahl, G. M. (2011). p53, Stem Cells, and Reprogramming: 
Tumor Suppression beyond Guarding the Genome. Genes Cancer 2, 404–19. 
Spring, C. A network-based analysis of colon cancer splicing changes reveals a 
tumorigenesis-favoring regulatory pathway emanating from ELK1. 
Srivastava, N., Hinton, G., Krizhevsky, A., Sutskever, I. and Salakhutdinov, R. 
(2014). Dropout: a simple way to prevent neural networks from overfitting. J. 
Mach. Learn. Res. 15, 1929–1958. 
Steger, D. J. and Workman, J. L. (1996). Remodeling chromatin structures for 
transcription: What happens to the histones? BioEssays 875–84. 
Stegle, O., Parts, L., Piipari, M., Winn, J. and Durbin, R. (2012). Using 
probabilistic estimation of expression residuals (PEER) to obtain increased 
power and interpretability of gene expression analyses. Nat. Protoc. 7, 500–7. 
Stork, C. and Zheng, S. (2017). Genome-Wide Profiling of RNA–Protein 
Interactions Using CLIP-Seq. Methods Mol. Biol. 137–151. 
Stormo, D. and Schneider, T. D. (1982). Use of the “Perceptron” algorithm to 
distinguish translational initiation sites in E. coli. 10, 2997–3011. 




Ingle, C. E., Dunning, M., Flicek, P., Koller, D., et al. (2007). Population 
genomics of human gene expression. Nat. Genet. 39, 1217–1224. 
Streuli, M. and Saito, H. (1989). Regulation of tissue-specific alternative splicing: 
exon-specific cis-elements govern the splicing of leukocyte common antigen 
pre-mRNA. 8, 787–796. 
Sug, S., Yoon, S., Ph, D., Fryar, C. D. and Carroll, M. D. (2015). Hypertension 
Prevalence and Control Among Adults#: United States, 2011-2014. 2011–
2014. 
Supek, F., Bošnjak, M., Škunca, N. and Šmuc, T. (2011). Revigo summarizes 
and visualizes long lists of gene ontology terms. PLoS One 6,. 
Sveen, A., Kilpinen, S., Ruusulehto, A., Lothe, R. A. and Skotheim, R. I. 
(2015). Aberrant RNA splicing in cancer#; expression changes and driver 
mutations of splicing factor genes. Oncogene 35, 2413–2427. 
The ENCODE Project Consortium (2012). An Integrated Encyclopedia of DNA 
Elements in the Human Genome. 489, 57–74. 
The UK Biobank Cardio-metabolic Traits Consortium Blood Pressure 
Working Group, Warren, H. R. and Al, E. E. et (2018). Genome-wide 
association analysis identifies novel blood pressure loci and offers biological 
insights into cardiovascular risk. 49, 403–415. 
Thomas, B. J., Rubio, E. D., Krumm, N., Broin, P. O., Bomsztyk, K., Welcsh, 
P., Greally, J. M., Golden, A. A. and Krumm, A. (2011). Allele-specific 
transcriptional elongation regulates monoallelic expression of the IGF2BP1 




Todeschini, A., Georges, A. and Veitia, R. A. (2014). Transcription factors#: 
specific DNA binding and specific gene regulation. Trends Genet. 30, 211–
219. 
Tollervey, J. R., Wang, Z., Hortobágyi, T., Witten, J. T., Zarnack, K., Kayikci, 
M., Clark, T. A., Schweitzer, A. C., Rot, G., Curk, T., et al. (2011a). 
Analysis of alternative splicing associated with aging and neurodegeneration 
in the human brain. Genome Res. 21, 1572–1582. 
Tollervey, J. R., Wang, Z., Hortobágyi, T., Witten, J. T., Zarnack, K., Kayikci, 
M., Clark, T. A., Schweitzer, A. C., Rot, G., Curk, T., et al. (2011b). 
Analysis of alternative splicing associated with aging and neurodegeneration 
in the human brain. Genome Res. 21, 1572–82. 
Tomlinson, I. P. M., Carvajal-carmona, L. G., Dobbins, S. E., Tenesa, A., 
Jones, A. M., Howarth, K., Palles, C., Broderick, P., Jaeger, E. E. M., 
Farrington, S., et al. Multiple Common Susceptibility Variants near BMP 
Pathway Loci GREM1 , BMP4 , and BMP2 Explain Part of the Missing 
Heritability of Colorectal Cancer. PLoS Genet. 7, 2–12. 
Tomovic, A. and Ã, E. J. O. (2007). Sequence analysis Position dependencies in 
transcription factor binding sites. 23, 933–941. 
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, 
H., Salzberg, S. L., Rinn, J. L. and Pachter, L. (2012). Differential gene and 
transcript expression analysis of RNA-seq experiments with TopHat and 
Cufflinks. Nat. Protoc. 7, 562–78. 




lipodystrophy do not lead to an accumulation of prelamin A. Nucleus 7, 512–
521. 
Tullet, J. M. A., Hertweck, M., An, J. H., Baker, J., Yun, J., Liu, S., Oliveira, 
R. P., Baumeister, R., Blackwell, T. K. and Hwang, J. Y. (2008). Direct 
inhibition of the longevity promoting factor SKN-1 by insulin-like signaling in 
C. elegans. Cell 132, 1025–1038. 
Visscher, P. M., Wray, N. R., Zhang, Q., Sklar, P., Mccarthy, M. I., Brown, M. 
A. and Yang, J. (2017). 10 Years of GWAS Discovery#: Biology , Function , 
and Translation. Am. J. Hum. Genet. 101, 5–22. 
Wahl, M. C., Will, C. L. and Lührmann, R. (2009). The Spliceosome: Design 
Principles of a Dynamic RNP Machine. Cell 136, 701–718. 
Wain, L. V, Vaez, A., Jansen, R., Joehanes, R., Most, P. J. Van Der, 
Erzurumluoglu, A. M., Reilly, P. O., Cabrera, C. P., Warren, H. R., Rose, 
L. M., et al. (2017). Novel Blood Pressure Locus and Gene Discovery Using 
Genome-Wide Association Study and Expression Data Sets From Blood and 
the Kidney. 
Wallace, D. C. (2005). A mitochondrial paradigm of metabolic and degenerative 
diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. 
Genet. 39, 359–407. 
Wang, Z. and Burge, C. B. (2008). Splicing regulation: from a parts list of 
regulatory elements to an integrated splicing code. RNA 14, 802–13. 
Wang, G.-S. and Cooper, T. A. (2007a). Splicing in disease: disruption of the 




Wang, G.-S. and Cooper, T. A. (2007b). Splicing in disease: disruption of the 
splicing code and the decoding machinery. Nat. Rev. Genet. 8, 749–61. 
Wang, E. T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., 
Kingsmore, S. F., Schroth, G. P. and Burge, C. B. (2008). Alternative 
isoform regulation in human tissue transcriptomes. Nature 456, 470–6. 
Wang, H., Burnett, T., Kono, S., Haiman, C. A., Iwasaki, M., Wilkens, L. R., 
Loo, L. W. M., Berg, D. Van Den, Kolonel, L. N., Henderson, B. E., et al. 
(2014a). Trans-ethnic genome-wide association study of colorectal cancer 
identifies a new susceptibility locus in VTI1A. Nat. Commun. 1–7. 
Wang, K., Das, A., Xiong, Z., Cao, K. and Hannenhalli, S. (2014b). Phenotype-
dependent coexpression gene clusters: application to normal and premature 
ageing. IEEE/ACM Trans. Comput. Biol. Bioinforma. 1–1. 
Wang, K., Cao, K. and Hannenhalli, S. (2015). Chromatin and Genomic 
determinants of alternative splicing. In ACM-BCB, pp. 345–354. 
Wang, K., Cao, K. and Hannenhalli, S. (2017). Chromatin and Genomic 
determinants of alternative splicing. 345–354. 
Wang, K., Wu, D., Zhang, H., Das, A., Basu, M., Malin, J., Cao, K. and 
Hannenhalli, S. (2018). Comprehensive map of age-associated splicing 
changes across human tissues and their contributions to age-associated 
diseases. Sci. Rep. 8, 10929. 
Watson, I. R., Takahashi, K., Futreal, P. A. and Chin, L. (2013). Emerging 
patterns of somatic mutations in cancer. Nat. Rev. Genet. 14, 703–18. 




BBA - Mol. Basis Dis. 1842, 1896–1902. 
Whitaker, J. W., Chen, Z. and Wang, W. (2014). Predicting the human 
epigenome from DNA motifs. Nat. Methods 12, 265–272. 
Will, C. L. and Lührmann, R. (2011). Spliceosome structure and function. Cold 
Spring Harb. Perspect. Biol. 3,. 
Wilson, K. L. and Foisner, R. (2010). Lamin-binding Proteins. Cold Spring Harb. 
Perspect. Biol. 1–17. 
Wingender, E., Dietze, P., Karas, H. and Knüppel, R. (1996). TRANSFAC#: a 
database on transcription factors and their DNA binding sites. Nucleic Acids 
Res 24, 238–241. 
Wyss-coray, T. (2015). Ageing, neurodegeneration and brain rejuvenation. 
Xiong, H. Y., Barash, Y. and Frey, B. J. (2011). Bayesian prediction of tissue-
regulated splicing using RNA sequence and cellular context. Bioinformatics 
27, 2554–62. 
Xu, Q., Modrek, B. and Lee, C. (2002). Genome-wide detection of tissue-specific 
alternative splicing in the human transcriptome. Nucleic Acids Res. 30, 3754–
66. 
Yang, C., Bolotin, E., Jiang, T., Sladek, F. M. and Martinez, E. (2007). 
Prevalence of the Initiator over the TATA box in human and yeast genes and 
identification of DNA motifs enriched in human TATA-less core promoters. 
389, 52–65. 
Yang, J., Huang, T., Petralia, F., Long, Q., Zhang, B., Argmann, C., Zhao, Y., 




gene expression changes across multiple tissues in human and the link to 
complex diseases. Sci. Rep. 5, 15145. 
Yao, C., Joehanes, R., Johnson, A. D., Huan, T., Ying, S., Freedman, J. E., 
Murabito, J., Lunetta, K. L., Metspalu, A., Munson, P. J., et al. (2014). 
Sex- and age-interacting eQTLs in human complex diseases. Hum. Mol. 
Genet. 23, 1947–1956. 
Yeo, G. and Burge, C. B. (2004). Maximum Entropy Modeling of Short Sequence 
Motifs with Applications to RNA Splicing Signals. J. Comput. Biol. 11, 377–
394. 
Yeo, G., Hoon, S., Venkatesh, B. and Burge, C. B. (2004). Variation in sequence 
and organization of splicing regulatory elements in vertebrate genes. Proc. 
Natl. Acad. Sci. U. S. A. 101, 15700–5. 
Yi, W., Clark, P. M., Mason, D. E., Keenan, M. C., Hill, C., Goddard, W. A., 
Peters, E. C., Driggers, E. M. and Hsieh-Wilson, L. C. (2012). PFK1 
Glycosylation Is a Key Regulator of Cancer Cell Growth and Central 
Metabolic Pathways. Science 337, 975–980. 
Yin, Y., Morgunova, E., Jolma, A., Kaasinen, E., Sahu, B., Khund-sayeed, S., 
Das, P. K., Kivioja, T., Dave, K., Zhong, F., et al. (2017). Impact of cytosine 
methylation on DNA binding specificities of human transcription factors. 
2239,. 
Yu, X., Lin, J., Zack, D. J. and Qian, J. (2006). Computational analysis of tissue-
specific combinatorial gene regulation: Predicting interaction between 




Zentner, G. E. and Scacheri, P. C. (2012). The Chromatin Fingerprint of Gene 
Enhancer Elements. 287, 30888–30896. 
Zhang, C., Zhang, Z., Castle, J., Sun, S., Johnson, J., Krainer, A. R. and 
Zhang, M. Q. (2008a). Defining the regulatory network of the tissue-specific 
splicing factors. 2550–2563. 
Zhang, W., Duan, S., Kistner, E. O., Bleibel, W. K., Huang, R. S., Clark, T. A., 
Chen, T. X., Schweitzer, A. C., Blume, J. E., Cox, N. J., et al. (2008b). 
Evaluation of Genetic Variation Contributing to Differences in Gene 
Expression between Populations. Am. J. Hum. Genet. 631–640. 
Zhao, K., Lu, Z., Park, J. W., Zhou, Q. and Xing, Y. (2013). GLiMMPS: robust 
statistical model for regulatory variation of alternative splicing using RNA-seq 
data. Genome Biol. 14, R74. 
Zhou, Y., Lu, Y. and Tian, W. (2012). Epigenetic features are significantly 
associated with alternative splicing. BMC Genomics 13, 123. 
Zhou, H.-L., Luo, G., Wise, J. A. and Lou, H. (2014). Regulation of alternative 
splicing by local histone modifications: potential roles for RNA-guided 
mechanisms. Nucleic Acids Res. 42, 701–13. 
Zhu, S., Wang, G., Liu, B. and Wang, Y. (2013). Modeling exon expression 
using histone modifications. PLoS One 8, e67448. 
Zhu, H., Wang, G., Qian, J., Sciences, M., Miller, E., Kimmel, S., Cancer, C. 
and Building, T. S. (2017). Transcription factors as readers and effectors of 





BIOLOGICAL SCIENCES GRADUATE PROGRAM 
Dr. Steve Fetter 
Dean of the Graduate School 
The Graduate School 
2123 Lee Building  
University of Maryland  
College Park, MD 20742 
Dear Dean Fetter, 
This letter is written to signify that the dissertation committee, committee chair, and the graduate 
director have all approved the use of previously published co-authored work in the final 
dissertation of Kun Wang, Biological Sciences, UID 112530525.  
Citations for the published work(s): 
1. Kun Wang, Di Wu, Haoyue Zhang, Avinash Das, Kan Cao, Sridhar Hannenhalli. Comprehensive
map of age-associated splicing changes across human tissues and their contributions to age-
associated diseases. Scientific Reports 2018 
2. Kun Wang, Kan Cao, and Sridhar Hannenhalli. Chromatin and Genomic determinants of
alternative splicing. Proceedings of ACM Conference on Bioinformatics, Computational 
Biology and Biomedicine (ACM BCB), Atlanta, 2015 
3. Kun Wang, Avinas Das, Zheng-Mei Xiong, Kan Cao and Sridhar Hannenhalli. Phenotype-
dependent coexpression gene clusters: application to normal and premature ageing. IEEE 
Transactions on Computational Biology and Bioinformatics(TCBB) (doi: 
TCBB.2014.2359446), 2014 
4. Kun Wang, A. Das, Z. Xiong, K. Cao, S. Hannenhalli. Identification of gene clusters with
phenotype-dependent expression with application to normal and premature ageing. 
Proceedings of ACM Conference on Bioinformatics, Computational Biology and 
Biomedicine (ACM BCB),Washington DC, 2013 
In accordance with the Graduate School's policy the dissertation committee has determined that 
they made substantial contributions to the included work. 
Per Graduate School policy the dissertation foreword will identify the scope and nature of the 

